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1Preface
Nanotechnology will be one of  the key technological drivers in building 
an innovation European Union (EU) based on smart, sustainable and inclusive 
growth. Nanotechnology has also been identified as the key-enabling tech nology 
(KET) for the EU. Nanotechnology has rapidly promoted the development a 
new generation of  smart and innovative products and processes that are nano-
enabled, and have created a tremendous growth potential for a large number of  
industry sectors. It is important that this development continues so that all the 
useful properties of  engineered nanomaterials (ENM) can be fully utilized in a 
number of  nanotechnology applications.
The marked benefits brought about by ENM and nanotechnology appli-
cations have also created some concerns of  their possible effects on human health 
and safety and environmental burden. A few observations on some potent ially 
harmful effects of  ENM have in some cases overshadowed the dramatic benefits 
of  these materials and their nanotechnology applications. However, the real 
concern, rather than observations on some hazards of  exposure to ENM, is the 
lack of  systematic studies on hazards of  or exposure to ENM. Hence, the true 
importance of  this document is the identification of  the knowledge gaps related 
to ENM safety, and directing the future research on ENM to enable the alle-
viation of  the uncertainty, the real source of  potential concerns associated with 
ENM and nanotechnology. 
This document on the strategic priorities of  nanosafety research during 
2015-2025 has been produced as a joint effort of  the European NanoSafety 
Cluster, a forum incorporating FP6 and FP7 funded nanosafety research pro-
jects. It also includes several nanosafety research projects, that have been funded 
by different EU Member States It identifies four major areas of  research would 
greatly benefit our current understanding of  ENM features, exposure to them, 
hazard mechanisms of  ENM, as well as their risk assessment and management. 
Hence, the strategic vision on the future directions of  European nanosafety re-
search presented in this document may have a major impact on the future nano-
safety research within and outside the European Union, and consequently, on 
the success of  nanotechnologies.
Kai Savolainen, Coordinator, NanoSafety Cluster Director, 
Nanosafety Research Center, 
Finnish Institute of  Occupational Health, Helsinki, Finland
Helsinki, June 4, 2013

3Executive  
summary
Nanotechnology has been identified as one of  the key enabling technolo-
gies (KET) in Horizon 2020 thus underlining the significance of  this field for 
Europe’s competitiveness and its ability to provide the innovative goods and 
services essential for meeting global challenges. In particular, nanotechnology 
offers substantial possibilities for improving the competitive position of  the EU 
and for responding to key societal challenges. Ensuring the safe and sustainable 
development and application of  the nanotechnologies is thus a key objective.
The aim of  this document entitled “Nanosafety in Europe 2015-2025: 
Towards Safe and Sustainable Nanomaterials and NanotechnologInnovation” 
(Strategic Research Agenda; SRA) is to introduce a strategic vision for future 
research on the safe use and safe applications of  engineered nanomaterials 
(ENM). The time horizon for this document is 2015-2025. The SRA has been 
developed by members of  the European NanoSafety Cluster, a forum for ongo-
ing FP6 and FP7 projects covering all aspects of  nanosafety. The implementa-
tion of  the SRA is expected to provide a major step forward in the development 
of  safe and sustainable nanomaterials.
The goals of  this document are to describe the current level of  knowledge 
of  the safety of  nanomaterials and nanotechnologies, to identify knowledge 
gaps, and to set out concrete goals for the research on safety of  ENM within 
the foreseeable future. In addition, an overview of  the nanosafety landscape 
is provided. Nanosafety is seen as an integral part of  the development of  any 
novel nanotechnology or product; a multi-disciplinary and multi-stakeholder 
approach is needed to promote a culture of  nanosafety in Europe and beyond. 
Key challenges today are that available tools for the assessment of  the 
safety of  ENM are often inappropriate, or so laborious that adequate safety 
assessment remains highly problematic. Current resources or test methods are 
not likely to enable safety assessment of  the numerous novel nanomaterials that 
are emerging at an ever increasing pace. This means that new safety assessment 
paradigms need to be developed during coming years to solve this problem. 
At the same time it is important to support regulators and the nanotechnology 
industry so that prosperity is maintained and current products are made safe for 
Executive summary 
4
citizens in Europe and elsewhere. This situation calls for rapid identification of  
research priorities and of  a roadmap for nanosafety; we cannot afford to wait. 
Several cross-cutting issues that need to be addressed in order to promote 
growth of  the nanotechnology industry are identified in this document. These 
cross-cutting issues include: 1) the regulatory framework for ENM and nano-
technologies, coupled to the important issue of  standardization to promote 
good practice and to facilitate communication; 2) the innovation/value chain 
for environmental health and safety and innovation and means to ‘unblock’ the 
value chain; 3) the development of  infrastructures for nanosafety to promote re-
search, education, and innovation; and 4) international collaboration and global 
dialogue, with a view towards a global research area in nanosafety, along with 5) 
communication and dissemination of  research to key stakeholders beyond the 
research community, including industry, regulatory bodies, and others.
In addition, the SRA describes the current status and the research needs 
and priorities for the coming 10 years in four main thematic areas: 1) nanomate-
rial identification and classification; 2) nanomaterial exposure and transforma-
tion; 3) hazard mechanisms related to effects on human health and the environ-
ment; and 4) tools for the predictive risk assessment and management including 
databases and ontologies. The SRA concludes with a set of  research priorities 
that are required in order to reach the goals of  the roadmap. Ultimately, the suc-
cessful and timely implementation of  this roadmap – which is subject to further 
refinements as new research priorities emerge - will lead to the development 
of  a nanoEHS (Environment, Health and Safety) tool box for exposure assess-
ment, for hazard prediction, and for risk assessment and prediction as well as 
management that will allow the sustainable implementation of  nanotechnolo-
gies. As an “enabling technology”, nanotechnology is applied early on and is a 
key element in the innovation/value chain. There is tremendous potential for 
nanotechnology to provide answers to societal solutions and it is therefore of  
critical importance to incorporate nanosafety into the development of  novel 
nanotechnologies and products – safety before design. 
5Strategic  
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Engineered nanomaterials promise 
remarkable benefits but their  
successful use requires resolution of  
potential health concerns
The aim of  this document is to provide a strategic vision for future research 
to promote the safe use and applications of  engineered nanomaterials (ENM). 
This goal takes on ever-increasing importance of  this goal in respect of  the rap-
id expansion in the production of  ENM and products incorporating these ma-
terials. This development will lead ultimately to mass production of  a number 
of  engineered nanomaterials, and this will inevitably increase the exposure not 
only of  workers but also of  consumers to these novel materials. This develop-
ment has also triggered increasing societal and public debate about the safety of  
ENM and associated technologies. These emphasize the importance of  setting 
priorities and goals on research of  safety of  ENM, thereby minimizing the un-
certainties around the safety and health issues surrounding these materials and 
nanotechnologies. Hence, the goal of  this document is also to describe the cur-
rent level of  knowledge about the safety of  ENM and technologies, to identify 
knowledge gaps, and set out goals for the research on safety of  ENM. Identify-
ing research priorities is essential if  one wishes to achieve a set of  concrete goals 
accompanied by time-lines and milestones with which to follow of  the progress 
of  the research efforts. In addition, the background and the current research 
landscape need to be surveyed. The time horizon set in this document is 2015 
- 2025, from the start of  the first research project funded by the “EU Horizon 
2020” Framework funding programme for research and innovation, until the 
termination of  the last project funded from that same programme. 
Strategic Research Agenda compact
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Engineered nanomaterials and quality of  life  
in Europe
The European Commission has recently (2011) adopted a recommendation on 
the definition of  nanomaterial according to which ‘nanomaterial’ means a natural, 
incidental or manufactured material containing particles, in an unbound state or as an aggregate 
or as an agglomerate and where, for 50 % or more of  the particles in the number size distribu-
tion, one or more external dimensions is in the size range 1 nm-100 nm. In specific cases and 
where warranted by concerns for the environment, health, safety or competitiveness the number 
size distribution threshold of  50 % may be replaced by a threshold between 1 and 
50 %. This definition is part of  the regulatory environment in which also this 
document has to be operational. 
The potential of  ENM and nanotechnologies to improve the quality of  
life and to contribute to economic growth and competitiveness of  industry is 
now widely recognized. Nanotechnologies can enable remarkable technologi-
cal advances and innovations in many industrial sectors. However, there is an 
ongoing debate about the potential risks of  ENM and nanotechnologies. In this 
context, it is important to consider that research and innovation have been iden-
tified as the key drivers of  European social and economic prosperity. Nanosafety 
research is in a key-position to solve any challenges related to the concerns of  
ENM health or environmental effects and causing challenges to the promotion 
of  these technologies.
Engineered nanomaterials, nanotechnology indus-
try and safety
Competitiveness of  the European industry lies at the heart of  achieving these 
goals, and hence the role of  innovations and the accelerated pace of  the com-
mercialization of  innovations have been recognized as being fundamental in 
this respect. The recent Communication from the Commission on Horizon 
2020 - The Programme for Research and Innovation emphasizes the impor-
tance of  research and innovation for society at large. These considerations infer 
that there will be major changes in the future European research landscape and 
funding opportunities and all interested parties will need to adapt and prepare 
to meet these challenges. The new Programme for Research and Innovation, 
Horizon 2020 places a major emphasis on securing a strong position on key ena-
bling technologies (KET) including nanotechnology and hence on engineered 
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nanomaterials. In particular, nanotechnology offers substantial possibilities for 
improving the competitive position of  the EU and for responding to key societal 
challenges. Ensuring the safe development and application of  nanotechnologies 
has been included in the broad line of  activities of  the Horizon 2020 proposal. 
The new technology applications not only should be safe themselves but should 
also offer substantial improvements to human health and environment protec-
tion while still remaining competitive. Due to the rapidly increasing production 
and use of  ENM and utilization of  nanotechnologies, it is self-evident that safety 
aspects must be fully understood and addressed. 
Key-issues of  a strategy document aiming at achiev-
ing an impact 
The key elements of  the strategy include the following:
1. Description of  the current state of  knowledge, the existing research 
 landscape and identification of  the requirements of  the research 
 environments and infrastructures essential for the promotion of  
 research on safe ENM and nanotechnologies.
2. Identification of  societal needs for the regulation of  safety of  these 
 materials and technologies.
3. Identification of  the necessary research goals for fulfilling of  the societal 
 needs and setting a time-line with milestones for the follow-up of  the 
 research progress.
4. Identification of  the research priorities that will allow reaching the goals 
 within the time-limit set by the strategy.
5. Identification of  the means by which the results of  the research can be 
 disseminated, implemented and exploited to evoke a change in ways 
 that will industry to promote the safe use of  ENM and to guarantee the 
 safety of  workers and consumers, enabling regulators to make educated 
 regulatory decisions.
6. Identification of  the needs for further possible regulatory actions and 
 possible further investments into infrastructures, educational and 
 funding programs to be able to fully capitalize on the technological and 
 economic benefits of  these materials and technologies.
Strategic Research Agenda compact
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Towards a new toxicology for the 
21st Century 
Nanotechnology is hailed as one of  the enabling technologies to innovation. 
Nanosafety, in turn, is concerned with the safe and sustainable development 
of  nanotechnology. Without nanosafety research, widespread use of  nanotech-
nologies in many sectors of  society may well be slowed down and could even 
come to a complete stand still. 
It is important to understand that we are still dealing with first generation 
of  nano-enabled products (i.e. passive nanostructures) but it is likely that we will 
soon be confronted by the second generation products containing active nano-
structures, and then to third generation systems of  integrated nano-systems and, 
finally, by the year 2020 according to some predictions, to fourth generation 
products or heterogenous molecular nano-systems that allow the manufacture 
of  molecular devices ‘by design’. This means that methods for assessment of  the 
safety of  next generation nano-enabled products also must evolve: nanotechnol-
ogy is a moving target and researchers in the nanosafety field cannot afford to 
be aiming at a target that no longer exists.
Some challenges we are facing in the science of  nanosafety related to ex-
posure and hazard research have been resolved but others still remain. Those 
e.g. for nanotoxicology are not unique to this sub-speciality of  toxicology but 
there is an urgent need for a “new” toxicology; toxicology for the 21st century. 
A proposal for a new, systems biology / toxicology approach was put forward 
in a 2007 report by the US National Academy of  Sciences on behalf  of  the US 
Environmental Protection Agency (EPA). The overall aim was to promote a 
shift from toxicity testing primarily in animal models to in vitro assays and in vivo 
assays using lower model organisms, along with computational modeling, thus 
enabling the evolution of  toxicology from being an observational science into a 
predictive science. The central part of  this novel toxicology is to describe toxic-
ity pathways which lead to understanding the molecular fundamentals. It has 
also been argued that “the testing of  substances for adverse effects on humans 
and the environment needs a radical overhaul if  we are to meet the challenges 
of  ensuring health and safety.” In fact, it has been provocatively stated that 
“there is almost no other scientific field in which the core experimental protocols 
have remained nearly unchanged for more than 40 years” and that this will re-
quire that an entirely new system be urgently developed, even to the extent that 
it may need to be built from scratch, incorporating and benefitting from modern 
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methods and state-of-the-art technologies. It may be worthwhile noting that an 
evolving scientific discipline such as nanotoxicology is optimally positioned to 
take on board these new approaches. 
We still lack a fundamental understanding of  how nanomaterials interact 
with living systems and, thus, we are not yet in a position to assess the relevant 
end-points for nanomaterial toxicity. At the same time, we are faced with a tsu-
nami of  new materials for which testing or screening of  toxicity is required. To 
resolve this situation, innovative methods for prediction of  nanomaterial toxicity 
are needed. 
NanoSafety Cluster – coordination of  nanosafety 
research in Europe
The European NanoSafety Cluster is a DG RTD NMP CSA initiative to maxi-
mize the synergies between the existing FP6 and FP7 projects addressing all 
aspects of  nanosafety including materials, hazard, databases, modeling and dis-
semination (see figure below). Synergy among the various FP6 and FP7 projects 
on nanosafety and other national projects, collaboration for maximizing impact, 
policy elaboration, planning of  future actions, and international cooperation are 
the main aims of  the European NanoSafety Cluster. About fifty projects deal-
ing with nanosafety have either been completed or are running under FP6 and 
FP7. These projects, together with a significant number of  nationally supported 
projects, represent valuable efforts of  the scientific and industrial research com-
munity towards improving our understanding of  these complex interactions. 
Information on all current or recently completed projects is collected in the 
NanoSafety Cluster Compendium.
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Organization of the European Nanosafety Cluster
The main objectives of the European NanoSafety Cluster are to:
- facilitate the formation of a consensus on nanotoxicology in Europe
- provide a single voice for discussions with external bodies
- avoid duplicating work and to improve efficiency
- improve the coherence of nanotoxicology studies and harmonize methods
- provide a forum for discussion, problem solving and planning R&D 
 activities in Europe
- provide industrial stakeholders and the general public knowledge on 
 the risks of nanomaterials for human health and the environment
Synergy among the projects, collaboration for maximizing impact, and inter-
national cooperation are the main aims of the European NanoSafety Cluster.
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Nanosafety research requires good governance
The International Risk Governance Council (IRGC) is an independent or-
ganization based in Switzerland that is focused on developing the concept and 
practice of  risk governance. IRGC recently (2010) published a report on “The 
Emergence of  Risks: Contributing Factors” in which it is postulated that emerg-
ing risks arise from a “fertile ground” that is cultivated by twelve contributing 
factors of  which “scientific unknowns” is one factor (see figure below). It is noted 
that “communication” has a particularly key role, as it can influence all the 
other factors. 
Communication
Information
asymmetries
Perverse incentives
Malicious motives and acts
Scientic unknowns
Loss os safety margins Positive feedback
Varying susceptibilities to risk
Conicts about interests, 
values and science
Social dynamics
Technological advances
Temporal complications
Twelve common factors contributing to emerging risks.
The twelve factors should not be interpreted as discrete units but as complex, in-
terdependent factors. Moreover, the document proposes that the attribution of 
cause(s) to the emergence of risks should be examined via by both reductionist and 
holistic approaches. The latter “systems perspective” approach focuses on describ-
ing the system as a whole and not as the sum of its parts.
Three independent scientific committees provide the European Commis-
sion with the scientific advice it needs when preparing policy and proposals 
relating to consumer safety, public health and the environment. The committees 
also draw the European Commission’s attention to the new or emerging prob-
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lems which may pose an actual or potential threat. The three committees are: 
the Scientific Committee on Consumer Products (SCCP), the Scientific Com-
mittee on Health and Environmental Risks (SCHER) and the Scientific Com-
mittee on Emerging and Newly-Identified Health Risks (SCENIHR) and all are 
made up of  external experts. In addition, the European Commission relies on 
the work of  the European Food Safety Authority (EFSA), the European Medi-
cines Evaluation Agency (EMEA), the European Centre for Disease prevention 
and Control (ECDC) and the European Chemicals Agency (ECHA). SCENI-
HR published a report in 2007 on the appropriateness of  the current risk as-
sessment methodology for new and existing substances for assessing the risks of  
nanomaterials. The aim was to assess the “fitness for use” of  the risk assessment 
methodologies described in the chemicals legislation for the risk assessment of  
nanomaterials, and to provide proposals for improvements. EFSA published a 
guidance document for the risk assessment of  engineered nanomaterial applica-
tions in food and feed in 2011. That report is the first to give practical guidance 
for addressing potential risks arising from applications of  nanotechnologies in 
the food and feed chain. In addition, the European Chemicals Agency (ECHA) 
published extensive guidance on regulatory risk assessment of  nanomaterials 
under the European Community Regulation on chemicals and their safe use 
(REACH) in April 2012. This guidance documents are additional to the general 
guidance of  Information Requirement and Chemical Safety Assessment under 
REACH. 
Nanotechnology is a multi-disciplinary field involving the skills of  scientists 
in disciplines such as material science, physics, chemistry, biology, engineering, 
toxicology, clinical medicine, and social science. Similarly, nanosafety research 
also depends on close cooperation between material science, biology, and toxi-
cology and risk assessment. This should be taken into account in the education 
of  the next generation of  nanosafety experts. 
Positive environment for nanosafety 
research is crucial
If  one wishes that the industries producing ENM and products incorporating 
these materials, as well as industry sectors utilizing nanotechnologies are going 
to flourish, then we need to provide a favorable environment to allow these com-
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mercial entities to be able to take the necessary risks to bring these new innova-
tions into successful marketable products. Hence, if  one wants to promote the 
success of  these key-enabling technologies (KET) as identified by the European 
Union communication on the new Programme for Research and Innovation - 
Horizon 2020, favorable environments for this research have to be created to 
lay a foundation for such goals. One needs to address which are the major suc-
cess factors that enable flourishing nanotechnology industry. This document has 
identified several cross-cutting issues that are absolutely necessary for ensuring 
success.
Impact of  chemicals and occupational  
safety regulations 
Chemical safety regulation in the EU is a structure based on two pillars. The 
first pillar is the legal framework for placing chemicals on the market, and the 
second is created from specific provisions for health, consumer, occupational 
safety and environmental protection. The regulatory framework can strongly 
support safe use of  ENM provided that such goal will become a clear regulatory 
target.
i) According to the information given in the Communication “Regulatory 
 Aspects of  Nanomaterials” all nanoparticles in chemical substances 
 must meet the requirements of  the REACH (Registration, Evaluation 
 and Authorization of  Chemicals) (Regulation (EC). 
ii) General requirements in relation to occupational safety and health of  
 workers at workplaces are presented in the Council Directive 89/391/EC. 
 The aim of  this framework directive is to ensure a high level of  protection 
 of  workers at work. The Council Directive 98/24/EC on the protection 
 of  the health and safety of  workers from the risks related to chemical 
 agents at work describes the minimum requirements for the protection 
 of  workers from risks to their safety and health arising, or likely to arise, 
 from the effects of  chemical agents, including ENM, that are present at 
 the workplace.
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14
Infrastructure for nanosafety research is  
highly important
Promoting those infrastructures that support nanosafety research within the 
European Union is a prerequisite for the competitiveness of  European nano-
technology research, innovations and industries. This will require institutional 
support for organizations with permanent financial funding from their own gov-
ernments, i.e. to research institutes, universities or industrial research laborato-
ries.
According to the European Commission Capacities Programme, the term 
‘research infrastructures’ (RI) refers to facilities, resources and related services 
used by the scientific community to conduct state-of-the-art research in their re-
spective fields. Examples include singular large-scale research installations, col-
lections, special habitats, libraries, databases, biological archives, clean rooms, 
integrated arrays of  small research installations, high speed communication 
networks, data infrastructure, networks of  computing facilities, as well as infra-
structural competence centres which provide a service for the wider research 
community based on an assembly of  techniques and know-how. In short, the 
term research infrastructure means building, required research facilities and 
equipment, management structures of  such infrastructures, and competences 
which are required for successful implementation of  research – in this case of  
nanosafety research. The EU should provide opportunities to support these in-
frastructures and that may require adapting the current rules for funding.
Options for EU nanosafety infrastructure – a proposal for the future 
Considering the options that would most effectively enable setting up of  infra-
structures to conduct European Union-wide nanosafety research, one possibility 
would be a single-site highly equipped facility with capacities to serve other EU 
nanosafety research facilities in strategic research areas. These types of  invest-
ments could be situated in a stable organization with guaranteed fundamental 
resources into the foreseeable future, meaning that a long-range planning would 
be important. 
Another possibility would involve networking of  high-quality nanosafety 
research organizations, i.e. organizations with suitable space and laboratories, 
research equipment, human resources and competences, national stable l fund-
ing and existing administrative support in research organizations within Euro-
Strategic Research Agenda compact
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pean Union Member States. 
This latter option, which would be potentially realistic at the European 
Union level, could be executed in collaboration with the European Commis-
sion and the European Union Member States, and their existing nanosafety 
research organizations. All the parties should have a vested interest in support-
ing this activity. This endeavour could lead to the identification of  a network of  
competence centres, i.e. research centres capable of  meeting a series of  relevant 
quality requirements.
The establishment a European Union wide Virtual Competence Centre 
Network on nanosafety would allow a better integration of  European compe-
tences targeting nanosafety research. This type of  Virtual Centre based on a 
network of  separate organizations would also mean that one could envisage 
the establishment of  an EU NanoSafety Research Centre which would have a 
relatively light administrative structure e.g. One important benefit of  such an 
approach would be that the associated organizations would benefit from long-
term basic governmental funding from their own EU Member State that could 
be supplemented by EU research funding to promote the efficacy of  this kind 
of  joint undertaking. 
Innovation, value chain, and nanosafety research 
The EU Flagship Initiative ”Innovation Union” aims to improve framework 
conditions and access to finance for research and innovation in order to ensure 
that innovative ideas can be turned into products and services that create growth 
and jobs. The Flagship “An industrial policy for the globalisation era” aims to 
improve the business environment, notably for SMEs, and to support the devel-
opment of  a strong and sustainable industrial base able to compete globally. At 
the heart of  these activities is the concept that Europe will undergo an industrial 
transformation based on scientific and technological leadership and excellence.
Deployment of  nanotechnology is a major driver for the trend to improve 
existing products by creating smaller components and better (in both functional 
and environmentally-friendly terms) performance materials. Engineered nano-
materials (ENM) and the technologies which utilise ENM represent one critical 
pathway to achieve these goals.   
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Environmental Health and Safety (EHS): a barrier to innovation?
The current debate, including the lack of  regulatory clarity and, in particular, 
the uncertainty surrounding the potential risks of  ENM have had a negative 
effect on the development, uptake and exploitation of  ENM in the European 
domain and have been identified as a major barrier to innovation based on these 
technologies. This has limited the extent to which these materials have been 
exploited through the value chain. The result of  this phenomenon has been a 
failure to fully exploit the potential benefits associated with ENM throughout 
innovation chain in Europe. One shall, therefore, to overcome these barriers 
since this will make it possible to open up these value chains and realise their full 
economic potential. This goal can only be achieved through the development of  
a sound science-based foundation from which one can build a trustworthy and 
affordable safety framework.
The EHS programme of  NMP research is not currently well integrated 
into the innovation-led FP7 work. Although many of  the NMP projects have 
industrial partners, these projects are more fundamental in their nature and 
are concerned with achieving an underlying knowledge, models and tools for 
subsequent application in risk assessment and management. This activity is not 
only critical as a way to underpin the knowledge base, but it is also important 
that EHS research should be organized to make it more directly linked to the 
development of  new materials, processes or products. Appropriate solutions will 
help to alleviate public concerns that that neither their health nor their envi-
ronment will be harmed; this will be best achieved by clearly identifying those 
materials and applications for which there are absolutely no safety issues. This 
will dramatically open up the possibility of  widening the range of  ENM and 
applications, free from concerns about potential safety issues.
Communication and dissemination widely are  
required to assure impact of  nanosafety research 
Targeted, neutral and reliable communication by the different stakeholders as-
sociated with nanosafety can markedly enhance the acceptability of  safe and 
trustworthy ENM and associated technologies and to promote a new safety cul-
ture in nanotechnologies. Key-stakeholders include regulators, industry, various 
interests groups, representatives of  media and the public at large. Public confi-
dence in nanotechnology is crucially important if  these products are to achieve 
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commercial success. Successful dialogue, dissemination of  reliable information 
on nanosafety, and outreach to various stakeholder groups will all help in assur-
ing the general public and decision-makers that health and environment aspects 
are being taken into account. This will dramatically open up the possibilities of  
widening the range of  ENM and applications while still maintaining consumer 
confidence. Hence, these activities will support safe and confident exploitation 
of  ENMs in a wide range of  products and processes for the benefit of  Europe 
and its citizens, and being able to have a global impact. One of  the key stake-
holders could also be the Virtual European Nanosafety Research Centre, whose 
Coordinator could act as a hub of  wide-reaching and global efforts to distribute 
neutral and balanced and trustworthy information on ENM and nanotechnolo-
gies within the European setting and globally. 
International Collaboration – nanosafety research 
is a global issue 
International collaboration may provide a fruitful platform for having a larger 
impact and obtaining benefits in research as well as in aspects related to gov-
ernance and safety issues of  nanotechnology. In fact, large projects involving 
a set of  demanding multidisciplinary, hypothesis driven research endeavours 
require international collaboration because in most cases the required expertise 
or resources may not be available in any one single country. Furthermore, inter-
national collaboration has its merits also because ground-breaking innovations 
often take place in the interface or cross-roads of  different scientific disciplines 
and research environments.
The globalization of  research is proceeding rapidly and this is having sig-
nificant implications for the European nanosafety research landscape. The fo-
rums of  the production of  new scientific knowledge are shifting from national 
to international arenas and comparisons of  certain indicators across countries 
point to a positive relationship between measures of  research collaboration and 
overall scientific impact. 
International partnerships create unique opportunities for enhancing sci-
entific excellence, physical and intellectual research environments and innova-
tive training of  young scientists. It The European Commission’s Nanosciences 
and nanotechnologies Action plan for Europe 2005-2009 has called for atten-
tion to and action on issues of  mutual benefit at a global level such as nomencla-
ture, metrology, common approaches to risk assessment and the establishment 
Strategic Research Agenda compact
18
of  a dedicated database to share toxicological and ecotoxicological as well as 
epidemiological data. Progress has been achieved in many respects to identify 
the areas requiring joint efforts and the ways forward. 
However, EU or global level coordination is far from achieving the goals 
of  adopting international standards, nomenclature and databases, though im-
portant steps have been taken in that direction. Many obstacles or disincentives 
still exist, hampering collaboration across national borders and hindering the 
senior researchers or young talented investigators from working together. There 
is still a critical need to share knowledge in the health, safety and environmental 
aspects of  nanotechnology. 
 
Common nanosafety research needs 
This document identifies four major research areas briefly introduced below, 
and they include: 1) material identification and classification; 2) exposure and 
transformation; 3) hazard mechanisms including both human toxicology and 
ecotoxicology; and 4) risk prediction tools including databases and ontologies. 
Nanomaterial identification and classification
Most of  the definitions of  a nanomaterial concentrate solely on the size aspect 
(1-100nm), which misses the fact that nanomaterials are a very diverse group of  
materials with greatly varying properties. In order to enable prediction of  im-
pacts, a classification based on key parameters or biological interactions should 
be adopted.
The following approaches to group nanomaterials have been identified:
1. Classification by dimensionality / shape / morphology:
 Shape-based classification is related to defining nanomaterials, and has 
 been synopsized in the ISO terminology.
2. Classification by composition / chemistry: 
 This approach groups nanomaterials based on their chemical properties.
3. Classification by complexity / functionality: 
 The nanomaterials that are in routine use in products currently are  
 likely to be displaced by nanomaterials designed to have multiple  
 functionalities, so called 2nd-4th generation nanomaterials.   
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4. Classification by biointerface: 
 A proposal related to the hypothesis that nanomaterials acquire a  
 biological identity upon contact with biofluids and living entities.  
 Systems biology approaches will help to identify the key impacts and  
 nanoparticle interaction networks
Approach for classification of  engineered nanomaterials
Sets of  physico-chemical parameters that should be reported for nanomaterials 
have been identified. However, not all properties are relevant for all nanomate-
rials, many are not easily measured on a routine basis, and many are context-
specific. Therefore, it is suggested that a distinction should be made between 
the synthetic and biological identity of  nanomaterials. The synthetic identity describes 
the chemical, structural and compositional nature of  the nanoparticles, and the 
biological identity describes the biomolecules that are absorbed onto the nanopar-
ticles under specific conditions and the impact of  these on the dispersion prop-
erties. 
The required research priorities on material characteristics  
include:
1. Develop systematic sets of  ENMs with properties varied in a stepwise 
 manner that will allow assessment of  the significance of  each property 
 for the toxicity of  that ENM.
2. Describe “reference” states and agreed media compositions to enable 
 identification of  significant biomarkers and enable a move towards a 
 predictive toxicity assessment.
3. Develop analytical methods that enable studying the longer term fate of  
 particles following their interaction with living systems, i.e. complex 
 matrices.
4. Developing risk assessment procedures that include the changes of  
 ENM during their life cycle in a targeted manner.
It is essential that there are nanomaterial identification and classification 
approaches to determine the key descriptors that can be used to reveal correla-
tions associated with impacts. The inter-relationship between the nanomateri-
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als’ identification and classification is a cross-cutting topic in this whole docu-
ment which feeds into the other nanosafety research themes.
Exposure, Transformation and the Life Cycle 
Exposure of  humans and the environment is a result of  many sequential or 
concurrent processes. These facts have emerged from research related to ENM 
production, ENM characterization, aging of  products containing ENM, human 
and environmental induced release of  ENM into the environment, transport, 
transformation, degradation and possibly accumulation of  ENM in the environ-
ment or along the food chain. The fundamental questions related to the existing 
frameworks have relevance to the now rapidly developing nanotechnologies, in 
particular those associated with the use of  ENM, are:
- Is this existing framework appropriate to ensure the safe production,  
 handling and use of  ENM?
- Are the existing regulations and test guidelines applicable for testing  
 and detecting the presence of  nanomaterials, do they have to be  
 adapted and/or do additions need to be made?
The current view is that the general existing regulatory frameworks are 
applicable but have to be adapted and extended for some ENM specific issues. 
It has been emphasized that ENMs are the subject of  some special properties, 
especially those related to the transformation of  materials during their life-cycle 
(LCA) or after their release into the environmental compartments which are 
known to alter their relevant substance characteristics e.g. size, shape, charge, 
state of  agglomeration etc. 
General processes and areas of  possible release and exposure:
1. Production
 Possible release during production may occur through leaks into water  
 and air in closed systems or open production processes.
2. Handling and use
 Handling and use covers several process-related stages e.g. handling of   
 powders, diffuse emission from production plants, mechanical  
 treatment of  nanomaterials 
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3. Aging
 Aging encompasses all processes taking place in the environment such  
 as selective degradation, wash-out, increased brittleness of  the material.
4. End of  Life (EoL) 
 End of  Life activities refer to activities related to  
 i) re-use or recycling;  
 ii) waste treatment, and  
 iii) disposal. In particular, during high energy processes, the release of   
 nano-objects may not be excluded.
The required research priorities on exposure, transportation and 
life cycle include: 
- Mechanistic understanding of  processes determining the release of  ENM.
- Understanding the transformation and transport of  ENM.
- Understanding workplace, consumer and environmental exposure.
Hazard mechanisms, biokinetics, and vulnerable 
people 
Hazard assessment of  ENMs has made good progress during recent years, but 
knowledge is still lacking in many areas including modes of  action and mecha-
nisms leading to toxicity, identification of  susceptible populations and vulnera-
ble conditions, and aspects of  biokinetics and its impact on toxicity. Mechanistic 
knowledge should be included in technology development, to help in the safe 
design of  new ENMs in a bottom-up approach, and will feed directly into the 
development of  a rational testing approach.
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The key factors in developing knowledge and understanding the 
toxicity of  ENMs are: 
1. identification of  the main modes of  actions of  toxicity for ENMs
2. understanding the transformation of  ENMs during their life cycle and 
 how this may influence their hazard potential
3. identification of  the key physicochemical determinants that modulate 
 ENM interactions and toxicity in biological systems
The required research priorities on hazard assessment include: 
Hazard assessment enabling grouping of  ENMs
1) Scientifically established grouping criteria 
2) Understanding the association between material characteristics and  
 the subsequent cellular events
3) Utilizing systems biology approaches in the prediction of  ENM safety
Biokinetics including translocation and clearance 
1) mechanistic knowledge resulting in groups of  ENMs with marked  
 similarities 
2) bioaccumulative properties of  ENMs and biokinetics
Susceptible populations and vulnerable conditions
1) Systematic research of  ENM effects on susceptible populations
2) Systematic research of  the effects of  ENM on individuals with  
 vulnerable conditions 
Environment
1) Fate of  ENMs in complex media and life cycle  
2) Improved prediction of  the (bio)degradation rate of  organic  
 nanomaterials 
3) Development of  standardized test methods for water environments and soil 
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Risk prediction and management tools 
As the scientific basis of  risk assessment (RA) for ENMs suffers from substantial 
limitations, both communication and dialogue are urgently needed with respect 
to risk management (RM) driven desired or approved actions. Databases and 
epidemiological or health studies can be considered as enabling ‘tools’, sup-
porting the processes of  RA and RM. Traditional risk assessment frameworks 
follow the four-step paradigm: 1) hazard identification; 2) hazard assessment; 3) 
exposure assessment; and 4) risk assessment.
The required research priorities on risk assessment include: 
Development of  ‘grouping’ strategies and nano-QSARs to predict relevant 
endpoints of  toxicity and ecotoxicity
1. In vitro and in vivo (animals and man) risk assessment.
2. Development of  standard test methods and validation of  relevant  
 in vivo/in vitro models. 
3. Characterization of  the hazard in terms of  quantitative dose-response  
 relationships, relevant for threshold limit values.
4. Characterization of  the hazard in terms of  quantitative time-response  
 relationships, relevant for the development of  a reaction.
5. Globally harmonized epidemiological studies to validate biomarkers  
 and to prevent/assess health effects in a longer perspective, and  
 relevant field study approaches to assess potential effects of  ENM at  
 the population level of  different environmental organisms.
To support the guidance in areas like risk management and decision-mak-
ing, additional research will be needed in the fields of  risk perception among 
many different targeted stakeholder groups and the main factors causing con-
cerns. 
The main achievement will be the development of  integrated risk assess-
ment and decision frameworks to enable forecasting the potential impacts of  na-
nomaterials on human health and the environment and adequate risk manage-
ment; this undertaking may require the development of  novel risk assessment 
strategies that will replace the current version, being equally reliable, affordable 
but faster.  
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The research priorities on the risk management include: 
1. Environmental impact on the basis of  in vivo/in vitro toxicological  
 studies and of  physical/chemical properties of  nanomaterials released  
 into the environment.
2. Models for release, fate and exposure to nanomaterials.
3. Integration of  LCA into risk assessment.
4. Integration of  risk assessment into decision framework of   
 risk management.
5. Integration of  safe-by-design, closed production-to-product and green  
 nanotechnology approaches into the development stages of  new  
 nanomaterials and their applications.
Research Priorities and Roadmap
The roadmap for nanosafety research 2015-2025 aims to provide an under-
standing of  where the European nanosafety should be at the end of  Horizon 
2020. The roadmap also identifies the steps and achievements needed to achieve 
this aim within this time frame. This time horizon has been chosen based on the 
timing of  the “Horizon 2020” Framework Programme for Innovation and Re-
search; its first calls will open in 2014. 
The milestones in the roadmap indicate the expected achievements of  na-
nosafety research at different time points, at 5-year intervals, during 2015-2025. 
These milestones are presented for the four thematic priority areas separately 
in four tables below, and have been described in detail in the previous chapters. 
In each table, the research priorities have been grouped under larger heading, 
topics, that cover several defined research priorities. 
The table on next page presents the roadmap, i.e. milestones 2015-2025, 
topics and research priorities in different topics at different time points under 
the thematic chapter on material characterization and grouping.
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Milestone Topic By 2015 By 2020 By 2025
Material
classification
Definition Classification 
systems in 
place
Naming  
structure
Ontologies in 
place
Characteriza­
tion of ENM 
in complex 
matrices
Robust me-
thods for ENM 
size determina-
tion
Methods for 
ENM surface 
characteriza-
tion
Methods for 
multicomposite 
ENM characte-
riazation 
Test& refe­
rence ENMs
Systematic sets 
of test ENMs
ENMs certified 
in reference 
biofluids
Full datasets 
on test ENMs
Validation Validated  
labelled versions 
of test ENMs
Validation of 
key metrics for 
impact
Correlation of 
uptake, form 
and impacts
Measurement 
principles
Versatile  
methods
Versatile refe-
rence methods 
available
Bio-nano-
interactions
Biomolecules 
for uptake, 
transport etc.
Reference bio-
interactions
NM impacts 
on protein 
function
Reference  
interactomes
NM proper-
ties leading 
to signalling 
disfunction
ENM  
engineering
Safety by  
design  
concepts
Safe design of 
new ENM in 
a bottom-up 
approach
ENM metrics 
for hazard 
assessment
Key descriptors Non-sperical 
descriptors 
defined
Full datasets 
on non-sphe-
rical reference 
ENMs
Nanomaterial identification and classification
Strategic Research Agenda compact
26
Milestone Topic By 2015 By 2020 By 2025
Release and 
exposure 
Mechanistic 
understanding
Process know-
ledge to allow 
the set-up of 
realistic labo-
ratory simula-
tion
Database on 
emission  
(per time) and 
release  
(per material 
unit) factors
Process  
dependent 
transformation
Transform­
ation, mobility/
transport
Gain know-
ledge on 
environmental 
mobility and 
transformation 
for computer 
simulation
Under standing 
effects of 
 ageing on 
nano-objects
Exposure  
scenarios
Workplace, 
consumer and 
environmental 
exposure
Compre-
hensive, 
harmonized 
exposure  
inventories
Exposure regi-
stries developed
Exposure mo-
dels available
Evaluation of 
exposure sce-
nario models
Exposure data 
and models 
evaluated
Models avai-
lable for use of 
product cycle 
and exposure 
assessment
Exposure and transformation
The table below depicts the roadmap related to the thematic chapter on 
exposure and transformation of  engineered nanomaterials, and presents the dif-
ferent topics areas covering a range of  specific priorities which compass the 
more detailed list of  the priorities in this thematic area during 2015-2025.
Strategic Research Agenda compact
27
Milestone Topic By 2015 By 2020 By 2025
Biokinetics  
and  
trans location
Prerequisites 
for research on 
ENM kinetics
Nanomaterial-
specific analyti-
cal equipment 
available
Biokinetics 
integrated into 
toxicological 
testing
Hazard  
assessment
New app­
roaches for 
ENM hazard 
assessment
Developing 
systems biology 
approaches 
using omics 
technologies
Development 
of appropriate 
QSAR models
A computatio-
nal tool that 
can assess in 
the predicting 
of ENM safety
Vulnerable 
conditions 
ENM and 
susceptible 
populations 
Systematic re-
search of ENM 
with known 
disorders
Validated in 
vitro models 
of appropriate 
ENM
Validated in 
vivo and ex 
vivo models 
for different 
diseases
Science-based 
regulatory 
approaches
Choice of test 
methods
Improved 
strategies for 
testing
Intelligent te-
sting strategies 
available
Regulation
Hazard
Within the topics, the subheadings then provide the separate research pri-
orities in the four thematic areas separately. All the topic areas and research pri-
orities have been drawn from the topic areas and research priorities presented 
in the four chapters presented above 1) material characterization; 2) Exposure 
assessment and release during the life cycle; 3) Hazards, biokinetics, and vulner-
able populations; and 4) Risk prediction and management tools.
The milestones for 2015, 2020, and 2025, related, topics, and related re-
search priorities under different topic separately are presented in a set of  four 
tables.
The table below introduces the roadmap of  the thematic chapter on Haz-
ard mechanisms, biokinetics and toxicity testing, i.e. the roadmap for 2015-
2025, the topics revealing several associated research priorities under this topic, 
and then the actual research priorities for the different time-frame separately.
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Milestone Topic By 2015 By 2020 By 2025
Risk assess-
ment
Pro­active risk 
management
Risk banding 
tools/ effec-
tive control 
measures deve-
lopment
High through-
put screening 
approaches 
validated
Tools Quantification 
of exposure 
reduction 
effectiveness
Testing and 
development 
of risk prioriti-
zation tools
RA-enabled 
LCA/ inte-
gration in 
decision tools
Epidemiology 
& health  
surveillance
Health effect Markers for 
short term  
effect identified
Markers for 
long term  
effect identified
Implemen-
tation of the 
markers
Register Health survei-
llance registries 
developed
Exposure 
registries deve-
loped
Using registries 
for research
Implementa-
tion of results 
for regulations
Study design Pilot panel stu-
dies completed
Case-control 
studies comple-
ted
Longitudinal 
studies started
Databases
Infrastructure Federated 
databases 
available
Format & data 
quality stan-
dards set
IT procedures 
for automatic 
uploading
Ontologies Ontologies in 
place
Automatisati-
on of ontolo-
gies
The risk prediction and management tools
The table below introduces the thematic chapter on Risk prediction and 
management tools, and the relevant milestones to be achieved during 2015-
2025, the wider topic areas under this thematic area, and the specific research 
priorities at different time points during 2015-2025.
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Milestone Topic By 2015 By 2020 By 2025
Risk  
management
Risk perception 
and guidance
Development 
of risk com-
munication 
strategies
Guidance on 
stakeholder 
concern  
assessment
Guidance on 
risk evaluation
Prevention 
through design 
approach
Integration of 
safe-by-design 
approaches 
into the 
development 
stages of new 
nanomaterials 
and their appli-
cations
The risk prediction and management tools (continued)
Implementation of the roadmap
Within the last 10-15 years, a number of  novel basic methods to explore ENM-
induced environmental health and safety (EHS) effects have been developed 
and validated. The implementation strategy proposed here is based on this ex-
isting knowledge. To facilitate and to enhance the advancement of  nanotech-
nology, it is of  utmost importance that we develop a successful implementation 
of  a comprehensive and implementable scientific research agenda.
The most important key for a successful implementation is the excellence 
of  the research proposed; this is aimed at meeting well identified and relevant 
priorities of  the Strategic Research Agenda (SRA). The SRA shall be realistic 
in terms of  goals and contents. Additional key elements of  a successful imple-
mentation of  such SRA for nanosafety research have been summarised in the 
key topics identified in the report of  the National Research Council (2012).
Key steps for implementing the strategy:
- Infrastructure for implementation and accountability
- Evaluation of  research progress and revision of  the strategy
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It is important to understand that all of  the elements listed above are im-
portant prerequisites for the implementation of  the research priorities and road-
map introduced in this document. In additions to those, also cross-cutting is-
sues including a favourable regulatory framework, appropriate European Union 
wide infrastructure – preferentially a network of  established competence centres 
working together in concert in the whole European arena should be established. 
Other crucial issues include a strong commitment from regulators to promote 
standardization, and the involvement of  industrial partners that are willing to 
adopt the safety by design approach in their business thinking. Encouraging an 
awareness of  the benefits of  nanosafety is important because this makes it pos-
sible to clearly highlight the benefits of  these new technologies and to commu-
nicate them in a tailored fashion to very varied and wide audiences i.e. ranging 
from the industrial representatives and regulators to academia and then to the 
general public. Finally it is important to remember that engineered nanomate-
rials, nanotechnologies and especially nanosafety are global issues that require 
global collaborations. 
We have identified four clear priorities: 1) material characterization; 2) ex-
posure, transport and life-cycle; 3) hazard mechanisms; and 4) risk assessment 
and management tools, but nonetheless there must be a continuous follow-up, 
review and evaluation to ensure the implementation of  this proposed strategy.
In summary, this research roadmap aims at providing directions towards 
a sustainable development of  nanotechnology based tools and products. It is 
based on the premises that a level of  generalised knowledge in the different areas 
mentioned and dealt with above shall be achieved within the next 10-15 years 
and this will mean that the new materials coming onto the market will be safer 
by design and this philosophy will be beneficial not only for Europe, its citizens 
but for the whole world.
 
31
1 Introduction  
and background
The aim of  this document is to introduce a strategic vision for future 
research to promote the safe use and application of  engineered nano materials 
(ENM). The importance of  this goal continues to increase due to the rapid 
expansion in the production of  ENM and products incorpo rating them. This 
development will lead ultimately to mass production of  a number of  engineered 
nanomaterials, and thereby to increased exposure of  workers and consumers 
to these novel materials. This development has also evoked increasing societal 
and public concerns on the safety of  ENM and associated techno logies. This 
 ev o lu tion emphasizes the importance of  setting priorities and goals on research 
of  safety of  ENM, thereby minimizing the uncertainties around the safety and 
health issues around these materials and nanotechnologies. Hence, the goal of  
the document in this context is also to describe the current level of  knowledge 
of  the safety of  these materials and technologies, to identify know ledge gaps, 
and set out defined goals for the research on safety of  ENM within the fore­
seeable future. Identifying research priorities assure that the set goals will also be 
reached. This will require the adoption of  the aforementioned concreted goals 
with time­lines and milestones that enable the follow­up of  the achievements of  
the proposed research priorities and goals to be identified later in this document. 
In this context, also the background and the current research environ ment and 
landscape need to be described. Key scientific observations and  regu la tory 
documents will also be referred to. The time horizon set in context will be set 
between 2015 and 2025, from the start of  the first research project funded by 
the “EU Horizon 2020” Framework funding programme for research and inno­
vation, until the end of  the last project funded from that programme. 
The European Commission has recently adopted a recommendation 
on the definition of  nanomaterial (COM (2011) 696), according to which 
‘nanomaterial’ means a natural, incidental or manufactured material 
containing particles, in an unbound state or as an aggregate or as an 
agglomerate and where, for 50 % or more of  the particles in the number 
size distribution, one or more external dimensions is in the size range 
1 nm­100 nm. In specific cases and where warranted by concerns for the 
environment, health, safety or competitiveness the number size distribution 
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threshold of  50 % may be replaced by a threshold between 1 and 50 %. Even 
though this definition has been currently incorporated into some pieces of  EU 
legislation, it has also recently been challenged because it has been considered to 
be an obstacle for research in addition to being a reflection of  relatively a static, 
not a dynamic, under standing of  the nature of  nanosized materials for the pur­
pose of  regu lations (Maynard, 2011). The definition has indeed been defended 
by the regulatory requirements of  engineered nanomaterials (Stamm, 2011). 
The potential of  ENM and nanotechnologies to improve the quality of  life 
and to contribute to economic growth and competitiveness of  industry has been 
widely recognized, not only in Europe, but globally. Nanotechnologies can en­
able remarkable technological advances and innovations in many industry sec­
tors. However, there is an ongoing scientific and political debate about potential 
risks of  ENM and nanotechnologies (EU NAP, 2006­2009; NNE, Sep 2012; 
NNE Feb, 2013). 
The EU 2020 strategy (COM(2010)2020 defines smart, sustainable and 
inclusive growth as the main European 2020 objective. Research and innovation 
have been identified as the key drivers of  European social and economic pros­
perity, capable of  promoting the achievement of  environmental sustainability 
(EU Green Paper, 2011). 
Competitiveness of  the European industry is understood to be a priority in 
achieving these goals, and hence the role of  innovations and an accelerated pace 
of  the commercialization of  innovations have been recognized as being funda­
mental in this respect. The recent Communication from the Commission on 
Horizon 2020 ­ The Programme for Research and Innovation (COM(2011)808) 
emphasizes the importance of  research and innovation for society at large. The 
same issues have been stressed in the EU Nanotechnology Action Plan 2005­
2009 (COM(2005)243). These strategic considerations all mean that there 
will be major changes in the future European research landscape and funding 
 opportunities and all interested parties will need to adapt and prepare to meet 
these challenges. The proposal for establishing the new Programme for Research 
and Innovation ­ Horizon 2020 (COM(2011) 809) places a major  emphasis on 
securing a strong position on key enabling technologies (KET) such as infor­
m ation and communication technologies (ICT), nanotechnology, advanced 
 materials, space technology or biotechnology, and underlines their significance 
for Europe’s competitiveness and its ability to provide the innovative goods and 
services essential for meeting global challenges. In particular, nanotechnology 
offers substantial possibilities for improving the competitive position of  the EU 
and for responding to key societal challenges. Ensuring the safe development 
Figure 1.1.
Aerosol studies with carbon  
nanotubes at Nanosafety  
research Centre in FIOH.  
Particle aerosolization occurs 
in a closed system which is 
capsulated by ventilated hoods 
(photo by Joonas Koivisto, 
FIOH) 
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and application of  nanotechnologies has been included in the broad line of  
activities of  Horizon 2020 proposal.
The new technology applications not only should be safe themselves but 
should also offer substantial improvements to human health and environment 
protection still remaining competitive. Due to the rapidly increasing produc­
tion and use of  ENM and utilization of  nanotechnologies, safety aspects must 
be fully understood and addressed. In figure 1.1. a well protected reseacher is 
performing carbon nanotube aerosol experiments.
According to a recent evaluation by the European Commission (2 nd Reg­
ulatory Review of  REACH (EC(2012) 572) it is unlikely that the size of  nano­
materials per se causes hazards or harm to the human health or the environ­
ment. Small size does enable easy access to living organisms and hence may 
lead to increased risks to various living systems. This leads directly to scientific 
uncertainty about the general safety of  these materials, stressing the need for 
safety assessment the nanosized substances. In fact, safety of  ENM and nan­
otechnologies have been emphasized, not only by the European Commission 
and several EU Member States, but also outside Europe, e.g. in the US 2011 
National Nanotechnology Initiative’s Environmental, Health, and Safety (EHS) 
Research Strategy (NNI, 2011) and in the recent report by US National Re­
search Council,(NRC, 2012). It has been envisioned that the safety of  processes 
as well as the technologies and products utilizing ENM, will be crucial in secur­
ing the success. Successful promotion and expansion of  research on safety of  
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ENM need to be able to timely predict with accuracy and reliability the chal­
lenges and opportunities of  novel ENM and nanotechnologies for the next 10 
to 20 years, i.e. we need to aim at the year 2025. In a recent communication Nel 
et al. (2012) called for a totally novel testing strategies for ENM to enable the 
available human and other resources in order to cope with this ever increasing 
challenge. Earlier, Hartung (2009) has called for such an approach as well.
EU­level research funding from the framework programmes for research 
and the upcoming Horizon 2020 especially emphasizes the European added 
value, results which cannot be achieved by the actions or resources of  a given 
EU Member State alone. The goal of  this document is not only to provide a 
strategic level vision on research priorities on the safety of  ENM, but also to il­
lustrate how advances emanating from this research can be of  benefit to the EU, 
its Member States, EU citizens, and globally. The time horizon of  the document 
at hand ­ extended until 2025 ­ also allows the implementation and exploita­
tion of  results of  nanosafety research projects funded from the Horizon 2020 
­  European Programme for Research and Innovation.
Towards this commitment, the European community of  scientists address­
ing the safety of  ENM and nanotechnologies in their research endeavour will 
establish coordination with EU and national authorities, industry and stake­
holders. It will assist the collaboration between stakeholders and projects, par­
ticularly with national platforms and other industry platforms. The EU scien­
tists dealing with research on safety of  ENM are in many ways integrated in the 
 European Technology Platforms such as NANOfutures European Technology 
Platform for Industrial Safety (ETPIS), maintaining, however, their integrity and 
independence. The ultimate goal of  the scientists addressing the safety of  ENM 
in their research is to assure the safety of  nanotechnologies from the handling 
of  the nanomaterials, the manufacture of  products incorporating, these mater­
ials to their safe use by the final user and their disposal i.e. safety throughout 
their entire life cycle. This will require establishing a new safety culture which 
should involve developing and implementing a complete system of  methods, 
techniques and equipment and competent scientific and technical community, 
and to inform the general public about the safety management and governance 
of  the technologies utilizing ENM.
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Consequences for the vision for 
2015-2025
Based on the achievements described above, the assessment of  risks and 
their management will become routine among regulators. Industry will have 
adopted a way of  working which will guarantee the incorporation of  safety of  
the novel ENMs and nano­based products and processes, thereby markedly and 
positively contributing to the nanosafety  in society within European Union and 
globally. This will require widespread adoption of  the safe­by­design principle 
in the planning of  ENM and in the creation of  industrial processes utilizing 
these novel materials. The knowledge and awareness related to ENM and nano­
technologies among European citizens will have markedly improved i.e. citi­
zens will be able to understand the fundamental issues surrounding nano­based 
products and issues important for ENM. This will have been due to neutral and 
reliable dissemination of  information on ENM by regulators, academia, as well 
as the industry
One of  the key drivers of  this positive development would be the creation 
of  a positive industrial attitude towards nanosafety. It will have become self­
evident to the different parties involved in the nanosciences associated with na­
nosafety that knowledge and trustworthiness are essential elements of  success of  
nanotechnologies. Safety enables the creativity and new innovations and hence 
the ability of  nanotechnologies to support wellbeing and social services. This 
positive development will allow regulators and decision makers to interact with 
other parties, academic community, industrial stakeholder, society at large, and 
various interest groups in the society. This is needed to carry out effective regula­
tion of  the safe use of  ENM thus guaranteeing the safety of  nanotechnologies 
and the products emerging from these processes. 
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EU and international strategy  
documents 
The importance of  nanosafety has been emphasized in several documents 
and comments issued by the European Commission, several European Union 
Member States or other countries. The safety of  ENM and nanotechnologies 
has been identified as one of  the key drivers of  the success of  nanotechnologies 
in all of  these documents. The European  Union Green Paper (EU Green Paper, 
2011) launched a public debate on the important issues to be taken into account 
for future EU research and inno vation funding programmes. The document 
also emphasizes the importance of  an empowering rather than a risk­driven ap­
proach in research on nano materials and nanotechnologies. In this context, the 
Green Paper consultation document notes the importance of  strengthening of  
the  European competitiveness, and it identifies key enabling technologies (KET) 
as means which would allow smart, sustainable and inclusive growth within the 
EU and beyond. Among the KETs, nanomaterials and nanotechnologies and 
their applications have a central position. 
In its communication on Regulatory Aspects of  Nanomaterials (COM 
(2008) 366) the Commission emphasizes that the current legislation in principle 
covers the potential health, safety and environmental risks in relation to ENM. 
However, the communication also notes the lack of  knowledge of  these issues 
on engineered nanomaterials and calls for more research and knowledge. Based 
on these goals and needs, later, in 2011, the Commission devised a definition for 
nanomaterials (COM (2011) 696). The importance of  the safety of  ENM and 
nanotechnologies had also been put forward in the Commission Communica­
tion on Nanosciences and Nanotechnologies: An Action Plan for Europe 2005­
2009 (COM(2005)243) and subsequently in the Commission Communication 
on Nanosciences and Nanotechnologies: An Action Plan for Europe, Second 
Implementation Report 2007­2009 (COM(2009)697). This Implementation Re­
port calls for European creativity, industrial inno vations from knowledge to mar­
ket, but it also addresses the societal dimension, i.e. expectations and concerns. 
It especially highlights health, safety, environment and consumer protection as 
well as bridging the knowledge gap between material sciences and applications 
of  ENM to overcome the need of  knowledge in areas like the characterization 
of  ENM, toxicity, ecotoxicity, safety and exposure assess ment. The implemen­
tation report also emphasizes the importance of  inter national collaboration in 
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relation to nanotechnologies, ENM, nanosciences and nanosafety in the context 
of  OECD, ISO and CEN. 
The Commission has also aimed at promoting the implementation of  
safety of  ENM and nanotechnologies in a number of  Reach Implementation 
Projects. These include the Report of  the European Commission’s Public On­
line Consult ation: Towards a Strategic Nanotechnology Action Plan (SNAP) 
2010­2015. Some of  the key conclusions of  the report were that more than 
80 % of  the respondents have positive expectations toward nanotechnologies. 
ICT, energy, and the health care sector are seen especially promising areas of  
nanotechnology applications. There were also major concerns identified by the 
respondents. A key concern expressed by the industry was the rate of  inno vation 
in Europe and the risk that Europe may fall behind in the exploitation of  its 
scientific base in nanotechnology. And finally, a concern shared by a number of  
parties was related to the safety of  ENM and their regulation. Further details 
related to ENM were identified in several Reach Implementation Projects for 
example on substance identification (RIP­oN1) which included aspects about 
the applicability of  REACH to ENM. The conclusion of  this report, as that 
of  many other reports, was that there are no specific definitions of  ENM in 
REACH but that the general substance definition covers also ENM. As stat­
ed earlier, Commission Definition was launched by the Commission in 2011 
(COM (2011) 696).
After the creation of  the Commission definition on nanomaterials, little 
progress has taken place. The definition of  nanomaterials will be utilized in 
the Cosmetics Legislation which will require labelling the presence of  nano­
materials in cosmetics products which have been produced after July 1, 2013. 
Since there have been concerns about the slow development in the implementa­
tion of  the definition in EU legislation, the Governments of  Austria, Belgium, 
Czech Republic, Denmark, France, Italy, Luxembourg, Spain, Sweden, Croatia 
and the Netherlands have called for action from the Commission and urged 
that it to undertake actions to guarantee the health of  European citizens and 
the protection of  the environment by ensuring that EU legislation takes pos­
sible risks associated with nanomaterials into account. A note from the Dutch 
Government, supported by the Governments of  the other aforementioned EU 
Member States urged that the European Commission should take the following 
measures without delay ”:
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1. Provide for adaptations to existing legislation (e.g. on chemicals,  
 biocides, cosmetics, additives and labelling) to improve the application  
 of  nanomaterials; 
2) Propose legislation on registration or market surveillance of   
 nanomaterials or products containing nanomaterials;  
3) Either through an amendment of  REACH or through supplementary  
 legislation, whatever is most appropriate given the urgency, publish a  
 proposal or an appropriate mix of  effective measure that should include: 
 ­ a solution to the current lack of  definitions within REACH;  
 ­ a review of  the current tonnage levels for nanomaterials within REACH; 
 ­ shortening the period within which information must be obtained;  
 ­ introducing specific requirements for nano materials such as  
  characterization and testing”.
Two recent and important United States Strategy documents have dis­
cussed issues related to the safety of  ENM and societal needs associated with 
them. The report by Roco et al. (2012) “Nanotechnology Research Directions 
for Societal Needs in 2020” discusses four major topics: 
1) methods and tools of  nanotechnology for investigation, synthesis, and  
 manufacturing; 
2) safe and sustainable development of  nanotechnology for responsible  
 and effective manage ment of  its potential including EHS aspects and  
 support for a sustainable environment in terms of  energy, water, food,  
 raw materials and climate; 
3) nanotechnology applications for advances of  bio­systems and  
 medicines, information technology and other technology areas;  
4) societal dimensions including elucidation, investing in physical  
 infrastructure, and governance of  nano technology for societal benefit. 
The report describes in a great detail progress in these areas since 2000. 
The report constantly emphasizes the importance of  the safe and sustainable 
development of  nanomaterials and nano technology applications. The main 
conclusions of  the report can be summarized as follows: 
1) continuous support for basic nanotechnology research; 
2) promoting focused R & D programs; 
3) advancing partnerships between industry, academia, NGOs, multiple  
 agencies and international organizations; 
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4) support of  precompetitive R & D platforms; 5) global coordination of   
 nanosciences; 
6) develop experimental and predictive methods for exposure and toxicity  
 to multiple nanostructured compounds. In addition, the report emphasizes 
7) horizontal, vertical, and system integration nanotechnology education  
 to create or expand regional centres for learning and research; and 
8) exploring new strategies for mass diss emination, public awareness, and 
 participation related to nanotechnology R & D breaking through  
 numerous barriers. 
Elements of the strategy
Governmental funding agencies globally, European Union, and private 
funding agencies have recently invested remarkable amount of  resources to 
support the research on safety of  nanomaterials. For example, this is clearly 
reflected in the numbers of  scientific publications during last decade which 
have increased in an exponential fashion. There has been a rapid increase in 
the publications on human health since 2000, less rapid on ecotoxicology since 
2005, but the number of  papers on exposure and assessment of  exposure has 
remained low throughout this period (Figure 1.2.).
The take­ home message of  the report is that a wide perspective 
on nanotechnologies including safety and societal needs is an absolute 
necessity for the future success of  nanotechnologies.
The National Nanotechnology Initiative has published recently 
(NNI, 2011) a strategy document with a focus on human health, safety 
and the  environment. This provides the US Federal Government’s view 
on key strategy issues of  EHS in the US. It also sets strategic goals 
for nanotechnology related EHS research and identifies the means to 
reach the goals set for 2020.
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In addition, the number of  breakthroughs and remarkable innovations has 
been much smaller than expected in spite of  the markedly increased volume of  
nanosafety research and its funding. This has prompted the funding agencies, 
governments and the academic community to search for ways to improve the 
cost benefit ratio of  the research undertakings, and to emphasize the social di­
mension and societal needs of  this research.
From the societal point, research serving risk assessment, management and 
governance has been modest in terms of  usefulness, timeliness and its systematic 
nature. Much of  the research has focused on mechanistic issues which may have 
remarkable merits but do not serve well the urgent societal needs. At the same 
one has to appreciate the concept that mechanistic innovations may well be of  
immense importance in the future also from regulatory perspective, since the 
regulations need to be based on scientific research.
The number of  strategy documents aiming at providing direction of  re­
Figure 1.2. depicts the total number of papers published during years 2001-2009 in 
the open literature on EHS of engineered nanomaterials, and separates papers on 
exposure assessment, ecotoxicology and human toxicology. 
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search on the safety of  ENM and nanotechnologies EU Action Plan 2006­2009 
(NAP 2006­2009), NNI Strategy document (NNI, 2011) and EU Green paper 
(2011) as well as the NAS EHS Strategy (2012) document seeking to find ways 
to identify a set of  priorities has rapidly increased. They all aim at finding ways 
to serve societal needs to assure the safety of  ENM. In these documents, also 
the concept has been made that the limited resources need to be considered and 
that duplication of  research efforts needs to be avoided.
The key elements of  the strategies usually include the following important 
items: 1. Description of  the current state of  knowledge, the existing research 
landscape and identification of  the requirements of  the research environments 
and infrastructures essential for the promotion of  research on safe ENM and 
nanotechnologies. 2. Identification of  societal needs for the regulation of  safety 
of  these materials and technologies. 3. Identification of  the necessary research 
goals for fulfilling of  the societal needs and setting a time­line with milestones 
for the follow­up of  the progress of  the research endeavors. 4. Identification of  
the research priorities that allow reaching the goals within the time­limit set by 
the strategy. 5. Identification of  the means by which the results of  the research 
can be disseminated, implemented and exploited to evoke a change in the ways 
industry can promote safe use of  ENM and assure the safety of  workers and 
consumers, enabling regulators to make educated regulatory decisions. 6. Iden­
tification of  the needs for further possible regulatory actions and possible further 
investments into infrastructures, educational and funding programs to be able 
to fully utilize the technological and economic benefits of  these materials and 
technologies. Many of  these elements are general for any given research strate­
gies, but when dealing with new and emerging technologies, public perception is 
always at the heart of  the strategic activities and has to be carefully considered. 
All these considerations highlight the importance of  understanding of  the as­
sociated research landscape.
Towards understanding of  
nanomaterials 
ENM are characterized by their complexity. This complexity is evident in not 
only in their physico­chemical characteristics and behaviour but also in their 
interactions with living systems. In some respects, they can be viewed as mater­
Figure 1.4. Size of objects in a nanometer scale. (modified from: National Cancer 
Institute, USA). 
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ials physically embodying the concept of  the 21 st century. Nanotechnologies 
and nanomaterials, in addition to being a new material paradigm, are at the 
same time positioned at the interface of  many scientific disciplines. Hence, 
nano technologies utilizing nanomaterials are in a unique position to nurture 
novel innovations. Due to the diverse nature of  nanomaterials, they have con­
tributed to the birth of  several subfields of  nanosciences such as optoelectronics 
and printed electronics, innovative construction materials, novel surfaces and 
packaging. They have been the impetus for the creation of  the discipline of  
safety­related nanotoxicology which is the foundation of  the safety assessment 
of  ENM, the focus of  this document.
Nanosciences and ­technologies deal with the manipulation of  matter in a 
size­range from 1 to 100 nm in at least one dimension. Some of  the recognized 
engineered nanomaterials have dimensions even smaller than 1 nm (e.g. fuller­
enes). In figure 1.4. some familiar objects are shown in a nanometer scale for 
comparision. This and the more narrow EU definition do not, however, reveal 
the truly innovative nature of  nanotechnology and the nanosciences, a criticism 
leveled by Maynard (2011). Indeed, the study of  nanotechnologies and nano­
sciences demands creativity because at the nano­scale particles have the poten­
tial to inter act with living organisms at the cellular even at the molecular levels 
(see Monopoli et al., 2012). In essence, cells are a biological micro­cosmos, the 
elements of  which are expressed at a nanoscale thereby bringing a qualitatively 
novel dimension to the material­biology interplay (Shvedova et al., 2010).
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Figure 1.5. Electron microscopic images of a) carbon nanotubes (photo by  
Minnamari Vippola, UTU); b) nanocellulose (photo by Esa Vanhala, FIOH);  
c) a chain of aggregated nanosized zinc oxide (photo by Esa Vanhala, FIOH) 
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When one considers the characteristics of  materials at the nanoscale, then 
the diversity of  classes and subgroups of  nanomaterials is truly astonishing. Ex­
amples of  different and emerging types of  nanomaterials include functionalised 
carbon/organic/metal nanotubes, nanowires, metal, metal oxide and organics 
nanoparticles, and graphene (Figure 1.5). They also include bioactive and bio­
degradable  ceramics and polymers, active gels, piezoelectrics, electrostrictives, 
ferro electrics, multiferroics, nonlinear/tunable metamaterials, shape memory 
materials, supramolecular polymers, stimuli sensitive polymers, and possible 
combinations of  these materials. Sometimes they are present in organized ar­
rays, and sometimes as simple mixtures. They can express characteristics that 
enable self­assembly of  nanosized materials into chemically similar but micro­
sized structures, one example being nanocellulose. However, it is the flexibility 
for manipulation which endows all these materials with a world of  possibilities 
and this is why products with nanomaterials can be so creative and innovative.
However, this plethora of  different types of  materials at nano­scale not 
only confers almost unlimited technological benefits but  it also holds the pos­
sibilities for unexpected interactions between these materials and biological sys­
tems at the molecular, cellular, organ and organism levels (see Nel et al., 2012; 
Shedova et al., 2010).        
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Nanotechnology and ENM already have had a major impact on electron­
ics, coatings, construction, food technology, the design of  new materials such 
as nanocellulose applications, telecommunication, environmental technologies, 
medical technologies and drug development, nano­biocide applications and en­
ergy production as well as new agriculture, water purification systems and the 
utilization of  solar energy among others. The possibilities associated with ENM 
are seemingly unlimited, and the developments seem to be proceeding towards 
ever more complexity. This also poses challenges for the regulation and societal 
control of  unlimited utilization of  these possibilities. In addition to their impact 
on society, also the possible effects of  ENM on human health and consequences 
to the environment are now recognized as very important. Public awareness 
and concern on the potential hazards of  the applications of  these materials and 
technologies are consequently on the rise, and these need to be taken into ac­
count, not ignored.
Hierarchy will be a key issue in the future development of  nanotechnologies. 
Hierarchy refers to the control of  structures in space on a nanoscale. However, 
it also means control of  the evolution of  a material with time. Hierar chy implies 
combining, in a predictable way, several nanomaterials, and finding synergies 
between them. But nanotechnology offers also the possibility to explore multiple 
combinations and their subsequent consequences at the nanoscale; these novel 
material characteristics can be thus anticipated or totally unexpected, positive 
or negative involving material­biology interactions. Weak inter actions such as 
hydrogen boding or coordination interactions may play a crucial role in the 
evolution of  the various events possibly occurring at the nano­scale, and which 
may play a crucial role in the evolution or in the generation of  man­made nano­
scale applications.
Importance of nanosafety 
Nanotechnologies belong to emerging technologies which hold the pro­
mise of  bringing significant economic and technological benefits but for which 
there is only limited knowledge on their possible hazard potential; for example 
exposure to these materials either in the environment or via consumer products. 
Assessing true workplace exposure may be challenging in some cases because 
of  lack of  understanding of  the predictive value of  different metrics in pre­
dicting human hazard and risk. Today, the most urgent challenge related to 
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ENM and nanotechnologies is how can we gather the essential knowledge that 
could be utilized for reliable risk assessment and adequate risk management 
and governance. Even though there is increasing amount of  information of  the 
hazard potential on several ENM, there is a dramatic lack of  systematic, and 
especially relevant, information on the potential hazards associated with these 
materials. What is lacking is the kind of  scientific knowledge which would be 
suitable for regulatory decision making i.e. reliable risk assessment data. As valu­
able as mechanistic studies are for our understanding of  the potential hazard 
mechanisms of  these materials, using their results in regulatory risk assessment 
is challenging unless they are associated with acceptable experimental animal 
studies serving risk assessment and management purposes.
To be able to respond to the societal needs for safe nanomaterials and 
nano technologies, it is necessary to complement valuable mechanistic studies 
with systematic short­term and long­ term animal experiments that would allow 
a reliable estimation of  the possible risks of  ENM, e.g. to provide the predictable 
no­effect levels (DNEL) which is a value widely used in the risk assessment of  
engineered nanomaterials and other chemicals in the context of  REACH leg­
islation. Currently, studies on nanomaterials cannot be used for risk assessment 
unless they have been adequately validated against appropriate animal studies 
as this is the only way to demonstrate that they have any predictive power. At 
present, these kinds of  validated in vitro studies simply do not exist, and this has 
hindered the development of  novel intelligent testing strategies of  these materials.
The current situation is especially challenging, as testing abilities and re­
sources do not allow investigators to make an adequate assessment of  safety and 
risks of  ENM (Environmental Science and Technology, 2009). Hartung (2009) 
in his paper ”Toxicology of  the 21st Century” published in Nature called for 
abandoning the existing experimental animal testing paradigm and moving to 
the use of  high throughput testing approaches. This is a very positive proposal 
which has been supported by Nel et al. (2012) who also emphasized the use of  
in vitro approaches utilizing high­throughput technologies and omics method­
ologies in the safety and toxicity testing of  ENM. From the regulatory point of  
view, these proposals while being very attractive, they have one critical flaw; but 
both lack the fundamental justification for their adoption. As long as there is no 
clear evidence of  the predictive power of  these approaches for in vivo systems, 
their acceptance as a part of  the regulatory framework of  nanomaterials or 
other chemicals is highly unlikely; there are simply too many uncertainties and 
safety is not an area where we can be afford to take risks with untested techno­
logies and techniques. Figure 1.6. shows an example of  mouse lung tissue after 
Figure 1.6. Light microsocopic image  
of lung tissue exposed to carbon na-
notubes (CNT). The arrow points to an 
aggregate of CNT (photo by  
Esa Vanhala, FIOH)
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exposure to carbon nanotubes. 
Currently most of  the existing in vitro or in vivo toxicity studies of  ENM 
allow ­ at best ­ one to make some kind of  comparison in terms of  the rela­
tive hazard potential provided that the batch­to­batch variability has been con­
sidered, the materials adequately characterized, the appropriate number of  
graded doses have been used, and predictive endpoints have been measured. 
Often the data are interesting but not suitable for quantitative or even qualita­
tive risk assessment. In addition to the shortcomings described above, very little 
is known of  the true internal dose of  the materials to which living organisms are 
being exposed. In most cases we do not have adequate methods to assess many 
crucial parameters e.g. the dose received by liver or other organs, because we do 
not possess the required knowledge of  the translocation of  the materials in the 
body and across biological barriers, or the means to assess the dose in a given 
organ or type of  cell in vivo. (Oberdörster et al., 2005).  
All the above considerations are highly relevant when assessing the safety 
of  ENM. One of  the major challenges is that, in many cases, technologies that 
would deliver the required piece of  information do not exist, or even if  theoreti­
cally the techniques are available, they would require such exhaustive resources 
to negate their implantation. There is enough information to question whether 
all the assessments are necessary ­ or, in the worst case scenario ­ enough. The 
majority of  ENM may be harmless or only modestly harmful, but there is a 
plethora of  evidence revealing many of  the materials may be highly harmful. 
Hence, the crucial challenge in all cases is to identify the harmful agents and 
to differentiate them from their innocent counterparts so that the appropriate 
regu latory decisions can be made to protect human health and the environment. 
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Thus, it is very important to gather reliable data on toxicity of  ENM to be 
used for risk assessment. It is equally important to gather all available data on 
exposure levels in workplaces, in the environment and through consumer prod­
ucts so that the state­of­the­art in terms of  hazard and exposure can be evalu­
ated (Figure 1.7.). These data can be used for further development of  regulatory 
decisions and risk management and governance of  ENM. These activities are 
currently being carried out within the frame of  EU 7th Framework Programme 
(FP7) projects such as MARINA, NanoValid, and NanoRegulatory Testing, all 
currently running large EU FP7 funded IP Projects (NSC Compendium, 2013). 
The major investments do not, however, resolve the underlying challenge in 
the assessment safety of  ENM and nanotechnologies, notably the gap between 
available resources and safety/toxicity assessment needs (Hartung, 2009; Nel et 
al., 2012). Most, if  not all, of  the current nanosafety research projects deal with 
the so called first generation passive nanomaterials, and the present challenges 
are truly immense. However, soon markets will be flooded with much more 
complex 2 nd  and 3 rd generation nanomaterials, and research on these materials 
is in its infancy and some investigators have stated that we do not possess the 
necessary research tools to evaluate their effects (see Roco et al., 2010).  
At the same time as data starts to become available and improving our 
under standing of  the potential hazards and exposure to the first generation 
nano materials, there is an urgent need to develop totally novel paradigms for 
the testing of  the second and third generation materials (Roco et al., 2010). This 
will require a systematic initiative to investigate the causalities and associations 
between characteristics, and the interactions of  ENM with biological systems at 
molecular, cellular, organ and organism levels, without forgetting various rele­
vant disease models. These studies should aim at identifying those material char­
acteristics that are associated with a harmful endpoint at some of  these levels. 
Bioinformatics and systems biology approaches could be highly advantageous 
in the development of  these new safety/toxicity assessment paradigms, which 
could allow us to make an evaluation of  the risks associated with various classes 
of  ENM. These systematic undertakings should cover the entire life­cycle of  
various ENM from cradle to grave. For example, an assessment of  leakages 
of  various nanomaterial incorporating products will be imperative if  we are 
to be able to assess the potential exposure of  humans and the environment to 
these materials. However, as long as safety aspects are ignored in the design of  
novel ENM, and nano­enabled products or processes, the assessment of  safety 
of  nanotechnologies will remain a major issue and a tremendous burden to the 
industry.  
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Hence, in the coming years, a remarkable challenge for the nanotechno logy 
industry, the academia and the regulators will be the exploitation a novel safety 
culture to the nanomaterial research and engineering community. Incorpo rating 
the safety­by­design as a part of  the core research activities of  nano material sci­
ences and the production of  ENM would be a major step forward in assuring 
nanosafety. This strategy will not be inexpensive, but the benefits that it will con­
fer will be undeniable. In order to incorporate nanosafety as part of  the creative 
process and in the final formulation of  the devices or materials themselves, some 
steps must be taken.   
As mentioned above, it is first necessary to gather knowledge on the safety 
issues of  ENM e.g. relating toxicity of  the materials with material characteris­
tics, to learn about the toxicity of  the different generations of  materials, their 
stability and degradability. Such information is available for a small number of  
ENM, but for most materials this information is lacking. Then, a proper risk 
assessment throughout the Life Cycle of  the materials from their generation 
to disposal becomes an unavoidable issue. The Life Cycle Analysis needs to 
become a key tool for safety assessment. It will be necessary to know when and 
where the product throughout its lifetime could be viewed as hazardous. The 
potential for exposure must be assessed separately for each of  the generations of  
nanomaterial to the end of  their life­cycle. In the risk analysis, the integration of  
a nanomaterial into some material, and the use and possible degradation of  the 
materials must be taken into account.  
This knowledge must be then integrated in the fabrication process but the 
success of  this approach will only become apparent when scientists, govern­
ment, and industry are convinced that this is the way to proceed. A strong dis­
semination and exploitation of  this new approach is therefore required to create 
the awareness­consciousness of  the various benefits and risks and ways that risk 
can be mitigated in the context of  nanotechnologies. In addition, tools must be 
provided to ensure the transfer the knowledge acquired in the nanosafety stud­
ies done in research institutes to the companies manufacturing nanomaterials. 
There must be standardized procedures to deal with nanomaterials and prod­
ucts entailing ENM. Finally, the expected massive production of  ENM may lead 
to new issues related to their disposal and the treatment of  ENM waste. This is 
an aspect which is too easily overlooked but it has to be recognized that it may 
have important long­term consequences for the human health and the environ­
ment. Basic questions such as should ENM be disposed as such or should they 
be processed prior to their disposal still need to be addressed.  
Figure 1.7. It is important to study exposure levels and evaluate the effects of 
nanomaterials both in workplaces and in the environment; a) Light microscopy 
picture of lung tissue with carbon nanotubes inside the cells (photo by Esa Van-
hala, FIOH); b) Light microscopy picture of Daphnia magnia with the gut full of 
algae (photo by Kukka Pakarinen, UEF); c) Workers handling nanomaterials are 
well protected against exposure (photo by Emmi Kallio, copyright FIOH)
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Conclusions
The challenges associated with the safety of  nanomaterials and nano­
technologies are global. The commercial benefits may be outweighed 
by the potentially harmful characteristics of  ENM. Since these emerg­
ing materials and technologies have been identified as the key enabling 
technologies guaranteeing the ability of  key­industrial sectors to com­
pete globally, their success requires also demands an assurance of  their 
safety.  
Today’s key challenges are that available tools for the assessment of  the 
safety are often inappropriate, or so laborious that adequate risk assess­
ment of  these materials and technologies remains highly problematic. 
Current resources or testing tools are not likely to enable safety assess­
ment of  the novel ENM that are flooding the markets. This means that 
totally new safety assessment paradigms need to be developed during 
the coming years to solve this problem. At the same time it is important 
to maintain the level of  current resources to assess the safety of  ENM 
and to support the regulators and industry so that it can maintain its 
ability to provide the prosperity and wellbeing of  citizens within Eu­
rope and beyond. This current situation calls for rapid identification of  
research priorities and development of  roadmap for necessary under­
taking to assure the safety of  nanomaterials and nano technologies in 
the future. Unfortunately this endeavour cannot be undertaken without 
a clear understanding of  the current research landscape within Europe 
and beyond and the analysis of  the environment with the societal chal­
lenges defining why these activities need to be carried out. The research 
landscape will be tackled in the following chapter. The aims are to pro­
vide an understanding of  the key challenges which we must confront 
in our attempts to promote the safety of  ENM and nanotechnologies. 
The best ways to conduct research on nanosafety to ultimately confirm 
their success are presented in Figure 1.8. Because of  the nature of  re­
search and the time gap between discoveries made in the laboratory 
until their implementation and exploitation; we have decided on a time 
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Figure 1.8. Key challenges in dealing with in order to promote the safety 
of engineered nanomaterials and nanotechnologies 
NEW TECHNOLOGIES 
AND PRODUCTSPREDICTING OF NANOSPECIFIC RISKS
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horizon from 2015 until 2025, i.e. the years that are relevant for the 
execution of  the “Horizon 2020” the next EU Funding Programme for 
joint European Research and Innovations.  
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2 The nano- 
safety research  
landscape
Nanosafety:  
facing the challenges
”Nanotechnology” was first introduced in 1971 by Norio Taniguchi as a term for 
ultra-precision machining. Nanosafety research, on the other hand, is a relatively 
new discipline. When the Royal Society and the Royal Academy of  Engineer-
ing, UK, report was published in 2004 on the implications of  nanoscience and 
nanotechnologies, very little information was available on how exactly engineered 
nano materials interact with biological systems. Indeed, although humans have 
been exposed to airborne nano-sized particles throughout evolution, such expo-
sure has increased dramatically over the last century due to anthropogenic sources. 
Moreover, as stated by Oberdörster et al. (2005) in their landmark review on the 
emerging discipline of  nanotoxicology, the rapidly developing field of  nanotech-
nology is likely to dramatically increase the exposure to nanomaterials through 
inhalation, ingestion, skin uptake, and injection (for clinical applications). Results 
of  previous work on particles and fibers (man-made or natural) can be viewed as 
the basis for the expanding field of  nanotoxicology, which can be defined as safety 
Nanotechnology is hailed as one of  the enabling technologies to inno-
vation. Nanosafety, in turn, is concerned with the safe and sustainable 
development of  nanotechnology. Without nanosafety research, wide-
spread use of  nanotechnologies in many sectors of  society would be 
hampered and could even come to a complete stand still. 
2 The nanosafety research landscape
56
It is important to consider that we are still dealing only with first genera-
tion nano-enabled products (i.e. passive nanostructures) but it is likely that we 
will move soon to second generation products containing active nanostructures, 
to third generation systems of  integrated nano-systems and, finally, by the year 
2020 according to some predictions, to fourth generation products or hetero-
genous molecular nano-systems that allow molecular devices ‘by design’ (see 
Roco et al., 2010). This means that methods for assessment of  the safety of  next 
generation nano-enabled products also must evolve: nanotechnology is a mov-
ing target and toxicologists cannot afford to miss the train.
Figure 2.1. Expected size of the market of products incorporating ENM by 2020. 
Adapted from Roco et al (2010).
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evaluation of  engineered nanostructures and nanodevices. Moreover, it is the very 
fact that man-made nanomaterials may interfere with biological systems at the 
nano-scale that raises cause for concern (Shvedova et al. 2010).
Figure 2.2.  
A macrophage full of 
nanosized titanium 
dioxide (black dots). 
(Photo by  
Esa Vanhala, FIOH)
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The challenges that we are facing in nanotoxicology are not unique to this 
sub-speciality of  toxicology but there is an urgent need for a “new” toxicology, 
toxicology for the 21st century. A proposal for a new, systems biology / toxico-
logy approach was put forward in a 2007 report by the US National Academy 
of  Sciences on behalf  of  the US Environmental Protection Agency (EPA). The 
overall aim is to enable a shift from toxicity testing primarily in animal models 
to in vitro assays and in vivo assays using lower model organisms, along with 
computational modeling, thus enabling the evolution of  toxicology from obser-
vational science to a predictive science (Collins, 2008).  The central part of  this 
novel toxicology is to describe toxicity pathways which lead to molecular under-
standing. This allows the development of  novel predictive models using compu-
tational approaches. In 2007, the US EPA launched a project entitled ToxCast 
to predict toxicity of  chemicals using computational, high-throughput screening 
(HTS) approach, and various toxicogenomic technologies, in line with the call 
for a new approach to chemicals testing. Hartung (2009) has also argued that 
“the testing of  substances for adverse effects on humans and the environment 
needs a radical overhaul if  we are to meet the challenges of  ensuring health and 
safety.” In fact, he provocatively stated that “there is almost no other scientific 
field in which the core experimental protocols have remained nearly unchanged 
for more than 40 years” and proposes that an entirely new system is urgently 
needed and should be built from scratch, using modern methods. It may be 
prudent to note that an evolving scientific discipline such as nanotoxico logy is 
optimally positioned to take on board these new approaches. 
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The large EU FP7 projects, NANOSOLUTIONS and NANOMILE are 
both dedicated to systems biology approaches to understanding the interactions 
of  engineered nanomaterials with living organisms and the environment.
The European Commission has invested a considerable sum in nanosafety- 
related research projects: close to fifty projects are either completed or ongoing 
and represent a total RTD investment of  €137 million from the NMP and other 
programmes, with 13 projects (€31 million) under FP6 and 34 projects (€106 
million) to date under FP7. These projects represent a significant effort of  the 
scientific and industrial research community in Europe. A considerable amount 
of  data on the potential hazard of  ENMs has accrued while information on 
exposure to ENMs and on safety of  nano-enabled products throughout their 
life cycle is still lacking. The problem with the hazard data obtained to date is 
that the results do not allow for any general conclusions. This is, in part, due to 
the lack of  standardized methods and reference materials for toxicity assessment 
(Krug, 2011).  In an attempt to resolve some of  these issues, the European Com-
mission has recently funded two large FP7 projects (MARINA and NanoValid) 
devoted to the development and validation of  reference methods and materials 
for life cycle analysis (LCA), exposure, hazard identification, and risk assessment 
of  ENMs. The two projects have a combined budget of  €18.6 million and will 
run for 4 years (2011-2015). 
We still lack a fundamental understanding of  how nanomaterials inter-
act with living system and, thus, we are not yet in a position to assess the 
relevant end-points for nanomaterial toxicity. At the same time, we are 
faced with an onslaught of  new materials for which testing or screening 
of  toxicity is required. To resolve this situation, methods for prediction 
of  nanomaterial toxicity are needed. 
Figure 2.3 Generator 
to aerosolize carbon 
nanotubes.(Photo 
by Joonas Koivisto, 
FIOH).
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Action plans and strategic funding 
instruments 
In the 2004 communication “Towards a European Strategy for Nanotechnol-
ogy”, the European Commission highlighted the importance of  nanosafety re-
search and the need to identify and address safety concerns at the earliest pos-
sible stage. In June 2005, the European Commission adopted the Action Plan 
“Nanosciences and Nanotechnologies: an Action plan for Europe 2005-2009”. 
This Action Plan defines a series of  articulated and interconnected actions for 
the immediate implementation of  a safe, integrated and responsible strategy for 
nanosciences and nanotechnologies.
Following the Action Plan, the Second Implementation Report 2007-2009 
stated: nano-enabled products will enjoy public acceptance only if  regulations 
adequately address the new challenges from the nano technologies, if  manufac-
turers can demonstrate their safety, and if  consumers perceive them as safe. This 
remains the key challenge today and into the foreseeable future, as the number 
of  potential applications for nano-enabled products continues to increase.
More recently, the European Commission held the public consultation 
“Towards a Strategic Nanotechnology Action Plan (SNAP) 2010-2015”. The 
European Commission is thus considering a new Action Plan for Nanotechnol-
ogy, addressing the technological and socie tal challenges and strengthening the 
research and innovation efforts, with increased emphasis on sustainable devel-
opment, competitiveness, environmental, health, and safety (EHS) issues. The 
latter is of  great relevance for the present document: there is a growing realiza-
tion that EHS issues are of  crucial importance for the successful implementa-
tion of  nanotechnologies.
2 The nanosafety research landscape
60
In addition, several European Member States present highly elaborated 
nanotechnology research portfolios. For instance, in 2011, the German Federal 
Ministry for Education and Research announced the adoption of  a new Nano-
technology Action Plan 2015, carrying on from the Action Plan of  2010. Nano-
safety research benefits from a close dialogue between the different actors – not 
only academic institutions but also industry - and the European NanoSafety 
Cluster provides a forum for such interactions.
Looking beyond Europe, the National Nanotechnology Initiative (NNI) in 
the United States coordinates funding for nanotechnology research and deve-
lopment among the 26 participating federal departments and agencies (see: 
www.nanogov.org). The 2013 US Federal Budget provides $1.8 billion for the 
NNI and the cumulative investment since 2001 totals over $18 billion and cu-
mulative investments in nanotechnology-related EHS research since 2005 is in 
total $650 million. In 2008, two Centers for the Environmental Implications of  
Nanotechnology (CEIN) were established with the focus on the assessment of  
nanomaterial interactions with the environment and with living systems. 
While joint calls for research proposals have proven difficult to implement, 
US and European scientists have nevertheless found ways to cooperate in the 
field of  nanosafety. In the FP7 project NANOMMUNE, devoted to studies of  
ENM effects on the immune system, almost half  of  the participating princi-
pal investigators were from the United States. In a more current example, the 
FP7-NanoTransKinetics project is paired with the US project “Nanoparticle 
Transport: From Cells to Organisms” funded by the US EPA, thus enabling EU 
and US scientists to work towards common research goals. However, these are 
scattered examples and more concerted efforts are needed; see below on inter-
national cooperation.
An ERA-NET is a coordination activity funded by the European Commis-
sion in FP7. The main objective is to provide a framework to network national 
and regional research programs, leading to concrete cooperation such as devel-
opment and implementation of  joint transnational calls for proposals. The FP7 
ERA-NET on Nanosafety: Safe Implementation of  Innovative  Nanosciences 
and Nanotechnology (SIINN) started in 2011 and it will run for 3 years. The ac-
tivities aim to promote the safe and rapid transfer of  European research results 
in nanoscience into industrial applications. National and regional resources are 
virtually pooled to create a transnational programme of  research. 
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The first call for transnational research proposals focused on the  
following topics:
•	 models	and	methods	for	analytical	tools,	theoretical	prediction,	 
 and characterization
•	 exposure	assessment
•	 impacts	of 	nanomaterials	on	the	environment
•	 properties	and	effects	of 	ENM
COST is an inter-governmental framework for European Cooperation 
in Science and Technology, allowing the coordination of  nationally-funded re-
search on a European level. The key features are:
 
	 •	 building	capacity	by	connecting	high-quality	scientific	 
  communities throughout Europe and worldwide
	 •	 providing	networking	opportunities	for	early	career	 
  investigators
	 •	 increasing	the	impact	of 	research	on	policy	makers,	regulatory	 
  bodies and national decision makers as well as the private sector
Through its inclusiveness COST supports integration of  research com-
munities, leverages national research investments and addresses issues of  
global relevance. In 2012, the COST action MODENA (“Modeling Nano-
material Toxicity”) on Quantitative Nanostructure-Toxicity Relationships 
(QNTR) computational modelling was approved and launched. QNTR 
computational modelling is an effective alternative to experimental testing 
since it enables the prediction of  (eco)-toxicological effects based on ENM 
structure only (Puzyn, 2012).
There are a number of  instruments for funding and coordination of  
nanosafety research at the EU level and at Member State level. Never-
theless, in order to maximize the benefits of  such investments, more 
concerted efforts are needed. The European NanoSafety Cluster may 
facilitate such interactions.
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European NanoSafety Cluster
The European NanoSafety Cluster is a DG RTD NMP CSA initiative to 
maxi mize the synergies between the existing FP6 and FP7 projects addressing 
all aspects of  nanosafety including materials, hazard, databases, modeling and 
dissemination (Figure 2.4.). Synergy among the various FP6 and FP7 projects 
on nanosafety and other national projects, collaboration for maxi mizing im-
pact, policy elaboration, planning of  future actions, and international coop-
eration are the main aims of  the European NanoSafety Cluster. About fifty 
projects dealing with nanosafety have either been completed or are running 
under FP6 and FP7. These projects together with a significant number of  
nationally supported projects represent valuable efforts of  the scientific and 
industrial research community towards progress. Information on all current or 
recently completed projects is collected in the NanoSafety Cluster Compen-
dium (www.nanosafetycluster.eu).
The main objectives of  the European NanoSafety Cluster 
are to: 
 - facilitate the formation of  a consensus on nanotoxicology  
  in Europe
 - provide a single voice for discussions with external bodies
 - avoid duplicating work and improve efficiency
 - improve the coherence of  nanotoxicology studies and  
  harmonize methods
 - provide a forum for discussion, problem solving and planning  
  R&D activities in Europe
 - provide industrial stakeholders and the general public knowledge  
  on the risks of  nanomaterials for human health and the  
  environment
Synergy among the projects, collaboration for maximizing impact,  
and international cooperation are the main aims of  the European  
NanoSafety Cluster.
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Figure 2.4. Organization of the European NanoSafety Cluster
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European stakeholder collaboration 
platforms 
By 2020 in European industry
- a new safety paradigm will have been widely adopted. Safety is  
  seen as a key factor for successful business and an inherent  
  element of  business performance.
- a structured self-regulated safety program is available. This will  
  have firm, measurable performance targets for improved  
  structural performance, accident elimination and will meet the  
  annual reduction rate stated in the Technology Platform objectives
- accident-free workplaces will become the norm. This develop- 
  ment will significantly contribute to the sustainable growth by  
  safer utilization of  technologies and life extension of  ageing  
  structures and, hence, with the improvement of  social welfare
The European Technology Platforms
The European Technology Platforms (ETPs) were launched some 10 years ago 
as industry-led stakeholder forums to define medium to long-term technological 
objectives and develop roadmaps to achieve them. Their aim was to contribute 
to increasing synergies between different actors, ultimately enhancing European 
competitiveness. The ETPs are independent organisations whose creation was 
supported by the European Commission. All ETPs have brought together stake-
holders, reached consensus on a common vision and established a Strategic Re-
search Agenda (SRA). Some have also developed a plan detailing the actions 
required to implement the SRA.
There are several ETPs of  direct relevance to the nanosafety research 
community, including the ETP on nanomedicine, ENIAC (nanoelectronics), 
SusChem (sustainable chemistry), ETPIS (industrial safety), and the ETP on 
innovative medicine. The European Technology Platform for Industrial Safety 
(ETPIS) aims at the improvement of  industrial safety by co-ordinated efforts in 
research, improved risk assessment and control methodologies. The vision for 
industrial safety performance as stated in the Strategic Research Agenda (2006) 
is summarized as follows:
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ETPIS is organized to nine Focus Groups and Hubs, one of  which is for 
 Nanosafety. The overall objective of  the HUB NANOSAFE is to develop 
synergies between projects dealing with safe nano manufacturing. This in-
cludes the development of:
- advanced detection and monitoring technologies at workplace
- secure integrated industrial processes
- a global approach all along the life cycle
- knowledge on health and environmental effects of  nanoparticles
Clearly, all of  these strategic aims are aligned with the aims and visions of  the 
European NanoSafety Cluster and its member projects. Thus, close coopera-
tion between the ETPIS and the nanosafety projects is needed. The NANO-
futures platform provides one such forum for integration (see below).
NANOfutures
The FP7 project, NANOfutures (www.nanofutures.eu) is a European 
Technology Integrating and Innovation Platform (ETIP), a multi-sectori-
al, integrating platform with the objective of  connecting and establishing 
cooperation and representation of  ETPs that involve nanotechnologies in 
their industrial sector and products. NANOfutures is open to industry, SMEs, 
NGOs, financial institutions, research institutions, universities and civil so-
ciety. It is an environment where these different entities are able to interact 
and develop a shared vision on nanotechnology. NANOfutures collaborates 
with ETPs on the basis of  a Memorandum of  Understanding. Eleven ETPs 
from different industry sectors participate in NANOfutures.
The recent NANOfutures Roadmap (2012) addresses key issues related 
to cross-sectorial research, technology and innovation as well as broad so-
cio-economic challenges to the implementation and commercialisation of  
sustainable and safe nanotechnology.  NANOfutures seeks to address why 
the economic and societal benefits from the major investments in nanotech-
nology research have not, as yet, materialized. There are probably several 
explanations for this, including the fact that broad cross-sectorial issues, 
including safety and regulation, have not been addressed in sufficient detail. 
The present document takes into account the work that is being carried 
out in NANOfutures but aims to define research priorities specifically for 
nanosafety.
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Research on the impact of  the increasingly widespread nanotechnolo-
gies on human health and the environment is of  global concern. It is 
important to avoid duplication and to leverage resources at the inter-
national level, not least in the field of  nanosafety. European researchers 
are engaged in a dialogue with their US counterparts in the field of  
environmental, health, and safety (EHS). 
The US-EU dialogue, “bridging nano-EHS research”, has three goals:
1. to engage in an active discussion on nano-EHS issues
2. to encourage joint programs of  research
3. to establish communities of  practice between researchers and  
 corresponding funding sources to enable collaborations
Communities of  Research (CoRs) are formed by groups of  people, 
sharing a significant interest in the field of  nanosafety. CoRs develop 
a shared repertoire of  resources: experiences, tools, ways of  address-
ing recurring questions and challenges (for further information, see: 
www.us-eu.org). The first three CoRs (predictive modelling for human 
health; ecotoxicity testing and predictive models; exposure through the 
life cycle) are supported from the National Nanotechnology Coordina-
tion Office in the United States while the remaining three CoRs (da-
tabases and ontology; risk assessment; risk management and control) 
receive administrative support from the European Commission. Each 
CoR has one EU co-chairperson and one US co-chairperson. The dia-
logue is promoted through regular meetings (Washington, DC in 2010; 
Helsinki, Finland in 2012) and in addition, each CoR organizes webi-
nars, telephone meetings. 
International cooperation,  
standardization and education
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The following Communities of  Research (CoRs) in nanosafety have been launched:
•	 Predictive	Modeling	for	Human	Health
•	 Ecotoxicity	Testing	&	Predictive	Models
•	 Exposure	Through	the	Life	Cycle
•	 Databases	&	Ontologies
•	 Risk	Assessment
•	 Risk	Management	&	Control
The OECD established the Working Party on the Safety of  Man-
ufactured Nanomaterials (WPMN) in 2006 with the objective to pro-
mote international cooperation in human health and environmental safety 
related aspects of  manufactured nanomaterials in order to assist in the 
development of  rigorous safety evaluation of  nanomaterials. The WPMN 
brings together more than 100 experts from governments and other stake-
holders from OECD countries and non-member economies. The work is 
implemented through specific projects to further develop appropriate meth-
ods and strategies to help ensure human health and environmental safety:
•	 OECD	 Database	 on	 Manufactured	 Nanomaterials	 to	 Inform	 and	 
 Analyse EHS Research Activities
•	 Safety	Testing	of 	a	Representative	Set	of 	Manufactured	Nanomaterials
•	 Manufactured	Nanomaterials	and	Test	Guidelines
•	 Co-operation	on	Voluntary	Schemes	and	Regulatory	Programmes
•	 Co-operation	on	Risk	Assessment
•	 The	role	of 	Alternative	Methods	in	Nanotoxicology
•	 Exposure	Measurement	and	Exposure	Mitigation
•	 Environmentally	Sustainable	Use	of 	Manufactured	Nanomaterials
The Sponsorship Programme on the Testing on Manufactured 
 Nanomaterials was launched in 2007. The program involves the pool-
ing of  expertise in OECD countries and non-member economies and 
funding of  the safety testing of  specific manufactured nanomaterials ac-
cording to an agreed upon priority list and a list of  end-points relevant 
for human health and environmental safety (www.oecd.org). The OECD 
publication series on the safety of  manufactured nanomaterials provides 
a wealth of  information including guidance manuals for safety assess-
ment of  nanomaterials.
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Conclusions
The International Risk Governance Council (IRGC) is an inde-
pendent organization based in Switzerland that is focused on develop-
ing the concept and practice of  risk governance. IRGC recently (2010) 
published a report on “The Emergence of  Risks: Contributing Fac-
tors” in which it is postulated that emerging risks arise from a “fer-
tile ground” that is cultivated by twelve contributing factors of  which 
“scientific unknowns” is one factor. It is noted that “communication” 
has a particularly key role, as it can influence all the other factors. The 
twelve factors should not be understood as discrete units but as com-
plex, interdependent factors. Moreover, the authors propose that the 
attribution of  cause(s) to the emergence of  risks should be informed by 
both reductionist and holistic inquiries. The latter “systems perspec-
tive” approach focuses on describing the system as a whole and not as 
the sum of  its parts.
The International (ISO) and the European (CEN) standardisa-
tion bodies have established working groups on nanotechnology. These 
working groups also cover the nomenclature and metrology of  nano-
technology and, hence, the issue of  definitions of  nanomaterials. The 
definition of  nanomaterials has been the subject of  heated debate and 
the Joint Research Centre (JRC) of  the European Commission recently 
published a report on “Considerations on a Definition of  Nanomaterial 
for Regulatory Purposes” (2010). The report gives an overview of  defi-
nitions by international, national and European institutions, and lists 
approaches used in European legislation. It summarises the advantages 
and shortcomings of  different elements typically used in available defi-
nitions, regarding their applicability in a regulatory context.
Indeed, as pointed out in the recent joint report from the JRC and 
the European Academies Science Advisory Council (EASAC) (2011), 
new initiatives in nano-specific training at the Master of  Science and 
PhD levels are important to support inter-disciplinarity and to provide 
the next generation of  nanosafety researchers with the skills to assess 
new generations of  ENMs.
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Three independent scientific committees provide the European 
Commission with the scientific advice it needs when preparing policy 
and proposals relating to consumer safety, public health and the envi-
ronment. The committees also draw the European Commission’s at-
tention to the new or emerging problems which may pose an actual or 
potential threat. The three committees are: the Scientific Committee 
on Consumer Products (SCCP), the Scientific Committee on Health 
and Environmental Risks (SCHER) and the Scientific Committee on 
Emerging and Newly-Identified Health Risks (SCENIHR) and are 
made up of  external experts. In addition, the European Commission 
relies on the work of  the European Food Safety Authority (EFSA), 
the European Medicines Evaluation Agency (EMEA), the European 
Centre for Disease prevention and Control (ECDC) and the European 
Chemicals Agency (ECHA). SCENIHR published a report in 2007 on 
the appropriateness of  the current risk assessment methodology for 
new and existing substances for assessing the risks of  nanomaterials. 
The aim was to assess the appropriateness of  risk assessment meth-
odologies described in the chemicals legislation for the risk assessment 
Figure 2.5. Twelve common factors contributing to emerging risks. [mofi-
died form IRGC, 2010]
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Nanotechnology is a multi-disciplinary field requiring the involvement 
of  scientists in disciplines such as material science, physics, chemistry, 
biology, engineering, toxicology, clinical medicine, and social science. 
Similarly, nanosafety research also depends on close cooperation be-
tween material science, biology, and toxicology and risk assessment. 
This should be taken into account in the education of  the next genera-
tion of  nanosafety experts. 
of  nanomaterials, and to provide suggestions for improvements. EFSA 
published a guidance document for the risk assessment of  engineered 
nanomaterial applications in food and feed in 2011 (EFSA, 2011). The 
report is the first to give practical guidance for addressing potential 
risks arising from applications of  nanotechnologies in the food and feed 
chain. 
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3 Prerequisites  
for nanosafety  
research
Safety has been identified by the EU Commission as a vital empowering  issue 
for the success of  ENM and nanotechnologies. Uncertainties related to the 
safety of  these materials and technologies have created a major obstacle for 
industry and down-stream actors to invest into nanotechnology research and 
produce new exploitable innovations. Indeed, the EU Commission considers 
that concerns on safety related to ENM and associated technologies are a major 
bottleneck for the willingness of  European companies in various industry sec-
tors to invest into nanotechnologies, and hence Europe is lagging behind the US 
and Japan in this highly competitive area.
One needs to address which are the major success factors that enable 
flourish ing nanotechnology industry. This document has identified several 
cross- cutting issues that are absolutely necessary for ensuring success.
To be able to flourish, the production of  ENM and products incorpo-
rating them, as well as in a wide sense industry sectors utilizing nano-
technologies need a favorable environment to take the necessary risks re-
quired for new innovations. Hence, if  one wants to promote the success 
of  these key-enabling technologies (KET) as identified by the  European 
Union communication on the new Programme for  Research and Inno-
vation - Horizon 2020, favorable environments for this  research have to 
be created to reach such goals. 
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Regulatory framework 
Regulations
Chemical safety regulation in the EU is a structure based on two pillars. The 
first pillar is the legal framework for placing chemicals on the market, and the 
second is created from specific provisions for health, consumer, occupational 
safety and environmental protection.
i) According to the information given in the Communication “Regula-
tory Aspects of  Nanomaterials” (EC, communication, 2006) all nanoparticles 
in chemical substances must meet the requirements of  the REACH (Regis-
tration, Evaluation and Authorization of  Chemicals) (Regulation (EC) No 
1907/2006). Although there are no provisions in REACH referring explicitly to 
nano materials, they are included by the definition of  a “substance”. The prin-
cipal objective of  the directive is to ensure a high level of  relevant protection of  
 human health and the environment.  
ii) General requirements in relation to occupational safety and health of  
workers at workplaces are presented in the Council Directive 89/391/EC. The 
aim of  this framework directive is to ensure a high level of  protection of  workers 
at work – including those exposed to nanomaterials - through the implementa-
tion of  preventive measures to guard against exposure to risks, and through 
provision of  information, consultation, balanced participation and training of  
workers and their representatives. The Council Directive 98/24/EC on the pro-
tection of  the health and safety of  workers from the risks related to chemical 
agents at work describes the minimum requirements for the protection of  work-
ers from risks to their safety and health arising, or likely to arise, from the effects 
of  chemical agents that are present at the workplace or as a result of  any work 
activity involving chemical agents. Product legislation lays down the require-
ments regarding specific products, such as medicinal products, plant protection 
products, cosmetics, food and feed additives.
Consumer products that are not the subject of  specific legislation have 
to meet the requirements of  the General Product Safety Directive (Direc-
tive 2001/95/EC).  Community regulation in these areas contains provisions 
in relation to health and safety of  consumers, workers, patients and users. As 
nano materials contained in such products are a subject of  REACH legislation, 
an assessment of  their environmental impact must be conducted. All product 
legislation requires the performance of  a risk assessment and the adoption of  
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risk management measures. Nanomaterials are not excluded from this obliga-
tion. The biocidal product regulation (Regulation (EC) 528/2012), which will 
be in force from September 2013, provides a framework of  rules that apply 
to the marketing of  biocidal products including nanomaterials substances and 
products (Directive 98/8/EC). The directive is intended to provide a high level 
of  protection for humans, animals and the environment against results of  use 
of  biocidal substances. Environmental regulation relevant in the nanotechno-
logy and nanomaterials context relates in particular to the Industrial Emission 
Directive (IED) dir 2010/75, the control of  major accident hazards involving 
dangerous substances (Seveso II), the water framework directive and a number 
of  waste directives. In principle, the IPPC Directive could be used to control for 
the environmental impacts of  nanomaterials and nanomaterials issues at IPPC 
installations through the inclusion of  such considerations into the Commission’s 
BAT Reference Document (BREFs) process should the need arise (Directive 
2008/1/EC).
The EC Cosmetic Regulation (Regulation (EC) 1223/2009), that will be 
implemented as of  July 1, 2013, requires cosmetic industries to provide specific 
data relevant for risk assessment purposes, and to notify the Commission of  all 
the products containing nanomaterials six months before they enter the market. 
The labels of  cosmetic products produced after July 1, 2013 also have to notify 
the consumers whether they contain nanomaterials.
The EU Regulation for Plastic materials and articles intended to come 
into contact with food (Regulation (EC) 10/2011) specifically states that “…
authorisations which are based on the risk assessment of  the conventional par-
ticle size of  a substance do not cover engineered nanoparticles.” Hence requir-
ing a novel risk assessment, and to date only three ENM have been authorized 
(titanium nitrate, silicon dioxide and carbon black). Finally, the last proposal 
for the Medical Devices Regulation includes some ENM specific requirements, 
considering all devices incorporating or consisting of  nanomaterial ”in class III 
unless the nanomaterial is encapsulated or bound in such a manner that it can-
not be released into the patient’s or user’s body when the device is used within 
its intended purpose.”
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Substances depending on their hazardous properties
For groundwater, EU Member States have to establish quality standards for 
pollutants representing a risk and in this respect, nanomaterials may also be in-
cluded (Directive 2006/118/EC). The Directive on waste lays down the ge neral 
framework and imposes an obligation on EU Member States to ensure that 
waste treatment does not adversely affect health and the environment (Directive 
2006/12/EC). Hazardous waste must display certain properties set out in an 
Annex to the Directive and feature on the European Waste List as hazardous. 
Wastes containing nanomaterials could be classified as hazardous, if  the nano-
material displays the relevant properties which render a waste to be hazardous. 
Specific legislation has been adapted to deal with particular waste streams or 
specific waste treatment processes, such as incineration (Directive 2001/80/EC) 
and landfill (Council Directive 1999/31/EC). Current EU waste legislation is 
concerned with the general requirements for the protection of  health and the 
environment during waste management. It also includes requirements for the 
management of  specific waste materials that may contain nanomaterials whilst 
not explicitly addressing the risks of  nanomaterials.
While the EU Commission originally considered the legal framework 
for nanotechnologies to be suitable in principle, amendments for chemicals, 
cos metics and foodstuffs have subsequently been enacted. The primary force 
behind these amendments has especially been the European Parliament, and 
further regulatory changes (e.g. workplace safety, biocidal products, medicinal 
products, medical devices and waste) can be expected. Specific projects to evalu-
ate the scope and requirements of  possible modifications of  relevant EU HSE 
regulations have been launched including the EU Safety& Health at Work leg-
islation.
With respect to the REACH requirements, the REACH implementation 
projects (RiP) provided a gap analysis for nanomaterials.  It was concluded that 
the existing REACH framework and the guidance can be considered as being 
applicable for nanomaterials, although a set of  recommendations was given as a 
guidance update (RiP, 2011). There is a need for reference materials, standard-
ized methods for identification/determination of  physico-chemical properties 
and hazard assessment, and specific end-points that should be considered. 
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Developments
Based on recently started research into the needs for possible modification of  
relevant EU HSE regulations, and adjustments of  REACH guidelines, the 
 European Commission, and European parliament, together with the EU Agen-
cies, EU Member State regulators, and competent authorities, should take de-
cisions and provide further guidelines for the implementation of  the regulations 
for nanomaterials. Legally binding limit values accepted by the EU Commission 
cannot be expected in the near- or mid-term future. However, expert-based pro-
visional limit values/ reference values for a pragmatic precautionary approach 
may be developed in the short- and midterm.
Standardization
Standardization related to the safety of  ENM will promote the spread of  good 
practices and rationalize the communication between the authorities and the in-
dustry, and other stakeholders. The new European Standardization Policy pro-
posal communicated on June 1st, 2011 emphasizes the importance of  increasing 
the number of  standards and to accelerate the development of  standards in a 
fast-changing global landscape. This is particularly true for nanotechnologies 
that impact on many industrial sectors and where safety and social acceptance 
are important elements. In the new European Standardization Policy proposal, 
standards in the field of  nanotechnologies are considered as very important 
because they can facilitate the introduction of  new products by bridging the gap 
between research and marketable products, and also because they will contri-
bute to the public acceptance of  these innovations.
The Commission has, in accordance with Directive 98/34/EC addressed 
a formal standardization mandate to the European Standardization Bodies 
CEN / CENELEC Mandate M/409 for the elaboration of  a program of  stand-
ards to take into account the specific properties of  nanotechnology and nano-
materials. This expresses the desire of  the European Commission that should be 
an  acceleration of  the process of  standardization of  nanotechnology in general. 
In 2010, CEN, CENELEC and ETSI accepted the Mandate M/461 requesting 
the delivery of  the standards listed in Annex I (Characterization of  and expo-
sure from nanomaterials) and Annex II (Health, Safety, and Environment) of  
the mandate.  CEN/TC 352 “nanotechnologies” has drafted a road map, with 
potential topics to be adapted by the various TCs within CEN.
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The contributions of  researchers, e.g. by direct participation in Guideline 
development groups or external review groups, is a key factor for the develop-
ment of  standards. However, standardization activities in research projects are 
in general of  low priority. The main commonly observed barriers for conduct-
ing standardization activities within a project are: lack of  awareness among re-
searchers of  what is going on in standardization, lack of  incentives for research-
ers to invest time and efforts, lack of  resources to invest time for standardization 
activities.
Developments to promote standardization
CEN-CENELEC has produced a position paper providing a set of  concrete 
proposals to integrate standardization within the framework of  the Program 
for Research and Innovation: Horizon - 2020. This proposal includes reference 
materials and improved standardization opportunities in the frame of  the Ho-
rizon - 2020. An integrated approach to initiate standardization as early as pos-
sible in the R & D promoting the innovations and research process, referred 
to as STAIR (STAndarisation, Innovation and Research) has been developed. 
The FP7 NanoSTAIR project builds on a sustainable process and platform in 
the field of  nanotechnologies to support the transfer of  knowledge to docu-
mentary standards in the STAIR framework. In this undertaking, bottom-up 
approaches will be used to identify standardization opportunities in EU and Na-
tional research projects, and create platforms to support the transfer of  research 
gained knowledge into documentary standards (see the NanoSTAIR turbine, 
Figure 3.1).
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Figure 3.1. The nanoSTAIR process can be seen as a turbine that accelerates the 
preparation of new work item proposals by identifying the potential candidates, by 
making explicit the needs from the main stakeholders and by pooling the resources 
and expertise to reach the necessary critical mass.
The turbine can be split in 4 steps:
(WP1) Research in the field of nanotechnologies is very intensive and fragmented 
over disciplines and countries. Some networks and associations are active to co-
ordinate research investment. The main objective: to identify the standardization 
opportunities from research results.
(WP2) Possible new standard work items had to be clustered according to content, 
needs and possibilities. The main objective: to bridge the gap between the research 
objectives and the standardization needs.
(WP3) The verification of the approach will be done with the preparation of stand-
ardization work item for demonstrating and verifying the feasibility.
(WP4) The outcomes produced will be assembled to construct tools and guidelines 
to promote and translate in a practical way European nano-research into documen-
tary standards.
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The nanoSTAIR process can be seen as a turbine that accelerates the 
preparation of  new work item proposals by identifying the potential 
candidates, by making explicit the needs from the main stakeholders 
and by pooling the resources and expertise to reach the necessary criti-
cal mass.
Apparently, the execution of  Mandate M/461 has been stimulated by the 
Commission to assign a budget for the development of  Standards and underly-
ing pre-normative research. Some of  the TCs and TC Working Groups have 
been very active in proposing standards and concurrent pre-normative research, 
for example in the area of  worker exposure. It is expected that the availability of  
resources will significantly benefit the engagement of  researchers in the process 
of  standardization.
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Conclusions
There is a large number of  regulations and recommendations within 
the European Union and in the EU Member States that in many ways 
regulate the development and use of  engineered nanomaterials and 
nano-enabled products as well as the development of  nano-based in-
novations. It is extremely important that these regulations create a logi-
cal framework that at not only promotes the potential of  novel nano-
technology innovations but also encourages the development of  new 
materials. At the same time, the regulatory framework can be used to 
assure that safety will be taken on board in a consistent way in the 
development of  novel engineered nanomaterials and nanotechnology 
products and processes. In essence, the regulatory framework should be 
one of  the main drivers promoting the safety of  engineered nanoma-
terials and nanotechnologies encouraging different parties to seriously 
consider safety as an essential part of  the development of  engineered 
nanomaterials and their applications. Hence regulations carry a very 
high potential to promote nanosafety. In addition to regulations, stan-
dardization is highly important in promoting the success of  engineered 
nanomaterials and technologies, and when incorporating safety as a 
vital issue in the stardardization process, these activities may become 
important drivers within European Union, EU Member States and be-
yond.
Promoting those infrastructures that support nanosafety research 
within the European Union is a prerequisite for the competitiveness of  
European nanotechnology research, innovations and industries. This 
will require institutional support for organizations with permanent 
 financial funding from their own governments, i.e. to research insti-
tutes, uni versities or industrial research laboratories.
Infrastructure
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Definitions and concepts
According to the European Commission Capacities Programme, the term ‘re-
search infrastructures’ (RI) refers to facilities, resources and related services used 
by the scientific community to conduct state-of-the-art research in their respec-
tive fields. Examples include singular large-scale research installations, collec-
tions, special habitats, libraries, databases, biological archives, clean rooms, 
integrated arrays of  small research installations, high speed communication 
networks, data infrastructure, synchrotrons and accelerators, networks of  com-
puting facilities, as well as infrastructural competence centres which provide a 
service for the wider research community based on an assembly of  techniques 
and know-how. RIs are therefore at the centre of  the knowledge triangle of  re-
search, education and innovation; producing knowledge through research, dif-
fusing it through education, and applying it through innovation. 
In short, research infrastructure means building, required research facili-
ties and equipment, management structures of  such infrastructures, and com-
petences which are required for successful implementation of  – in this case – of  
nanosafety research.
Nanosafety research is vital to enable commercially 
valuable innovations of  nanotechnologies 
Despite significant research and development (R&D) investment over the last 
10 years, several critical road-blocks preventing the rapid implementation of  
commercially valuable innovations in a safe and responsible manner have been 
encountered. This fact is acknowledged by all stakeholders, and progress has not 
taken place to the expected extent. The real and perceived unknown hazards 
and risks of  nanomaterials, allied to concerns about the reliability of  current 
testing approaches, have been highlighted at many levels; from the scientists 
working in this area, from the media, even from high-ranking of  government of-
ficials. To complicate the situation further, significant variations in the reported 
biological and toxicity outcomes of  nominally identical materials have caused 
concern for the scientists and this has been reflected in, reports in media. This is 
a scenario for alarm and if  not urgently addressed, it lead to a loss of  confidence 
in science which in turn could destabilise nanotechnologies since it could lead to 
a loss of  consumer confidence, a loss of  public acceptance and to commercial 
disasters. Keeping this in mind, one should consider the various options about 
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how best to develop the infrastructure supporting nanosafety research so that 
relevant programmes and ideas can be effectively implemented. At the same 
time, it is important to understand that the contents of  the nanosafety research 
are only indirectly associated with the requirements that need to be devised to 
create the desired infrastructure. This not only varies as a function of  time and 
space and available competence requirements but is confronted by challenges 
posed by the emerging technologies.
One remarkable challenge to obtaining an optimal infrastructure is how 
to best utilize different required competences in order to resolve current and 
emerging research challenges, i.e. the governance and convergence of  multiple 
scientific disciplines so that they can address this new challenge. The multi-dis-
ciplinarity of  nanotoxicology means that it encompasses the fields of  chemistry, 
biology, physics and engineering (Ostrowski et al., 2008).
The importance of  strengthening of  the nanosafety research infrastructure 
was emphasized by the European Commission and resulted in a project the goal 
of  which is to improve an analytical Research Infrastructure for characterisa-
tion of  nanomaterials for nanosafety assessment. As a result, the QualityNano 
research project was established. 
A key element that emerges from the above analysis is that the develop-
ment of  even temporary or transient nanosafety research infrastructures may be 
valuable for supporting successful nanosafety research to further support effec-
tive safety assessment of  nanomaterials / nano-products. This means that the 
assessment of  nanomaterials safety should not be performed after the fact, or as 
a side project, but must instead it has to be an intrinsic step in the development 
of  nanotechnology projects.
Infrastructure and expertise for nanosafety assess-
ment must be an intrinsic part of  nanotechnology   
In order to build nanomaterial-based products which are safer by design, and to 
propagate best practice in nanosafety assessment it is vital to bridge the current 
gap between nanotechnology developments and nanosafety assessment. This 
is particularly important with regards to the research infrastructures involved 
in the production or in the processing of  nanomaterials. One crucial stage is 
to remove, control and improve the stability of  the quality of  various types of  
engineered nanomaterials produced for commercial purposes, e.g. consumer 
products or downstream industrial applications. A European research infra-
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structure for nanosafety assessment should be coupled with a state-of-the-art 
capability for nanomaterial synthesis, labelling and surface functionalization as 
well as equipped with facilities allowing animal and human exposure and eco-
toxicity assessment. However, the most practical solution is that there should be 
a distributed set of  facilities, linked by best practice. These facilities will share 
an underlying focus on quality and quality assurance, data quality and data 
sharing protocols, common databases to enable modelling and development of  
quantitative structure-property and/or structure-activity relationships (QSARs 
/ QPARs), and they will work hand-in-glove with the regulatory authorities and 
relevant industry platforms such as the European Technology Platforms and 
industry organisations.
Options for setting up European Union-wide long-
range nanosafety infrastructure in the future 
When considering options that would most effectively enable setting up of  infra-
structures to conduct European Union-wide nanosafety research, one possibil-
ity would be to establish a single-site highly equipped facility with capacities to 
serve other EU nanosafety research facilities in strategic research areas. For ex-
ample, these would include material characterization, and the performance of  
large-scale toxicity studies. The strategic capacities should also include the fol-
lowing services:  bioinformatics, data management, utilization of  systems biolo-
gy approaches, and modelling of  exposures and biological effects. Furthermore, 
another important support service for research and regulatory activities on engi-
neered nanomaterials would be the capability to undertake risk assessment and 
the creation of  databases and generating ontologies for nanomaterials. Finally, 
several other highly sophisticated techniques and methods, and substantial in-
vestments in research equipment and laboratory space would be required. 
These types of  investments could be situated in a stable organization with 
guaranteed fundamental resources into the foreseeable future, meaning that a 
long-range planning would be possible. For example, this kind of  organization 
would be able to guarantee that there would be no changes of  key personnel 
or short-term changes in research orientations due to unpredictable shifts in 
national research policies. Hence, there should be at least a governmental level, 
perhaps even an EU level, commitment to provide a long-term support for such 
a facility and to assure that this can be relatively long-term established centre of  
the required competences. 
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This option would require a long-term political commitment from either a 
single EU Member State, or the European Commission both in terms of  finan-
cial support and ensuring the required human resources and competences. Due 
to the current financial situation and other circumstances, the establishment of  
a single-site European Union Nanosafety Centre is most likely not a viable op-
tion. In fact there is nothing at present which could be viewed as a gestational 
EU-level centre; its establishment would also require a high degree of  consensus 
among involved EU Member States. To date, the required competences which 
would be needed in this kind of  infrastructure capable of  undertaking state-
of-the-art nanosafety research are scattered around the European Union, and 
hence one need to seek an alternative solution to resolve this urgent issue and 
this needs to be addressed in the very near future.
One possibility could involve the mapping of  available high-quality nano-
safety research organizations, i.e. organizations with suitable space and labora-
tories, research equipment, human resources and competences, local funding 
and existing administrative support in research organizations within European 
Union Member States. One could also consider establishing a high-level group 
of  decision makers representing different organizations and other stakeholders 
to assess possibilities for these kinds of  endeavour with an associated aim to 
identify the relevant interested parties which possess the available resources with 
human competences and research equipment and laboratory spaces for differ-
ent nanosafety research orientations. 
In addition to discipline-specific analysis, also an analysis for discovery-
driven and regulatory-supporting research facilities should be carried out. This 
undertaking, which is potentially realistic at the European Union level, could be 
executed in collaboration with the European Commission and the European 
Union Member States, and their existing nanosafety research organizations. All 
the parties should have a vested interest in supporting this activity. This endeav-
our could lead to the identification of  a network of  competence centres, i.e. 
research centres capable of  meeting a series of  relevant quality requirements.
The goal of  the latter undertaking would be to establish a network of  na-
nosafety research competence centres with different capabilities and objectives. 
These would consist not only of  centres working on hypothesis and discovery/
innovation approaches but also those with expertise focused on research serving 
regulations. This could also lead to fruitful cross-fertilization of  both approaches. 
Even though there would be a number of  legal and other obstacles along this 
path, it would allow the different parties to maintain their independence and 
hence would allow them to collaborate more freely which each other. Establish-
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Conclusions 
A realistic option for EU serving would be the establishment of  a net-
work of  competence centres, lead by the European Commission with 
the EU Member States’ support. Funding should come from the EU 
Commission to strengthen the networking and ensuring the exe cution 
of  excellent research collaboration within this Virtual Nanosafety 
 Research Centre with a light administration. The Centre would consist 
of  a limited number of  organizations that would quality as partners 
in this endeavor. One of  the partner organizations would serve as the 
Coordinator of  this activity to manage the day-to-day activities of  the 
Virtual Centre and to streamline its activities of  sharing of  responsi-
bilities and also the organizing of  visits of  scientists within this unique 
nanosafety research collaboration setting.
ing a European Union wide Virtual Competence Centre Network would allow 
a better integration of  European competences directed to nanosafety research. 
This type of  Virtual Centre based on a network of  individual organizations 
would also mean that one could envisage the establishment of  an EU Nano-
Safety  Research Centre which would have a relatively light administrative struc-
ture e.g. with a rotating chairing of  the administrative governance of  the net-
work. One important benefit of  such approach would be that the associated 
organizations would have long-term basic governmental funding from their own 
EU Member State. The collaboration and networking structure could then be 
further complimented by temporary EU Commission funded projects providing 
support for network administration, mainstreaming of  activities and an active 
networking visits of  scientists between the partners.
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Innovation and value chain
In its Horizon 2020 Strategy (Europe 2020), the EU has identified 
priorities to promote smart, sustainable and inclusive growth through-
out the EU and to promote the EU as the most competitive global 
know ledge-based society providing prosperity and social stability for its 
 citizens. Innovation is at the core of  this strategy.
Innovation and nanotechnology
Within the Strategy, the Commission has identified seven flagship initiatives to 
catalyse progress under each priority theme with innovation at the core of  the 
activity. The Flagship Initiative “Innovation Union” aims to improve frame-
work conditions and access to finance for research and innovation in order to 
ensure that innovative ideas can be turned into products and services that create 
growth and jobs. The Flagship “An industrial policy for the globalisation era” 
aims to improve the business environment, notably for SMEs, and to support 
the develop ment of  a strong and sustainable industrial base able to compete 
 globally. At the heart of  these activities is the concept that Europe will undergo 
an industrial transformation based on scientific and technological leadership 
and excellence
In the Strategy, the EU has highlighted nanotechnology as one of  the 
Key Enabling Technologies (KETs) to promote smart, sustainable and inclusive 
growth. As an “enabling technology”, nanotechnology should be applied early 
on and be a key element in the “value chain” being used to realise smaller, 
quicker, more powerful, or more “intelligent” intermediates and systems com-
ponents for products with significantly improved or even completely new func-
tions. (High Level Group on KET Report, 2010). There is huge potential for 
nanotechnology to provide employment and societal solutions.
Deployment of  nanotechnology is a major driver for the trend to improve 
existing products by creating smaller components and better (in both functional 
and environmentally-friendly terms) performance materials. Engineered nano-
3 Prerequisites for nanosafety research 
88
materials (ENM) and the technologies which utilise ENM represent one critical 
pathway to achieve these goals. EU FP7 project NANOfutures, the European 
Technology Platform (ETP) for Nanotechnology supports these aims by provid-
ing an integrating platform that brings together all relevant stakeholder group-
ings involved in nanotechnology.  Specifically, NANOfutures aims to i) identify 
and optimise synergies between European and National Platforms, research 
programmes, JTI, ERA-NETs and other CSAs and research projects related to 
nanotechnology, in order to reduce the fragmentation of  the European nano-
technology and coordinate future strategies; ii) identify key strategic nanotech-
nology nodes addressing issues of  cross-sectorial and nano-specific relevance for 
the innovation and rapid uptake of  nanotechnologies in order to increase EU 
competitiveness; and iii) construct and disseminate an integrated Industrial and 
Research Roadmap for European Nanotechnology. 
EHS barriers to innovation 
Issues regarding the safety of  ENM, in relation to their potential adverse 
 effects to human health and the environment, have been well-document in the 
scientific literature giving rise to increasing concerns for regulators, as well as 
consumers and the industries that use ENM. An extensive programme of  high 
quality research is currently underway at an international level in an attempt 
to address and alleviate these concerns. Europe is playing a leading role in this 
activity through projects funded under the ‘Nanosciences, Nanotechnologies, 
Materials and new Production Technologies (NMP)’ theme of  the Framework 
Programme (FP 7), and its predecessor FP6, including the projects funded as 
part of  the NanoSafety Cluster. However, these research activities have not yet 
yielded outcomes of  sufficient clarity to address the many uncertainties sur-
rounding EHS issues. In fact, the often contradictory nature of  the research 
outcomes has been identified as a major contributor to the uncertainty.
The current debate, including the lack of  regulatory clarity and, in par-
ticular, the uncertainty surrounding the potential risks of  ENM have had a 
negative effect on the development, uptake and exploitation of  ENM in the 
European domain and have been identified as a major barrier to innovation 
based on these technologies (EASAC-JRC, 2011). This has limited the extent 
to which these materials have been exploited through the value chain. The re-
sult of  this has been a failure to fully exploit the potential benefits associated 
with ENM throughout innovation chain in Europe. Hence, major potential eco-
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nomic bene fits resulting from materials, processes and products based on ENM 
have been lost or at least significantly delayed. It is therefore of  the utmost im-
portance to overcome these barriers in order to open up these value chains and 
realise their full economic potential. This goal can only be achieved through the 
development of  a sound science-based foundation from which to build a reliable 
and affordable safety framework.
EHS solutions to innovation barriers 
The current programme of  research being carried out in Europe as part of  
the NanoSafety Cluster activity is probably the largest coherent programme of  
research in any part of  the world. The research activity underway already in 
part addresses many aspects of  the innovation (value) chain. Projects have been 
concerned with among others:
1 Understanding mechanisms of  toxicity (including ecotoxicity)
2 Development of  dose-response relationships
3 Assessment of  distribution, fate and behaviour of  nanomaterials
4 Measurement and modelling of  exposure
5 Development and evaluation of  risk assessment methodologies
6 Assessment of  life cycle issues
Activities have included strategic review and definition of  state-of-the-art, 
networking, infrastructure development, assessment and adaptation of  existing 
methodologies, fundamental research, application of  evolving state of  the art 
and dissemination activities.
However, the EHS programme of  NMP research is not currently well inte-
grated into the innovation-led FP7 work. Although many of  the NMP projects 
have industrial partners, and are working with commercial nanomaterials and 
processes, these projects are more fundamental in nature and are concerned 
with developing an underlying knowledge, models and tools for subsequent 
 application in risk assessment and management. Whilst this activity is critical 
to underpin the knowledge base, which will provide confidence in future nano-
technology-based products and processes at some point, it is important that EHS 
research should be organized that is more directly linked to the development of  
new materials, processes or products.  Some projects of  this nature are in pro-
gress, including NANCORE, ELECTROGRAPH and NANOMASTER. In 
these projects, the innovation aspects are being supplemented by an EHS work 
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package which attempts to address risk questions relevant to the specific applica-
tion. Although these projects provide a direct route into the innovation process, 
the EHS component is typically rather minor and they tend to provide project-
specific, rather than generalizable, solutions. 
Fundamental research is critical and needs to be continued. However, it 
seems certain that the current projects will not produce all of  the answers to 
all of  the questions which surround nanomaterials. However one should not 
be overly pessimistic; it is clear that much better integration with the innova-
tion chain is essential. A full Innovation Chain approach would allow a more 
targeted type of  EHS research to be carried out. One relevant concept is that of  
“Corridors for Innovation” initially described by Grobe (2011). This was origi-
nally envisaged as a stakeholder dialogue concept that would develop a list of  
materials with a “licence to innovate” from researchers, regulators, risk assessors 
and civil society organisations. This would include examples of  nanomaterials 
using specific limited types of  formulation/processing for certain types of  ac-
cepted applications which are “proven to be safe” over the entire lifecycle. This 
is a powerful idea in itself; however stakeholder dialogue alone is not sufficient 
to achieve this goal. Real research will be required to develop and optimise the 
solution. In these ‘corridors for innovation’ the spaces to innovate will be those 
areas where EHS barriers have been identified, defined and addressed. The 
challenge is to construct these corridors.
One option for implementation would be to develop large-scale EHS pro-
jects with the purpose of  identifying, mapping, solving and acting as a curator 
to produce the solutions of  the EHS issues for specific innovation chains. The 
dimensions of  these corridors would encompass the entire life cycle including 
development, manufacture, use, release to the environment and end of  life. 
The type of  work that would be necessary would include toxicology, exposure, 
risk assessment, product safety, environmental release, fate and behaviour.  The 
model for these projects is similar to the innovation-led projects that are current-
ly on-going but on a much larger scale such that the outcomes are generalizable 
to the whole chain rather than simply being applicable to a specific application. 
A key aspect of  achieving this goal will demand a shift in perspective from iden-
tifying what the risks are, to clarifying how we can find solutions that support 
and facilitate innovation.
In a general sense, EHS issues could be mapped and applied to the generic 
innovation (value) chain as depicted in Figure 3.2, requiring the development of  
both data and standardised methods to support better integration and innova-
tion at each stage of  the value chain.  
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Figure 3.2. Application of general EHS issues to the generic innovation (value) chain.
This idea is clearly generic, and implementation requires understanding 
and identifying the specific market-driven value chains within Europe, defining 
the major corridors of  innovation within these corridors to which EHS issues 
could be mapped and subsequently addressed through targeted safety research. 
This approach should allow better alignment and integration of  safety research 
into the innovation process and future technological developments. Through 
its road mapping activities, the NANOfutures project is already in the process 
of  identifying these specific value chains and mapping safety and sustainability 
 issues, and some proposed actions, along the innovation pathway.
How does this link to the NSC Strategy
Many of  the linkages within this approach to the NanoSafety Cluster strategy 
are already in place, as described in the rest of  this document. There remains a 
need for research projects supported by the NanoSafety Cluster to be relevant, 
reproducible and of  high quality, focussed on achieving scientific excellence.  In 
order to address and overcome EHS barriers to innovation there is now the pos-
sibility of  undertaking large-scale innovation projects that take custody of  EHS 
issues in the whole innovation chain, identifying and mapping EHS issues to 
specific value chains, finding solutions to these issues and maintaining visibility 
and open access to the developing knowledge; these are the crucial topics that 
need to be addressed.  
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If  we are to achieve this goal, then a change of  attitude will be required, 
moving from a focus on clarifying what the risks are, towards a focus on identi-
fying solutions that support innovation. Whilst fundamental research is critical 
and needs to continue, going forward better integration of  targeted nano-EHS 
projects into the innovation chain is essential to support and promote responsible 
development and open up the ‘corridors of  innovation’. These corridors need 
to be constructed around Europe’s prioritised and specific innovation  (value) 
chains. The corridors need to be designed, built, reinforced with knowledge, 
rigorously defended and made open for business.
Whilst it is not the purpose of  the NanoSafety Cluster activity to identify 
and define what these specific innovation chains will be, it should be their inten-
tion to work with those who do have custody of  these value chains to ensure 
that a clear and coherent approach is taken. Only in this way will it be possible 
to guarantee that EHS issues are addressed and the barriers to innovation are 
overcome.
Conclusions
Appropriate EHS solutions, aligned with specific innovation chains and 
technological developments, have the potential to exert enormous im-
pacts on the nanotechnology industry, regulators and society; they can 
provide positive and widespread benefits to the European Union and 
its citizens. Such solutions will provide a basis by which the toxic poten-
tial of  all types on ENM can be understood and defined and provide 
industry, consumers and the regulatory community with reduced un-
certainty and bring clarity to the current stormy debate swirling around 
the safety of  ENM. The development and exploitation of  appropriate 
solutions will support the innovation process by reducing the overall 
uncertainty concerning the safety of  ENM but identifying in definitive 
terms which ENM in which applications are probably safe and which 
are not. Appropriate solutions will enable industry to make choices, 
early in the innovation path about selecting ENM on the basis of  their 
characteristics and to prioritise the use of  safe ENM in their products. 
Early identification of  safe ENM and the use of  these materials in the 
development of  new products is an example of  safety-by-design, i.e. by 
incorporating safety at the very start of  the process. Hence, the likeli-
hood of  risks emerging at a later point will be effectively eliminated. 
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As a result, the various costs related to safety to the industry can be 
substantially reduced, enabling the manufacturing companies to focus 
their investment on safe materials.
EHS solutions mapped to the specific requirements of  market-
driven value chains will provide industry at all stages in the innovation 
chain with the confidence that the materials that they are using will 
not present future business risks (reputation, litigation) resulting from 
unforeseen safety problems with their materials and this will maximise 
and support the uptake of  these materials in the development of  new 
processes and products. The provision of  reliable and relevant data will 
allow regulators to prioritise their activity to support the use of  ENM 
proven to be safe, and hence to minimise the regulatory requirements 
for other ENM for which their safety has been demonstrated.
Appropriate solutions will help to relieve public concerns that 
that their health and the environment will not be harmed, this will 
be achieved by clearly identifying those materials and applications for 
which there are effectively no safety issues. This will dramatically open 
up the possibility of  widening the range of  ENM and applications, free 
from concerns about potential safety issues.
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Communication and dissemination
The current debate and the uncertainty surrounding the potential risks of  
ENMs may have had a negative effect on the development, uptake and exploi-
tation of  these materials throughout Europe (Owen et al., 2009) and this has 
led to a failure to fully exploit these materials in Europe and globally. This poses 
a special challenge to the communication and outreach related to ENM and 
nano technologies, and emphasizes the role of  safety, trust and confidence as 
goals of  these activities.
Targeted, neutral and reliable communication by the different stakehold-
ers associated with nanosafety can markedly enhance the acceptability of  safe 
and trustworthy ENM and associated technologies and to promote a new safety 
culture in nanotechnologies. Key-stakeholders include regulators, industry, vari-
ous interests groups, representatives of  media and the public at large. Public 
confidence in nanotechnology is paramount if  these products are to achieve 
commercial success. Successful dialogue, dissemination of  reliable information 
on nanosafety, and outreach to various stakeholder groups will all help assuring 
that health and environment aspects are being taken into account. This will 
dramatically open up the possibilities of  widening the range of  ENM and appli-
cations while still maintaining consumer confidence. Hence, these activities will 
support safe and confident exploitation of  ENMs in a wide range of  products 
and processes for the benefit of  Europe and its citizens, and globally. One of  
the key stakeholders could also be the Virtual European Nanosafety Research 
Centre, whose Coordinator  could act as  a hub of  wide-reaching and global 
efforts to distribute neutral and balanced and trustworthy information on ENM 
and nanotechnologies within the European setting and globally (see the section 
on Infrastructures). 
Some major tasks shall be addressed by communication and dissemination 
activities.
Communication: 
•	 Integration	of 	all	relevant	key	stakeholders	(see	below)
•	 Dialogue	 in	 focus	 groups	 to	 gain	 added	 value	 via	 detailed	 in	 depth	 
 discussion, this will involve representatives of  all key stakeholder groups 
 within European Union, North America, Asian countries and other 
 global interest groups
•	 Active	 communication	 with	 press/media	 to	 facilitate	 science-based	 
 information transfer to the general public
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•	 Setting	up	a	framework	which	will	bring	together	and	coordinate	the	 
 activities of  national centres (established by national authorities in 
 member states; see the section on Nanosafety Infrastructure and above) 
 to exchange their results in scientific high-level groups on European 
 level (bottom-up), as well as communicating back to the national level 
 details about the best practices (top-down)
Dissemination:
•	 Standardized	 preparation	 and	 reporting	 of 	 project	 outcomes,	 
 including all relevant information addressing different user-groups; e.g. 
 regulators will need access to reviewed results, researchers will need 
 raw-data-access, industry/investors will need up-scaling-information, etc.
•	 Shortening	 significantly	 the	 timespan	 from	 the	 scientific	 discovery	 to	 
 publication in peer-reviewed journals public  by convincing the 
 scientific journals to speed up the publication process
•	 Setting	 up	 scientific	 expert	 groups	 in	 defined	 focus	 groups	 to	 review	 
 the achieved outputs of  projects, and to disseminate these results via 
 a publication-tool which will be published by the European 
 Commission (e.g. all data of  projects have to be made available to the 
 scientific community in templates, stringently structured to make results 
 comparable and to find out to which level the information can be 
 standardized so it can be the basis for further research)
•	 Development	 of 	 a	 scientifically	 sound	 blueprint	 for	 nano- 
 epidemiological studies e.g. including classification of  exposure in 
 epidemiological studies, a minimum set of  biomarkers, general 
 nano-assessment strategy, preparation of  epidemiologic cohorts to 
 ensure the health of  exposed populations
Science-based communication and information-dissemination will be the 
key-elements in achieving sustainability of  nanotechnological advances. How-
ever, the involvement of  the regulatory community is vital because it needs to 
have confidence in the reliability of  the outcomes emerging from the research 
endeavours. A sense of  confidence between the regulators and other stakehold-
ers would also provide flexibility and knowledge and form a sound foundation 
for decision-making for example refocusing research onto potential areas of  
concern. This kind of  flexible dialogue and adequate communication may be 
one way to generate a step-change in the process of  conducting risk assessment 
that will remove a massive testing burden from industry (which can represent a 
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major bottleneck for innovation in terms of  both cost and time). This interac-
tion will also enable regulators to simplify their procedures, removing another 
major bottleneck delaying the introduction of  innovative products. The removal 
of  these significant barriers to innovation will contribute to a quantum increase 
in the competitiveness of  the European companies in world’s leading markets.
Key stakeholders
The key stakeholders in the nanosafety dialogue include the research and inno-
vation communities, industry and consumer associations, standardization and 
regulatory bodies, various interest groups, NGOs and civil society, representa-
tives of  media and the general public.
Research community
One of  the key aspects is the establishment of  close and trusting working re-
lationships throughout the different segments of  the nanomaterial, nanosafety 
and nanotechnology scientific communities. One important collaborator in 
this context will be the EU NanoSafety Cluster (NSC), and the projects and 
 organizations involved in the work of  NanoSafety Cluster. This very document 
is an outcome of  the joint collaboration by NSC partners, and this emphasizes 
the importance of  assuring seamless collaboration within the NSC which has 
enabled its production. In the future it will be increasingly important to estab-
lish close working relationships with the scientific communities in the US and 
Canada, South America, Africa, Asia and Australia-Oceania. This can be based 
on the smooth cooperation already achieved within European community in-
volving all of  the relevant European countries. To reach these goals much more 
emphasis must be put on the dissemination and outreach of  knowledge about 
nanosafety and establishing strong exchange programs for scientists. A head-
start has already been made in creating a dialogue with the US research and 
regulatory communities by establishing the six Communities of  Research (CoR) 
in different scientific disciplines (see Chapter 2 on Research Landscape).
Hence, there is still place for improving the collaboration within the NSC 
and the multinational European research projects through more vigorous dis-
semination of  knowledge, information sharing between projects, exchange 
programs for junior and senior scientists, and overall more resource allocation 
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to dissemination and outreach programmes to enable genuine transparency 
in  European collaboration of  scientists, research groups and research organi-
zations. A first step towards the strengthening of  European science commu-
nity will be the setting up of  focus groups (e.g. nanosafety within NSC, nano-
medicine within European Technology Platform on Nanomedicine (ETPN), 
nano toxicology to be arranged using existing national structures), which will 
discuss the new information emerging from the projects by arranging periodical 
discussions, These can help to disseminate identified best practices throughout 
the European wide framework. Through this approach, the science commu-
nity will become better connected, and this can speed up their developments 
compared to what can be achieved in international communities, endowing on 
Europe a leading role at the international level.
Industry, innovation community and industry associations
The ENM producers and the downstream industries need to be encouraged to 
adopt a novel safety culture e.g through the safety-by-design concept. This will 
require an active input from those companies which are in the forefront of  the 
production of  these materials and it will emphasize the special social responsi-
bilities of  these enterprises. In fact, these companies occupy a strategic position 
to have an impact on the whole range of  other industrial sectors; by their own 
behaviour they would put positive pressure on all companies that produce ENM 
or are downstream users of  these materials. The corporate image particularly 
of  large companies is important for their success. A part of  the strategic research 
activity can be the production of  guidelines on how to encourage companies to 
utilize nanosafety by making them aware that this policy can polish their corpo-
rate image. The design elements of  this corporate image still need to be further 
developed. Close cooperation and interaction with the research community will 
be mandatory for maintaining the pace of  international market developments. 
The research community will benefit through undertaking cooperation with en-
terprises because of  the relevance and business potential of  the applications 
or marketable products, as well as via scientific merits for their track record. 
Equally, industry will be confident that it is bringing to the market safe nano-
technological products.  
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Furthermore, the reasons used by industry for its selection of  materials i.e. 
how they are used and designed will also be crucial from the life-cycle perspec-
tive of  ENM. This highlights the potentially important role of  the industrial 
partners and the industry associations to which they belong. These associations 
include the Nanotechnology Industrial Association (NIA) and CEFIC.
This dialogue will be crucial for the successful dissemination of  knowledge 
of  innovations and ensuring the outreach of  such innovations. This goal will 
require a close collaboration with the NANOfutures industrial platform and 
also an active interaction with the European Platform for Industrial Safety will 
be vital. These issues have been considered in detail when discussing how best 
to create the NANOfutures Roadmap. For example, NANOfutures will con-
tinually gather information on the needs of  industry regarding the innovations 
emerging from the project. Thus, the contribution of  NANOfutures will further 
amplify impact of  the designated research priorities and its expected outcomes. 
Furthermore, collaboration with the other aforementioned key industrial as-
sociations, especially CEFIC and NIA, will provide this activity with the source 
data to be processed in the project.
Collaboration with industrial partners is a significant component of  this 
proposal, the interaction with industry associations that have advisory roles and 
which enjoy close advisory interactions with the innovation-research community 
(NANOfutures, ETPIS) mean that the goals of  the identified research priorities 
and this could be expected to extend their impact as they become incorporated 
into practice through regulation and standards.
Standardization and Regulatory bodies
Collaboration with CEN/CENELEC and the ISO organization’s appropriate 
Technical Committees would be highly justified. However, to be involved in the 
standard setting either in the European (CEN/CENELEC) or global standard 
setting (ISO) requires increased resources. These issues have been dealt with in 
an earlier chapter in more detail, but the issue is also relevant in this context.
In the European Union, the EU Commission plays a key role in regu-
latory activities within the European setting. Hence, from the dissemination 
and exploitation point of  view a close collaboration with the EU Commission, 
 especially DG Research, DG Enterprise, DG Environment, DG Employment, 
and DG SANCO will be very important. Other important interested parties 
within the EU setting are the European Chemicals Agency (ECHA), DG Joint 
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Research Centre, and the European Agency for Safety and Health at Work, 
as well as the European Food Safety Authority. All these key partners occupy 
key positions in promoting a positive change throughout the nanotechnology 
industrial sector a conceptual transformation making safety a crucial issue. This 
will provide regulators with the means to regulate the safe use of  ENM and to 
promote safe industrial applications of  ENM. The European Agency for Safety 
and Health at Work (EU-OSHA) working in support of  the European Com-
mission and the Parliament has the responsibility for collecting, digesting and 
disseminating information related to occupational safety and health within and 
beyond the EU. This body has also been active in the area of  nanosafety. It can 
be viewed as a very effective organization for dissemination and publicizing the 
data emerging from this project. In combination and coordinated cooperation 
with the European framework, the effectiveness and impact of  the activities 
conducted by both groups can be significantly increased.
It is important that there should be knowledge dissemination and an 
emphasis of  the importance of  the safety of  ENM. For example, this can be 
achieved by devising the safety-by design paradigms and these are best created 
by working closely together with reliable global partners. Another key collabo-
rator will be the Organization for Economic Cooperation and Development 
(OECD). It will be important to build a close working relationship between the 
various stakeholders in nanosafety with this organization. The collaboration is 
already well established but should be further improved by allocating more re-
sources to highlighting collaborations with a global impact on nanosafety e.g. 
through the OECD Sponsorship Program on ENM. These contacts and out-
comes of  the NANoREG-project will be one way to ensure that this activity will 
have a maximal impact on the global industrial and regulatory communities 
and governments. There are other international organizations that play key-
roles in nanosafety dissemination activities e.g. the World Health Organization 
(WHO) and International Labour Organization (ILO).
Interest groups and NGOs
Business Europe representing European Union employers’ organizations and 
ETUC encompassing European Union labour unions are key parties voicing 
the views of  European civil society. Both groups represent different, but impor-
tant, sectors of  the society, and hence are in a position to amplify the exploita-
tion of  the innovations of  the project to their members. For this reason, both 
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parties need to be a part of  the dissemination and outreach activities of  the 
European strategic research endeavours on nanosafety. Non-governmental 
organizations and the interest groups at not only European but also the na-
tional levels are important and their viewpoints need to be heard during the 
development process of  the nano-assessment strategy. By taking into account 
the views of  these stakeholders at an early stage, it will make it easier to con-
vince their members of  the importance of  accepting the key elements of  the 
strategy i.e. from an occupational health and safety perspective as well as from 
general health and environmental points of  view. Without cooperation with 
these groups, the development of  a common strategy would be at risk of  fail-
ing to be implemented.
Media and PR
It would be worth considering a central hub for dissemination of  information 
and for outreach on nanosafety in addition to the work that is already being 
carried out by individual organizations. This would allow for coordinated and 
well-orchestrated efforts to achieve the goals proposed in the roadmap pre-
sented in chapter 6 of  this document. A suitable candidate for the information 
and knowledge dissemination hub could be the Coordinating organization of  
the Virtual European Nanosafety Centre, as postulated in the above section 
on  “Infrastructure”.  
Media and PR work needs to be carefully targeted for different audiences 
so that the main messages associated with safety and benefits (science based 
knowledge) as well as the potential risks of  ENM can be conveyed in a tailored 
fashion to the different target groups. The main groups include; 1) regulators 
at the EU and EU Member State level; 2) industrial sectors and companies; 
3) industrial associations; 4) social partners at the EU and EU Member state 
level; 5) consumer and other interests organizations including e.g. Friends of  
the Earth, Greenpeace, etc.; and 6) the general public. In the future, govern-
ments and decision makers, international non-governmental organization, 
global enterprises and world-wide public audience through global communi-
cation networks, especially TV and various forms of  social media will become 
increasingly important. These can be used not only to ensure that the message 
has a global impact but they can also be accessed to promote global network-
ing of  European stakeholders.
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In this context, the means of  conveying the targeted messages need to be 
carefully considered. In the case when the target group is small, such as major 
industrial companies, industrial association and regulators, one effective way 
to spread the message may be to organize workshops with carefully chosen 
speakers who have the ability to deliver the messages in a comprehensive fash-
ion for that selected audience. These groups might also need to have dialogue 
and outreach events at the EU and at the EU Member State level. The small 
groups may include social partners, employee organizations and labour unions 
at both EU and EU Member State level. Tailored workshops or dialogue ori-
ented events could be a useful way to reach out to different interests group both 
at the EU and the EU Member State level. A special message targeted to deci-
sion makers might be a highly useful approach for all of  the above mentioned 
groups, especially those serving political and policy-level decisions makers and 
industry leaders.
When one considers industrial workplaces and the general public then the 
audience becomes huge; the interests of  a vast audience will vary extensively, 
much more than in the smaller limited interest groups listed above. In this case, 
close contact with the mass media and carefully tailored delivery of  the main 
messages would be highly advantageous, provided that the key media can be 
approached and convinced about the importance of  the topic and the messages. 
The information intended for broadcast via the mass media should be delivered 
in all official EU languages and preferentially at a Member State level (top-down 
approach). Provided that some of  the main drivers of  the media attention, e.g. 
main TV news channels and leading newspapers can be interested, the delivery 
of  the messages and dissemination of  information by the mass media would be 
highly effective.
General public
Special attention should be paid to the way that scientific research findings are 
communicated to the general public. The general public’s confidence in science 
and research should be nurtured and one of  the best ways is for the research-
ers to learn how to communicate their results effectively and attractively to the 
public at large.
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Conclusions 
The dissemination and outreach activities should strive to make 
all relevant knowledge emerging from the strategic research available 
to other qualified and relevant parties. 
Networking activities should emphasize the translation of  re-
search and industrial knowledge to all relevant stakeholder groups. 
There is a pressing need to make society aware of  the realities of  
nanotechnology and of  the potential applications foreseen in the near 
future, including both the risks and benefits. Timely online sharing of  
data while allowing for confidential business information should be 
the goal. Global networking will be central in this respect. Openness 
and transparency will continue to be important parts of  the network-
ing, and this will only be achievable with a large degree of  recipro-
cal trust.  Efficient networking may require that new communication 
and networking paradigms are developed. The use of  the Internet 
and participation in virtual  forums and on-line cooperation will con-
tinuously influence the efficiency of  networks, but the importance of  
physical meetings will still remain substantial, especially when devel-
oping and initialising new focus areas until common trust has been 
established. Centres of  Excellence for nanotechnology networking 
should be created at the national level and supported by national 
authorities. Networking platforms should be financially supported 
or subsidised to enable new parties to initially access and enter the 
networking activities A European framework which coordinates the 
national centres should outline the synergetic potential of  on-going 
research activities. It will be important to establish this central hub for 
dissemination of  information and for outreach on nanosafety in order 
to facilitate coordinated communication and knowledge dissemina-
tion efforts.
It is noteworthy that EU funded project reporting takes place 
only through the European Commission. It would be advantageous to 
change this practice by installing a “database of  research programs” 
which would act as a common reporting platform for all the project-
outcomes to be collected using a standardized format and permitting 
comparison of  all data. One location for such a database could be 
in the server of  the proposed Coordinator of  the European Virtual 
Nano safety Centre (see section on “Infrastructure”).
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It is crucial to amplify and to promote communication and dis-
semination of  neutral and reliable information on ENM and nanotech-
nologies. Currently, the state-of-the-art in communication is (i) missing 
a critical review of  research results at the national and international 
level, (ii) has no existing standardized communication rules or process-
es, (iii) has no coherent involvement of  stakeholders in the scientific dis-
cussion and communication process, and (iv) has no coordinated way 
of  overcoming these communication- and coordination-deficiencies. 
The coordination of  all these activities needs to be strongly enhanced 
through better contacts between key-stakeholders in the nanosafety is-
sues and by effectively using available mass media and other means of  
communication and dialogue to reach all the stakeholders and also the 
public at large, not just in Europe, but globally.
An important step would be the establishment of  an effective dia-
logue between science and industry. This would overcome the present 
lack of  knowledge-transfer. Industry should not feel that it is giving 
away precious secrets but should realize that it is gaining access to valu-
able resources. In this way, cooperation should be viewed a win-win-
situation for both science and industry. 
It is crucial that the communication on nanosafety will encourage the 
translation of  new safety-related discoveries to the core industrial con-
cerns, to their business philosophy so that the promotion of  safety-by-
design concept can be easily explained and accepted by the different 
stakeholders, including the general public. This is an important area of  
research and innovations but its outcomes should not be obscured by 
poor communication. The incorporation of  safety into ENM needs to 
be made visible through effective communication. This would allow an 
assurance of  safety in conjunction with a guarantee of  the commercial 
success of  the nanotechnologies.
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International Collaboration
International collaboration, both across the EU and globally, may pro-
vide a fruitful platform for having a larger impact and obtaining benefits 
in research as well as in aspects related to governance and safety issues 
of  nanotechnology. In fact, large projects involving a set of  demanding 
multidisciplinary, hypothesis driven research endeavours require inter-
national collaboration because in most cases the required expertise or 
resources may not be available in any one single country. Furthermore, 
international collaboration has its merits also because ground-breaking 
innovations often take place in the interface or cross-roads of  different 
scientific disciplines and research environments.
The globalization of  research is proceeding rapidly and this is having sig-
nificant implications for the European nanosafety research landscape (see chap-
ter 2 on “Research Landscape”). The forums of  the production of  new scientific 
knowledge are shifting from national to international arenas and comparisons of  
certain indicators across countries point to a positive relationship between mea-
sures of  research collaboration and overall scientific impact (OECDa, 2011). 
International partnerships create unique opportunities for enhancing sci-
entific excellence, physical and intellectual research environments and innova-
tive training of  young scientists. Researchers gain greater access to informa-
tion, ideas and facilities, which can facilitate the achievement of  a critical mass 
and a more rapid advancement of  knowledge and discoveries (EC, 2008). It is 
important to note that the driver for cooperation is not the cooperation itself. 
It is the goal of  advancing better nanosafety research and knowledge sharing, 
bringing greater benefits for citizens and industries around the world in an era 
shaped by the need of  addressing the major global challenges, many of  which 
are closely linked to nanotechnology and thus to nanosafety research. Interna-
tional collaboration can take many forms ranging from mobility and physical 
cooperation to virtual cooperation, cross-border contract research, participation 
in international research organisations and, finally, to various levels of  coordina-
tion activities and multi-stakeholder dialogue (Boekholt et al., 2008).
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The European Commission’s Nanosciences and nanotechnologies  Action 
plan for Europe 2005-2009 has called for attention to and action on issues of  
mutual benefit at a global level such as nomenclature, metrology, common 
 approaches to risk assessment and the establishment of  a dedicated database 
to share toxicological and ecotoxicological as well as epidemiological data (EC, 
2005). Many international congresses, conferences and workshops have been 
held, addressing the environmental, health and safety aspects of  nanotech-
nology. Progress has been achieved in many respects to identify the areas requir-
ing joint efforts and the ways forward. However, EU or global level coordination 
is far from achieving goals of  adopting international standards, nomenclature 
and databases, though important steps have been taken in that direction. Many 
obstacles or disincentives still exist, hampering collaboration across national 
borders and hindering the senior researchers or young talented investigators 
from working together. There is still a critical need to share knowledge in the 
health, safety and environmental aspects of  nanotechnology and addressing the 
so-called nano-divide between the developed and developing countries. 
EU policy framework
The research framework programme has been the key financial instrument to 
promote EU-led international cooperation in science and technology (War-
rington et al., 2011). FP7 enables science driven international collaboration 
within the research projects since it is possible for research teams from basically 
all countries to participate in projects (provided they meet the requirements). In 
addition to the general openness to internationalization in the FP7 programme 
and support for international mobility and capacity building, specific third 
countries or regions can be included in calls for proposals for all themes under 
‘Cooperation’ (EC, 2008). FP7 has also integrated the Specific International 
Cooperation Actions (SICAs) into the thematic programs.
The upcoming Framework Programme for Research and Innovation - Ho-
rizon 2020, will likely highlight the importance of  international collaboration in 
research. As stated in the Proposal for the Council decision on Horizon 2020, 
international cooperation with partners in third countries is necessary to ad-
dress effectively many specific objectives defined in Horizon 2020. Activities at 
the international level are important in enhancing the competitiveness of  Eu-
ropean industry by promoting the take-up and trade of  novel technologies, for 
instance through the development of  worldwide standards and interoperability 
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guidelines, and by promoting the acceptance and deployment of  European so-
lutions outside Europe” (EC, 2011). However, FP7 or the upcoming framework 
programme, Horizon 2020, represents only a small proportion of  all research 
in Europe as most research investment is by the Member States (public and pri-
vate). The international collaboration opportunities in nanosafety should not be 
geared only towards the framework programme, but also multiple instruments 
and channels are needed in order to accommodate the research, policy and 
harmonization needs related to nano EHS issues.
In addition to the researcher-led cooperation opportunities provided in 
the framework programme, the European Union is signatory to Science and 
Technology (S&T) Agreements with a number of  third countries, and these 
S&T Agreements provide another platform for collaboration. They enable in-
stitutional dialogue and link policy and science more closely together. Nano-
technology research is included in several EC S&T Agreements. The S&T col-
laboration between EC and the third countries is characterized by a top-down 
approach. Acknowledging that the EU cannot collaborate with every single 
country and in every field, the Strategic Forum for International S&T Coopera-
tion (SFIC) has been mandated to drive forward the European partnerships for 
international S&T cooperation. To date, however, the SFIC roadmaps or activi-
ties have not directly emphasized the need for collaboration in the field of  nano-
safety research. The focus has been to a greater or lesser extent on the global 
grand challenges; however some of  these are closely linked to nanotechnology 
applications and solutions.
NanoSafety Cluster - from collaboration  
within EU towards joint collaborative EU-US 
research activities
International cooperation has also become one of  the key activities of  
the NanoSafety Cluster. In recent years, the European Commission 
has promoted dialogue with the US regulators and the US scientific 
nanosafety community based on the S&T Agreement between the EC 
and the US. Collaboration efforts between the European Commission 
and the US National Nanotechnology Initiative aim at bridging EU-
US activity in the area of  nanosafety research in close collaboration 
with researchers, regulators, and granting agencies.
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Continuous discussions on global EHS research needs and chal-
lenges have led to a joint initiative to create EU-US Communities of  
Research (CoRs). The Communities of  Research are voluntary activi-
ties of  EU and US scientists and their goal is to promote collaboration 
in nanosafety research to be better able to face the global challenges 
related to the promotion of  nanosafety research and its consequences.
Source: EU NanoSafety Cluster
Examples of  multilateral cooperation and global 
initiatives
A responsible and coordinated approach is needed to ensure that potential chal-
lenges related to nanotechnology are addressed. Multilateral cooperation links 
closely to the regulatory, standardization and risk-assessment activities. In  other 
words, international collaboration in the development and introduction of  
standards for nanotechnologies will help early commercialisation, inno vations, 
market development and potentially even contribute to better consumer accept-
ance. However, the multitude of  actors (some of  them described in Figure 3.3.) 
in international cooperation and global initiatives in nanotechnology poses a 
 challenge also for the coordination of  activities of  EHS research. There needs 
to be a continual dialogue between scientists, researchers, policymakers and reg-
ulatory community to develop scientifically informed and evidence-based poli-
cies and ethically and socially sustainable solutions. An extensive inter national 
dialogue on future research needs and research activities is also important in this 
regard. Ideas to establish global consortia to solve global nanosafety  challenges 
have been discussed and such ideas are perhaps increasingly on the inter national 
agenda.
Organisation for Economic Cooperation & Development (OECD), and 
in particular, the OECD Working Party on Nanotechnology (WPN) is in 
a central role in the promoting of  development joint global initiatives on res-
ponsible development and applicability of  nanotechnology between OECD 
Member States, OECD Observer States and other stakeholders. The WPN 
was established in March 2007 to advise upon emerging policy issues of  sci-
ence, technology and innovation also related to the safe of  nanotechnology. It 
is a subsidiary group of  the Committee for Scientific and Technological Policy 
(CSTP). The WPN works co-operatively with other OECD groups, including 
the Working Party on Manufactured Nanomaterials (WPMN, subsidiary to the 
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Chemicals Committee). The Working Party on Nanotechnology works in close 
collaboration also with the Working Party on Biotechnology (WPB); the group 
of  National Experts for Scientific and Technological Indicators (NESTI) and 
their respective committees. (OECD, 2012).
The Working Party on Manufactured Nanomaterials (WPMN) 
focuses on human health and environmental safety implications of  manufac-
tured nanomaterials (limited mainly to the chemicals sector), and aims to en-
sure that the approach to hazard, exposure and risk assessment is of  a high, 
science-based, and internationally harmonised standard. Its programme seeks 
to promote international co-operation on the human health and environmental 
safety of  manufactured nanomaterials, and involves the safety testing and risk 
assessment of  manufactured nanomaterials. The WPMN is implementing its 
work through specific projects including development of  databases, research 
strategies, test guidelines, and, more specifically, it has launched a Sponsorship 
Programme for testing a set of  thirteen manufactured nanomaterials (OECD b, 
2011). Each of  them has a sponsor country and supporting countries on a vol-
untary basis. The first stage of  this OECD Sponsorship Programme has ended 
and countries are seeking ways to initiate the second stage of  this initiative. 
Moreover the WPMN has been developing guidance on how to apply chemical 
test guidelines for nanomaterial assessment and evaluating need for new test 
methods.
Other multilateral agencies include World Health Organization (WHO 
which also maintains a Network of  Collaborating Centres in the nanosafety 
area), Food and Agriculture Organization of  the United Nations (FAO), Inter-
national Labour Organization (ILO), United Nations Industrial Development 
Organization (UNIDO), United Nations Environment Programme (UNEP), 
United  Nations Institute for Training and Research (UNITAR) and United 
 Nations Educational, Scientific and Cultural Organization (UNESCO). The UN 
agencies address nanosafety EHS aspects to varying degrees based on their own 
missions and activities and many of  them are involved in the Strategic Approach 
to International Chemicals Management (SAICM). In the SAICM Process inter-
national scientific organizations have also played a role though governments have 
firmly assured that the SAICM process is preferentially an intergovernmental 
activity. When needed, the views of  the global scientific community are sought.
The International Standards Organisation (ISO) is a non-gov-
ernmental organization and the world’s largest developer and publisher of  
Inter national Standards. International Standards Organisation Technical 
Committee 229 (ISO TC/229) works on standardization in the field of  nano-
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technologies. In the area of  risk management, the International Council on 
Nano technology (ICON) is one of  the key multi-stakeholder organizations 
for catalyzing global activities that lead to sound and responsible risk assess-
ment, management, and communications and whose mission is to develop and 
communicate information regarding potential environmental and health risks 
of  nanotechnology and hence fostering risk reduction and maximizing societal 
benefit.  The International Risk Governance Council (IRGC) also works 
on risks related to nanotechnology even though this area is not its primary tar-
get. The IRGC is an independent organization working to facilitate understand-
ing and management of  global risks that impact on human health and safety, 
the environment, the economy and society at large. One of  the informal global 
initiatives is the International Dialogue on Responsible Research and 
Development of  Nanotechnology that has been facilitated through the UN 
Meridian Institute and in which individual countries have played an important 
role through informal intergovernmental collaboration. The European Com-
mission has also been actively involved. This informal dialogue provides a space 
for facilitating international sharing and brings together various stakeholders 
to benchmark initiatives, identify differences and explore synergies, with the 
ultimate aim of  contributing to a responsible and sustainable development of  
nanotechnology. Some International forums and initiatives on nanotechnology 
are presented in figure 3.3. 
3 Prerequisites for nanosafety research 
110
Figure 3.3. A diagram of international multilateral cooperation forums and initia-
tives on nanotechnology. 
SAICM (Strategic Approach for International Chemicals Management) is a policy 
framework to foster the sound management of chemicals aiming at improvning 
chemical safety globally.
SAICM
ISO
OECD Joint Meeting
Chemicals Committee
United Nations
OECD        CSTP
EC: ; SANCO, ENT, ENV, JRC
ISO TL 229
Nanotech
WPMN - safety
WHO, ILO
UNIDO, UNITAR
FAO, UNEP
UNESCO
ICON yms.
ECHA
Test guidelines
Programme
WPN
-applications
3 Prerequisites for nanosafety research 
111
Common Obstacles and Needs
Research can be identified also within other areas. Different legal systems and 
institutional settings can create difficulties and delays and represent a further ad-
ministrative burden. Administrative and financial procedures regulating inter-
national cooperation contracts are often considered to be exceedingly complex 
and demanding (Warrington et al, 2011).
Furthermore, differences in ethical standards and IPR practices and legis-
lation may be obstacles to collaboration. Lack of  awareness and information 
about the cooperation opportunities and various funding instruments may 
many of  the potential users of  these cooperation opportunities are unaware 
of  their existence. The multitude of  funding instruments and constant project 
 application cycles may also lead to “application fatigue” that could have nega-
tive impact on targeted calls on international collaboration. An open and trans-
parent planning and implementation process of  international calls and joint 
activities could enhance researchers’ interests and facilitate their activity and 
simplify call cycles.
International cooperation opportunities for nanosafety research should 
move beyond the opportunities offered in the context of  the current and fu-
ture framework programme. Complimentary aspects should include bottom-up 
collaboration opportunities in forming alliances and strengthening the inter-
national dimensions of  the European Research Area in nanosafety research. 
This may require from the Members States a more proactive and coordinated 
approach. Nevertheless, there is a need for bottom-up, science-driven research 
and science-driven collaboration and this cannot be implemented from the top-
down, but rather through a vigorous dialogue between the researchers in the 
field. Enhancing international collaboration in nanosafety research also requires 
recognition of  differences in cultures and practices and reaching beyond the 
conventional, bureaucratic or short-sighted approaches.
Creating auspicious framework conditions would include:
•	 markedly	 improved	 information	sharing	between	nanosafety	research	 
 communities to avoid lack of  knowledge of  available opportunities for 
 collaboration, and to promote integration of  nanosafety research 
 communities in different continents and regions
•	 better	 coordination	 and	 cooperation;	 optimizing	 the	use	 of 	 national,	 
 European and global resources and avoiding duplication of  activities
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•	 developing	 user-friendly	 frameworks	 and	 instruments	 in	 creating	 
 win-win situations (not just FP)
•	 allocating	resources	for	international	collaboration
•	 exploring	 and	 developing	 international	 co-funding	 mechanisms,	 
 establishing joint network(s), (virtual) institutes or joint programme(s) 
 for nanosafety research
•	 supporting	researcher	mobility,	optimizing	various	mobility	instruments	 
 and continue the efforts for removing the barriers related to mobility 
 (incl. competitive salaries and benefits for scientists)
•	 enhancing	 awareness	 raising	 activities	 and	 visibility	 about	 the	 
 collaboration opportunities and instruments (incl. horizontal and 
 specific)
•	 supporting	and	meeting	the	urgent	needs	of 	nanosafety	infrastructure
•	 creating	mutual	benefits	and	investing	in	the	attractiveness	of 	Europe	as	 
 a top research destination
•	 political	level	initiatives	and	institutional	frameworks	or	arrangements	 
 might open new doors in some cases (e.g. EC-EPA and EC-NIH 
 collaboration)
International Dialogue in Nanosafety - towards a 
Global Research Area?
The international dialogue and collaboration activities have helped to 
understand the complexity of  EHS aspects, further highlighting the 
need for joint international efforts in developing protocols and test 
methods to assess the health and safety impacts of  nanomaterials and 
to provide proper characterization methods. Harmonizing ethical 
standards, IPR practices and development of  common standardiza-
tion practices would facilitate collaboration and conducting research, 
and thus ultimately, yield benefits to citizens and industries around the 
world.
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Joint international efforts in the field of  nanosafety are an important step 
towards the development of  coordinated global collaboration and a move for-
ward from the European Research Area (ERA) to a Global Research Area 
(GLOREA). One could say that steps in this direction have already been taken 
in the form of  informal global initiatives and dialogues. Nevertheless, effective 
implementation of  the ERA and its cornerstones should provide a basis for 
the development of  the GLOREA. In this sense, it is clear that the European 
Commission and the Member States will continue to have a significant role 
in  advancing multi-stakeholder collaboration and global efforts in addressing 
the responsible and sustainable use of  nanotechnology and bridging the nano- 
divide. Despite the various actors in the international forums of  nanosafety, 
there are no truly global institutions or instruments that would address the EHS 
issues in a comprehensive and coordinated manner. Perhaps the concept of  
GLOREA would thus reflect better the future mind set in planning and imple-
menting policies and instruments that help bridging the gaps at the global level 
while finding a suitable balance between European and global interests.
An important future consideration of  global research collaboration on 
nano safety, or the establishment of  GLOREA, is the role of  developing  countries 
and emerging economies in this activity. Emerging economies and emerging sci-
ence countries such as China, Brazil, South Africa and Thailand are currently 
making huge investments into nanotechnology including nanosafety, and these 
endeavours should be integrated with the leading actors in the area of  nano-
safety, namely EU, US, Japan, Russia, Canada and Australia.
Conclusions
It is important to establish mechanisms and easy-to-apply-funding 
instruments (worth applying) for international, formal and informal, 
collaborative activities in nanosafety research. The opportunities for 
joint calls and co-funding should be explored. Multi-annual planning 
in cooperative activities and potential joint calls by the Commission 
and the member states and the third countries (allowing some degree 
of  flexibility) would facilitate the planning and implementation of  
research activities of  nanosafety research community and thus po-
tentially generate larger participation and impact. Open and timely 
communication on collaboration opportunities is another of  the key 
issues.
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It is also important to create joint platforms or enlarging the cur-
rent forums to include the emerging science countries in EHS research 
activities and to continue efforts to address the nano-divide (e.g. open-
source databases). The GLOREA concept (starting with few third 
countries) may be one way to advance nanosafety through more coor-
dinated and effective research efforts.
The importance of  supporting international cooperation in terms 
of  nanosafety research infrastructures continues to grow: an important 
area for progress involves mapping of  the needs for large-scale inter-
national infrastructure investment, taking into account the European 
Strategy Forum on Research Infrastructures (ESFRI) processes in in-
ternational collaboration and future RI roadmaps.
There is a clear need to intensity dialogue with the Strategic Fo-
rum for International Collaboration (SFIC) in nanosafety while engag-
ing the researchers as part of  the process. Continued efforts to remove 
the common barriers to international collaboration (harmonizing 
practices, IPR issues, legislation etc.) is another area that needs to be 
tackled.
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4 Common  
nano safety  
research themes
The NanoSafety Cluster (NSC) has arranged several meetings in which discus-
sions have focused on the future key-challenges associated with the safe use of  
ENM and safety evaluation in the context of  the nanotechnologies. At the same 
time, also the means by which this research could promote and enable major 
improvements in safety of  ENM and lead to reliable, affordable, and faster than 
current evaluation of  hazards and risk of  ENM have been examined. 
The key-issues identified have included a full understanding of  the differ-
ent characteristics of  ENM, and the relationships of  these characteristics with 
ensuring harmful effects of  ENM on living organisms at molecular, cellular, 
organ and organism levels. Functionalization expands enormously the range of  
ENM available and this aspect has also been actively discussed. One of  the key 
discussion topics has been the importance of  characteristics of  ENM for their 
penetration through biological barriers, and the interactions of  ENM with vari-
ous biological molecules upon entering a given organism. The effects on both 
human and environmental species have been thoroughly assessed. Naturally, be-
fore any effects can occur, exposure to ENM is necessary, and the understanding 
of  the associations between ENM dose and effects in all organisms have been 
evaluated. Not surprisingly, the definition of  dose metrics (characteristics) has 
triggered much attention and debate on which metrics of  ENM, mass, number 
concentration or surface area should be used to define the dose of  ENM e.g. in 
toxicity studies. 
Substantial attention has also been paid to the potential exposures to ENM 
through the various steps of  the production of  ENM, the release of  ENM at 
different stages of  the life-cycle of  ENM, and also from various surfaces, matri-
ces, materials or products. The effects of  wear and disposal i.e. through to the 
end of  the material’s life have been considered as an important potential source 
of  exposure in different environmental compartments. Exposure to ENM from 
nano-enabled products as well as the whole life-cycle assessment of  ENM from 
cradle to grave has gathered considerable attention. Exposure routes including 
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aerosols, slurries and dispersions in processes, and importance of  the release 
from products into the air or other environmental compartments from expo-
sure point of  view have been evaluated. 
Recent developments advancing our understanding of  the behavior of  
ENM in different matrices and environmental compartments, as well as in 
mammalian and environmental organisms have also been reviewed. A special 
emphasis was given to the foreseeable development of  future types of  ENM. 
Novel, emerging 2nd generation active nanomaterials, self-assembling 3rd gen-
eration nanomaterials and nanosystems, and the 4th generation systems of  na-
nosystems and nanorobotics have been considered. It has been noted that most 
of  the current safety research deals with the 1st generation ENM and the data 
on the emerging materials is quickly required. These considerations have been 
extended to all areas of  the priority discussions, and hence implicitly included 
in all thematic areas identified during discussions.
Hazards have been extensively analyzed including translocation of  ENM 
(absorption, distribution, metabolism, excretion), identification of  the key-
target organs of  hazards, and the role of  ENM-bio-interactions, molecular 
mechanisms, and protein and other coronas (phospholipid, sugars, nucleic ac-
ids) on the ENM characteristics and kinetic behavior. The special features of  
mammalian and environmental organisms have been carefully considered in 
this context. In addition, the development of  various hazard/toxicity testing 
strategies that would allow quicker and more affordable hazard and risk assess-
ment have been examined.
A high emphasis has been given to issues related to risk assessment and 
management of  ENM. The high priority of  novel risk assessment paradigms 
and the need to obtain human data have been considered in this context. 
Hence, the importance of  worker surveys, exposure assessment field studies, 
epidemiological studies, and the establishment of  exposure, company and 
worker registers in these contexts have been discussed. 
Based on these considerations, conducted by all interested members of  
the NSC, the issues of  nanosafety emerging in the near future and requiring 
rapid solutions have been identified. These four identified priority thematic 
areas are: 
1) material identification and classification; 
2) exposure and transformation; 
3) hazard mechanisms including both human toxicology and  
 ecotoxicology; and 
4) risk prediction tools including databases and ontologies. 
4 Common nanosafety research themes 
121
This text was prepared by an Editorial Group consisting of  the chairs of  
the thematic areas, the coordinator of  the NSC, and a few additional members 
volunteering to participate in this endeavour. These individuals were appointed 
to prepare a coherent document, emphasizing the identified priority research 
themes, preparing a roadmap for their implementation, and considering other 
elements to be included in this document.
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4.1 Nanomaterial identification and  
classification
Most of  the definitions of  a nanomaterial concentrate solely on the size 
aspect (1-100nm), which misses the fact that nanomaterials are a very 
diverse group of  materials with greatly varying properties. In order to 
enable prediction of  impacts, a classification based on key parameters 
or biological interactions should be adopted.
State-of-the-art
Naming and classifying nanomaterials
There have been multiple efforts to define nanomaterials, including a focus 
on defining them for regulatory purposes which enables products contain-
ing nanomaterials to be identified and regulated, with limited success to 
date. Most of  these definitions focus solely on size aspect of  the nanoscale 
size (1-100nm) with some also including surface area and shape. There have 
been also been several suggestions for approaches to classify and prioritise 
nanomaterials for safety assessment, including the OECD Sponsorship pro-
gramme approach based on commercial importance and volume of  pro-
duction. 
The emphasis in the EU Commission’s definition on nanomaterials is 
on external dimensions, which may result in the exclusion from the defini-
tion of  materials with an internal structure (e.g. porous materials with a 
relatively large internal surface area) or materials with a surface structure 
at the nanoscale. Further information is, therefore, necessary on the inter-
pretation of  information on nanomaterials in products and the impact of  
porosity (internal surface area) on the hazard of  nanomaterials.
The proper detection and characterization of  nanomaterials is a criti-
cal pre-requirement for the safety assessment of  the materials under study. 
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The development of  new and more robust methods and techniques for 
the detection and characterization of  nanomaterials will also greatly im-
prove the traceability and exposure assessment of  nanomaterials present 
in consumer products. The results of  recent research indicate that the 
size, size distribution and the surface properties of  the particles are key 
parameters if  one wishes to understand their behaviour.
The first and simplest characterization of  NM should involve their 
particle size distribution (PSD); several techniques are available, but there 
is a clear gap in knowledge about the best approaches for a meaningful 
and cost-effective detection, size measurement and characterization of  
nanoparticles. An additional challenge exists for agglomerated ENM. 
Although the meaning of  the term agglomerate is related to a measur-
able unit (i.e. external surface area), debate can still be expected on this 
issue. First, this assessment requires comparison of  the surface area of  
the material with aggregates/agglomerates to the surface area without 
aggregates/agglomerates. The latter parameters can at present only be 
mathematically estimated from the size distribution of  the primary par-
ticles, but this kind of  mathematical estimation of  the surface area is 
highly dependent on the quality of  information on primary particle size. 
Furthermore, measurement of  surface area is a common practice for 
powders, but no straightforward technique is (yet) available for particles 
dispersed in liquid. In addition, guidance on when the surface area of  
the aggregate/agglomerate can be considered to be the same or similar 
to that of  the individual components is not available at the moment. In 
the Questions and Answers that accompany the Commission’s Recom-
mendation of  nanomaterials (EC(2011), it is clearly stated that aggre-
gates and agglomerates are considered as being nanomaterials whenever 
the constituent particles are in the size range 1 – 100 nm. This is based 
on the fact that agglomerated or aggregated particles may exhibit the 
same properties as unbound particles. Moreover, there can be cases dur-
ing the life-cycle of  a nanomaterial where the particles are released from 
weakly bound agglomerates or under certain conditions even from more 
strongly bound aggregates.
A gap in terms of  classifying nanomaterials is the fact that there are 
multiple different variants of  each type of  nanomaterial, all of  which 
may differ in terms of  their impacts. Thus, there is a critical need for 
an – International Union of  Pure and Applied Chemistry (IUPAC)-type 
approach to naming and describing nanomaterials. 
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Approaches to group nanomaterials have been presented 
below:
1. Classification by dimensionality / shape / morphology:
 Shape-based classification is related to defining nanomaterials,  
 and has been synopsized in the ISO terminology.
2. Classification by composition / chemistry: 
 This approach groups nanomaterials based on their chemical  
 properties.
3. Classification by complexity / functionality: 
 The nanomaterials that are in routine use in products currently  
 are likely to be displaced by nanomaterials designed to have  
 multiple functionalities, so called 2nd-4th generation nano-materials. 
4. Classification by biointerface: 
 A proposal relates to the hypothesis that nanomaterials acquire 
 a biological identity upon contact with biofluids and living  
 entities. Systems biology approaches will help identify  
 the key impacts and nanoparticle interaction networks.  
Multiple reports have identified sets of  physico-chemical parameters that 
should be reported for nanomaterials. However, not all properties are relevant 
for all nanomaterials, and many are not easily measured on a routine basis. 
An additional challenge is the fact that many of  the physico-chemical proper-
ties of  nanomaterials are context-dependent, and as such change depending 
on the surroundings in which the ENM are presented. Thus, we suggest the 
distinction between the synthetic and biological identity of  nanomaterials. The synth­
etic identity describes the chemical, structural and compositional nature of  the 
Figure 4.1. Nanoparticles and biomolecular interfaces: illustration of the concepts 
of synthetic and biological identity of nanomaterials. 
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nano particles, including any surface coatings, ligands or labelling molecules; the 
biological identity describes the biomoelcules that absorb to the nanoparticles un-
der specific conditions and the impact of  these on the dispersion properties, as 
shown schematically in Figure 4.1. 
Clear guidance on parameters to report will improve data quality, enabling 
a cross-comparison of  data and modelling and QSAR approaches. Over the 
next 5-10 years, the grouping of  nanomaterials will become based on a deeper 
understanding of  the characteristics of  the nanoparticles and their interactions 
with their surroundings, and how these link to nanomaterials’ fate, behaviour 
and impacts on living systems.  
In addition to the inherent variability in these materials, there is also an 
enormous level of  evolution / transformation of  nanomaterials properties, as 
they age, as they seek to reduce the energy associated with their surfaces, and as 
they interact with their surroundings. Assays to assess particle age, surface reac-
tivity and evolution of  surfaces should be developed and applied as standard as 
a part of  the characterisation of  nanomaterials.
Nanomaterials display a wide range of  toxicities, with many being per-
fectly safe and other requiring some restrictions on their use to ensure that the 
benefits of  application outweigh the risks for harm to human health or the en-
vironment. Thus, strategies that enable identification of  low, medium and high 
toxicity nanoparticles are urgently needed. A set of  so-called reference states 
should also be agreed to allow cross-comparability of  studies and to allow the 
establishment of  a baseline set of  characterization data. 
The OECD guidelines for Physical-Chemical Properties and Material 
Characterization were updated in 2010 and have now started to consider inter-
actions with surroundings / characterization in situ as they now recommend the 
determination of  size and size distribution dry and in relevant media (OECD, 
2010). Given the capacity to interact with their surroundings, nanomaterials 
have both a synthetic and biological identity, which both may have an impact. 
It is increasingly clear that the biological behavior and consequences of  na-
noparticles are largely dictated by how they interface with biology (Figure 4.1). 
These ideas are equally applicable to nanoparticles dispersed in environmental 
milieu, where decaying plant and animal matter interact with nanoparticles and 
thus affect their stability, dispersability and environmental fate and behavior. On 
this basis, we have introduced the concepts of  the synthetic and biological iden-
tity of  the nanomaterials; both of  these properties need to be fully characterized 
in all studies in order to make the data meaningful, comparable and useful for 
predictive, read-across and grouping efforts.
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Physiochemical properties
Size (distribution)
Shape
Agglomeration or aggregation state
Crystal structure
Surface chemistry/charge/area
Stability over time/dissolution
Dosing metric
Uptake
EM, AFM, DLS, NTA
EM, AFM, UV-vis (for plasmonic nanoparticles)
EM, DLS, UV-vis (for plasmonic nanoparticles)
XRD, ED
AES, EELS, XPS, solid-state NMR, ζ-potential, BET
DLS, UV-vis, ICP-AES, ICP-MS, colorimetric assays
Variable
ICP-AES, ICP-MS, TEM, fluorescence, flow cytometry, NAA
Common characterization methods a,b
Table 4.1. Important ENM properties and common methods for  characterization
aAbbreviations: EM, electron microscopy; AFM, atomic force microscopy; DLS, dynamic light 
scattering; NTA, nanoparticle-tracking analysis; UV-vis, UV-visible spectroscopy; XRD, X-ray 
diffraction; ED, electron diffraction; AES, Auger electron spectroscopy; EELS, electron energy 
loss spectroscopy; XPS, X-ray photoelectron spectroscopy; NMR, nuclear magnetic resonance; 
BET, nitrogen adsorption/desorption isotherm; ICP-AES, inductively coupled plasma atomic 
emission spectroscopy; ICP-MS, inductively coupled plasma mass spectrometry; NAA, neutron 
activation analysis.
bNot an exhaustive list of  characterization approaches. 
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There are several techniques that can potentially be used to characterize 
these materials. Many of  these methods have been listed in Table 4.1. 
However, several problems need to be solved before reaching a more ro-
bust and systematic application of  these techniques for the characterization of  
nanosized materials, especially in complex matrices such as real products and 
biological systems (see below). In particular, developing standard samples, sam-
ples preparation and analysis protocols, will be a mandatory step in making 
advances in this field.
Detection and characterization of  ENM in complex matrices
It is becoming exceedingly clear that the behaviour, fate, and toxicity of  ENM 
clearly depend on their surface properties. Thus, there is an urgent need for 
techniques able to characterize the surface properties (such as composition, 
chemistry, physical-chemical parameters) of  NM both in pristine form, after the 
eventual engineering process and finally in complex matrices.
The current techniques available to measure NM size can be divided into 
three classes: 1) imaging-based, 2) light scattering-based, 3) separation methods.
1) Electron microscopy-based such as scanning electron microscopy (SEM) 
and transmission electron microscopy (TEM). These techniques are the most 
frequently used ones to characterize NM; they are very accurate and can meas-
ure mixtures of  NM of  different sizes3. However, they are complex and expen-
sive, require some sample preparation and only a very small proportion of  the 
total sample is actually analysed.
2) Laser light scattering-based such as dynamic light scattering (DLS), multi 
angle light scattering (MALS), particle tracking analysis (PTA). DLS and MALS 
are rather simple to use, fast, relatively low cost, but can give misleading results 
when used to analyse samples containing non-spherical particles or particles of  
different sizes and in complex media. PTA calculates particle size on a particle-
by particle basis but suffers from a lower size detection value of  around 30 nm.
3) Separation methods such as centrifugal particle sedimentation (CPS), 
analytical ultracentrifugation (AUC), and flow field flow (FFF) fractionation can 
be used. The major feature of  CPS and AUC techniques is that they are effec-
tive in dealing with particle size mixtures. On the negative side, their accuracy 
may be compromised. FFF is a highly promising technique that can separate 
and measure complex mixtures containing NP of  different sizes (down to 1 nm), 
it has an excellent dynamic range, and the various components can be recovered 
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for further analysis. FFF suffers from a limited precision in measuring the abso-
lute size of  NP, but this limitation can be largely overcome by combining FFF 
with other sizing techniques such as light scattering.
Advanced / Emerging techniques
There are other techniques currently being developed that show great 
promise in being able to address some of  the shortcomings of  the more estab-
lished techniques.
•	 Single	particle	inductively	coupled	plasma	mass	spectrometry	(ICP-MS)
•	 Coulter	counter	and	related	pore-based	sensing	(e.g.	iZON)
One possible solution towards an analytical platform able to measure the 
nanoparticle size distribution in complex matrices is the use of  a multi-step ap-
proach where different building blocks are used in a sequential order. These 
building blocks would be: size separation, followed by size measurement, and 
particle quantification and eventual characterization.
There are also several approaches dealing with the chemical modifications 
induced by the presence of  ENM in complex media such as blood plasma and 
their influence on potential oxidative stress induced by ENM. These cell-free 
high-throughput approaches are particularly promising and necessitate further 
investigation.            
Beyond the State-of-the-art 
Synthetic identity of  nanomaterials
To date, most efforts towards classification of  nanomaterials have been by com-
position / chemistry as shown in Table 4.2. Nanoforms of  most conventional 
materials are currently considered as part of  the bulk registration.
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Composition Examples Properties / Features
Metals
Metal oxides
Carbon-based
Silicates / Zeolites / clays / 
ceramics Polymeric
Liposome / micelle
Quantum dots
Other 
Silica, titania, ceria,  
zinc oxide
Carbon nanotubes  
Fullerenes Graphene
Mica, kaolins Synthetic  
variants
PGLA, PEG, hyaluronic acid 
dendrimers polystyrene
Lipids, vesicles, cubosomes
CdSe, CdTe, ZnS
Niobates, carbonates
Wide range of variants,
Amorphous and crystalline forms,
Different oxidative states,
Dissolution, 
Ubiquitous in nature (background)
Ordered structures,
Defined geometries, 
UV-vis absorbance,
Conductivity / electrical properties
Large surface area,
Often catalytic,
Highly adsorptive
Biodegradable,
Biocompatible
Derived from natural products,
Delivery and imaging applications
UV-vis absorbance, 
Fluorescence stability,
Emission tuneability,
Semiconductors
Developed for specific applications
Table 4.2. Classification of nanomaterials by chemical composition
The limitation of  this approach is that it does not include a detailed de-
scription of  the surface coatings, stabilising agents, labelling entities, and other 
surface functionalization that constitute the nanoparticle. Additionally, it does 
not take account of  the multiple different synthesis routes, each of  which can 
lead to different physico-chemical properties (Napierska et al., 2010). This will 
become increasingly important for the description and categorisation of  the 
more complex structural and functional nanoparticles, such as the so-called 2nd, 
3rd, and 4th generation nanomaterials, which will possess complex geometries, 
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hybrid compositions and complex functionalities. In addition, the degradation 
of  complex mixtures entailing nanomaterials can lead to products with the na-
nomaterials associated with other elements present in the mixture. The size of  
the product may not be nanoscale, and the product of  degradation may not be 
toxic themselves, but they may become degraded into nanomaterials.
By 2020 there will be established norms for naming of  nanomaterials, and 
the properties that can be correlated with uptake and impact will have been 
identified and validated as predictors of  toxicity for new materials. Based on 
these properties, strategies for nanomaterials grouping will have been estab-
lished, on the basis of  application of  quantitative property-activity relationships.
 For certain nanomaterial types and media, the results obtained are dif-
ferent when data are assessed on a mass-dose basis or instead of  via alternative 
metrics, such as surface area or particle count. There are studies where the 
effects were assessed using different metrics; the observed toxicity of  the nano-
materials studied was deemed to be closely related to the surface area dose, and 
further, hazard categorisation of  the different nanomaterials could be made in 
relation to surface area (Duffin et al., 2002; Duffin et al., 2007; Oberdörster et 
al., 2005; Stoeger et al., 2006).
Wittmaack (2007) however, indicated that particle number was a better 
dosemetric in nanomaterials hazard studies. Oberdörster et al. (2005), postu-
lated that the surface area concept should be considered in the context of  na-
nomaterial surface properties such as chemistry, charge, coating, crystallinity, 
porosity, and reactivity. Nevertheless, it is clear that there is no consensus on the 
suitable metrics to define the appropriate dose for ENM, not a surprising situa-
tion considering that so little is known on the association between ENM metrics 
and their biological effects.
Examples of  environmental studies in this area are those of  Van Hoecke 
et al. (2008; 2009). These authors assessed the effects of  different nanomateri-
als (SiO2 and CeO2) on algae and Daphnia, respectively. In both studies, hazard 
results could be explained by differences in surface area. Consequently, they re-
ported that toxicity was related to surface area and not exclusively to mass, even 
though there was nanoparticle agglomeration/aggregation. However, in most 
studies, often the surface area assessments have been carried out on dry parti-
cles, using BET, or even the data reported has originated from the manufacturer. 
Similarly it is unclear how particle numbers should and could be assessed given 
the tendency of  particles to aggregate/agglomerate in liquid media. Therefore, 
although these results are important it is essential that technological develop-
ments will permit a more accurate measurement of  surface area and particle 
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number in exposure media.
The strategy proposed to determine the correct dose metrics for nanopar-
ticles will be to solve the analytical research gaps in order to obtain a clearer pic-
ture of  the properties of  the different nanoparticles and then, the most relevant 
dose metric could be suggested for groups of  nanoparticles with well-defined 
characteristics.
Biological identity of  nanomaterials
A hypothesis that emerged from FP6 and FP7-funded research projects relates 
to the hypothesis that nanomaterials acquire a biological identity upon contact 
with biofluids (e.g. river water, cell culture medium, blood or other bodily fluids) 
and living entities (e.g. cells, organisms, animals, humans, and that this corona of  
biomolecules determines their fate and behaviour. Significantly more research 
is needed to translate this into an implementable classification system, but the 
methods to achieve this are emerging, and systems biology approaches will help 
identify key impacts and nanoparticle interaction networks (interactomes). It 
has already been shown that the amount of  uptake and the localisation of  na-
noparticles is dependent on the presence or absence of  serum proteins, and that 
the nature and composition of  a nanoparticle’s protein corona is dependent on 
the concentration of  proteins to which the nanoparticles are exposed: thus the 
corona at low proteins concentrations (e.g. such as used for in vitro studies) can 
be dramatically different from that at higher protein concentrations (e.g. those 
present in vivo), suggesting that a reconsideration of  how in vitro studies are de-
signed in order to enable correlations with in vivo and human impacts  (Monopoli 
et a., 2011).  
It is important to note that interactions between nanoparticles and biomol-
ecules, and the formation of  the bionano-interface, has consequences for both 
the nanoparticle surface itself, and potentially also for the proteins and other 
biomolecules contained in the biomolecule corona. Note that a review paper on 
aspects of  the bio-nanointerface and its role in determining nanoparticle fate 
and behaviour, based on the inputs to this strategic research agenda has been 
submitted to BioNanoMaterials, and contains additional details and discussion 
of  this topic (Ahluwalila et al., 2013 submitted).
The composition of  the biomolecule corona, and the subsequent stabil-
ity, available dose and consequent biological interactions of  nanoparticles, have 
been found to depend on the specific details of  the biofluid in which the nano-
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particles are dispersed, which may account for much of  the contradictory reports 
present in the literature for nominally identical materials to date. Thus, the same 
(batch of) nanoparticles dispersed in different cell culture media (e.g. DMEM or 
RPMI) containing identical concentrations of  Foetal Bovine Serum (FBS) have 
been shown to result in quite different coronas, both in terms of  their thickness 
and dynamics (Maiorano et al., 2010). The authors of  that study observed that 
DMEM elicits the formation of  a large time-dependent protein corona, while 
RPMI shows different dynamics with reduced protein coating. These different 
coronas had implications for uptake and impact, with the protein-NP complexes 
formed in RPMI being more abundantly internalized in cells as compared to 
protein-NP complexes formed in DMEM, consequently exerting overall higher 
cytotoxic effects (Maiorano et al., 2010). These results suggest that cell culture 
medium composition and ionic strength can alter adsorption of  proteins onto 
the nanoparticle surface, which can impact on the particle agglomeration and 
potentially alter the available dose of  nanoparticles under the different exposure 
conditions. Thus, by not having the characterisation of  the nanoparticles in the 
two different media, it is not possible to make any interpretation of  the data on 
the basis of  whether the different protein coronas result in different available 
doses, which could potentially explain the different observed impacts.  
A study of  the interaction of  nanoparticles with surfactant protein A (SP-
A), the predominant protein component of  alveolar lining fluid (the first bio-
fluid inhaled nanoparticles encounter) found different particle-protein interac-
tions for each of  eight different nanoparticles. Interestingly, three variants of  
the same material (cerium dioxide nanoparticles) revealed different adsorption 
patterns despite the materials being nominally identical and indistinguishable 
from one another in electron microscopy images (Schulze et al., 2010). This 
suggests that the protein corona composition (the bio-nano interface) could be 
a very sensitive tool to distinguish subtle material differences and for prediction 
of  biological impacts, once firmer correlations between adsorbed biomolecules 
and signaling or other effects are confirmed.
Building on these findings, it is vital that nanomaterials be considered as 
biological entities, and studied as such – hence the introduction of  the concept 
of  a biological identity to complement the synthetic identity described above. A 
similar recommendation was made by an ERA SKEP – funded project “Nano-
materials in REACH” in its final report (SKEP), which recommended that 
ECHA consider NMs as biological entities and build on lessons from regulation 
of  protein therapeutics and other biological substances. 
Key steps in the short to medium term include understanding and eventu-
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ally predicting which chemical, geometrical and physico-chemical parameters 
of  nanomaterials lead them to preferentially adsorb which proteins, and con-
necting the absorbed proteins with observed impacts, such as uptake, localiza-
tion and signalling. For example, the role of  opsonins and dysopsonins is well un-
derstood in terms of  phagocytotic recognition. However, much work is required 
to tease out the signalling pathways influenced by biomolecules contained at 
the bio-nano interface, whether these be functioning normally or experiencing 
altered functionality as a result of  conformation changes induced by binding to 
the surface.
Libraries of  nanoparticles allowing grouping and nanoQSARs1:
If  we wish to advance the field, then there is an urgent need for sets of  test 
nanomaterials, where the physico-chemical properties are systematically differ-
ent. This would allow testing in a variety of  end-points, which will enable ap-
plication of  QSARs. Coupled to this, is a requirement for certified reference 
nanomaterials for all end-points. Characterisation of  the reference materials 
and the particle libraries under biological conditions is not a trivial issue, as the 
relationships between the nanoparticle properties and those of  the surrounding 
media affecting aggregation/agglomeration state and the resulting changes of  
toxicity cannot be predicted based on current knowledge due to the plethora 
of  factors involved in the interaction of  nanomaterials with biological entities 
(Rabolli et al., 2010) that also include properties of  the cell type being studied 
(Albanese et al., 2011).
Despite a growing amount of  data devoted to nano issues, there are still 
no results of  comprehensive, systematic studies within each of  the nanomaterial 
classes. Even if  a group of  similar nanomaterials has been tested, the number 
of  the considered group members is insufficient from a QSAR perspective. This 
relates to a key nanomaterials need; the creation of  a series of  nanoparticles 
which have their properties varied one at a time to allow systematic evaluation.
1nanoQS/PARs – quantitative structure or property-activity relationships for nanomaterials to 
allow grouping and categorization and eventual prediction of  impacts from physico-chemical or 
biological properties (synthetic and/or biological identity.
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Labelled nanoparticles as tools for quantification of  relevant dose-
response relationships
In order to correlate dose with response, labelled nanoparticles are considered 
as the best approach: these labels involve the use of  fluorescently, isotopically 
or radio-labelled nanoparticles. However, from a regulatory viewpoint, the use 
of  labelled variants is unproven as yet, and there are concerns that the label-
ling process itself  may change the physico-chemical properties of  the particles, 
resulting in different uptake and impact behaviours compared to the equivalent 
unlabelled particles.
Thus, there is an urgent need for labelled variants of  selected classes of  
nanomaterials that are confirmed to possess similar properties, stabilities and in-
teractions as their unlabelled counterparts. This may require core-shell models, 
as some research has revealed that labelling can dramatically affect the structure 
and stability of  nanomaterials, limiting their usefulness for regulatory purposes 
unless such issues are addressed as a priority and the sameness confirmed.
New approaches for hazard assessment enabling 
knowledge based grouping of  ENMs
It will be impossible to assess the risk of  all ENM with all modifications and in 
all use scenarios using current case-by-case approaches. It is important to move 
away from purely descriptive toxicology of  ENM to a predictive toxicology/
nanosafety assessment, based on a thorough understanding of  the dynamics of  
the biological behaviour of  ENM derived from an understanding of  their mate-
rial characteristics. In order to identify the most relevant hazard-associated fea-
tures as well as the most critical molecular signatures that predict the safety of  
the ENMs, state-of-the-art and beyond-the-state-of-the-art systems biology and 
bioinformatics approaches will need to be utilized. These novel approaches are 
being actively developed and some have been successfully applied in bioinfor-
matics. By 2020, the ultimate goal will be to develop a computational tool, i.e. 
ENM SAFETY CLASSIFIER. This tool will predict ENM Safety based on the 
evaluation of  minimal but sufficient amounts of  information to provide a robust 
ENM safety classification. This novel prediction tool is clearly beyond-the-state-
of-the-art but when available it will promote the utilization of  safety-by-design 
principle, and also be capable of  improving the speed of  hazard identification 
and risk assessment. This tool will be tested and validated in close collaboration 
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with industry; it possesses enormous potential to promote marketing innova-
tions based on nanotechnologies.
By the end of  the time horizon viewed in this document, it should be pos-
sible to assign certain biological effects to specific material properties and group 
ENM based on these material characteristics. Although, ENM have been shown 
to undergo interactions with cellular systems in vitro, this approach has only been 
partly successful to date. This will be a high research priority for the next years 
and it is anticipated that the correlation between properties of  the materials and 
cellular functions will have been clarified by 2020.
As a complement, groupings may be based on similar biopersistence and 
biokinetic properties. Kinetics may also give a measure for grouping/summing 
nanomaterials. The same tissue distribution pattern may be one criterion for 
grouping of  different nanomaterials. If  a nanomaterial exhibits a different tis-
sue distribution, this may result in different effects. Grouping may also be based 
on similar or common biological effects, including early effects and ENM-cell 
structure-interaction. Grouping based on early biological effects is tightly linked 
to the Adverse Outcome Pathway (AOP) concept of  the OECD and the tox21c 
initiative in the USA (http://epa.gov/ncct/Tox21/). An illustration of  the 
grouping of  nanomaterials is presented in Figure 4.2, and futher details can be 
found in the full manuscript developed from the inputs to the nanosafety cluster 
vision 2020 (Oomen et al., 2013).
Figure 4.2. Illustration of grouping of nanomaterials based on material properties 
or/and biological effects. 
4 Common nanosafety research themes 
136
Rationale for the development of  testing strategies
A concern-driven guidance for toxicity testing of  nanomaterials will be devel-
oped. This will enable focused research on nanomaterials that may be of  par-
ticular concern based on expected exposure routes, material-properties as well 
as hazard and biokinetic data. This approach is in line with the 3R principle 
(Replacement, Reduction, Refinement), which focuses on the replacement of  
animal testing methods with alternatives that do not use animals, advocating 
that living animals are only to be used for crucial and focussed studies.
Based on the above information, integrated testing strategies will be devel-
oped for different types of  ENM, starting by non-testing and existing toxicologi-
cal data, proceeding with tests using acellular systems, and further proceeding 
through cellular systems to in vivo, long-term testing approaches when neces-
sary. These strategies will be based on a thorough understanding of  the ma-
trix-dependent ENM biokinetics enabled by continuous sampling, analyses and 
characterization paradigm. The strategies will be based on validated methods 
with proven predictive power and they will be designed both to evaluate human 
health and environmental safety/risk assessment.
In 2020, guidance will be developed to determine how best nanomaterials 
can be grouped and how these groupings should be constructed. In addition 
to avoiding extensive hazard testing of  nanomaterials, this will also provide in-
sights when information on exposure and hazard for nanomaterials can be used 
for risk assessment purposes.
Safe design of  new ENM in a bottom-up approach
The development and implementation of  Safety by Design (SbyD) control strat-
egies with its “primary” prevention value of  risk management, represents one 
of  the biggest challenge of  nanotechnology that should guarantee its sustainable 
development.
It will be necessary to combine exposure, biokinetics and hazard data for 
the purposes of  both risk assessment and grouping. The AOP approach will 
provide guidance regarding the integration of  material properties, exposure, 
biokinetics and hazard data. This is a priority for future research on the safety 
of  ENMs.
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Surface engineering has opened the doors to the development of  a 
second, third, and fourth generation of  ENM. Self-assembling bottom-up 
techniques have been widely developed at industrial scale, to create, ma-
nipulate and integrate nanophases into more complex nanomaterials with 
new or improved technological features.
Materials scientists have the chance to address such knowledge to the 
control of  hazard specific properties by preserving nanoscale reactivity, to-
wards the integration of  safe-by-design approaches into the development 
stages of  new nanomaterials and their applications. 
The conceptual framework to identify key features that drive the de-
sign of  safe nanomaterials (Roca et al., 2012) is reported in Figure 4.3. 
It includes a first level of  data generation/gathering. The understanding 
of  the mechanism that governs both the adverse effects of  NMs on bio-
logical system and the emission/exposure potential in terms of  fate from 
nano-aereosolization to bio-uptake is, infact, fundamental to implement a 
rational approach for the safe design of  nanomaterials. At a second level 
the observed evidences on nano-bio interaction mechanism should be sup-
ported by predicting models. Finally, at a third level the safer by design 
NMs should be implemented within real industrial processing lines, allow-
ing cost-benefit analysis and the promotion of  primary prevention based 
risk control measurements.
Figure 4.3. – Components of “Nano design” framework
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The required research priorities to achieve this are to:
 1. Develop systematic sets of  ENMs with properties varied in a 
  stepwise manner that will allow assessment of  the significance 
  of  each property for toxicity.
 2. Describe “reference” states and agreed media compositions to 
  enable identification of  significant biomarkers and enable a 
  move towards a predictive toxicity assessment.
 3. Understand the longer term fate of  particles following their 
  interaction with living systems.
Nanomaterial identification and classification approaches to deter-
mine the key descriptors that can be used to reveal correlations associ-
ated with impacts. The inter-relationship between the nanomaterials’ 
identification and classification is a cross-cutting topic and Figure 4.4. 
illus trates how it feeds into the other cross-cutting nanosafety research 
themes:
Conclusions 
A full understanding of  the key descriptors for characterising ENM 
along with validated methods to identify and quantify ENM in complex 
matrices in vital in order to identify crucial parameters relevant for risk 
assessment. This is also important for the measurement of  the relevant 
ENM properties that correlate exposure with biological impacts. This 
will require agreed reference states for nanomaterials characterization, 
libraries of  reference materials, and a framework for understanding 
later generation nanomaterials. 
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Figure 4.4. Inter-relationship between the sub-elements of Identification 
and classification and the other cross-cutting themes.  
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Some of  the above mentioned research areas have been formalized for 
traditional chemicals and products. There are some major harmonized or regu-
lated activities e.g. OECD test guidelines for environmental fate studies, CEN 
standards such as dustiness tests for powdery materials and the regulation of  
chemicals Registration, Evaluation, Authorisation and Restriction of  Chemical 
substances (REACH), just to name a few. The fundamental questions related 
to the existing frameworks have relevance to the now rapidly developing nano-
technologies, in particular those associated with the use of  ENM, are:
- Is this existing framework appropriate to ensure the safe production, 
 handling and use of  ENM?
- Are the existing regulations and test guidelines applicable for testing 
 nanomaterials, do they have to be adapted and/or do additions need to 
 be made?
 The current view is that the general existing regulatory frameworks are 
 applicable but have to be adapted and extended for some ENM specific 
 issues.
4.2 Exposure, transformation and 
the life cycle
Exposure of  humans and the environment is a result of  many sequen-
tial or concurrent processes. These facts have emerged from research 
related to ENM production, ENM characterization, aging of  products 
containing ENM, human and environmental induced release of  ENM 
into the environment, transport, transformation, degradation and 
 possibly accumulation of  ENM in the environment or along the food 
chain.
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The clustered section below on exposure and transformation elaborates 
our current knowledge and the research areas which need to be addressed in 
 order to derive accurate and reliable data for assessments. It has been empha-
sized that ENMs are the subject of  some special properties, especially those 
related to the transformation of  materials during their life-cycle or after their 
release into the environmental compartments which are known to alter their 
relevant substance characteristics e.g. size, shape, charge, state of  agglomeration 
etc. Should that occur, this may modify substantially their hazard and exposure 
characteristics. Therefore, our knowledge with regard to transformation and 
current exposure models for conventional substance are not likely to be appro-
priate for the prediction of  exposure to throughout the different stages of  the 
life cycle.
State-of-the-art
Studies relating to ENM exposure have, to date, focused largely on occu pational 
settings. Workplaces are better aware of  the type(s) of  ENM involved, and work-
place exposures typically involve potentially higher acute and/or repeated ex-
posures at relatively high concentrations. In comparison, far less research has 
been conducted on exposure to ENMs after their incorporation into consumer 
products. This remains a significant problem as exposure is largely dependent 
on patterns of  usage and method of  application. Research into the area of  en-
vironmental release over the whole life cycle and exposure is confounded by its 
complexity due to the large number of  contributing factors. This area remains 
in its infancy, despite the fact that there is an ever-increasing potential exposure.
In summary, it is clear that more information on the use of  ENM, 
potential for ENM release and exposure in occupational, consumer and 
environmental contexts is urgently needed in order to derive a compre-
hensive overview of   possible human and environmental exposures.
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Figure 4.5. Nanomaterials from release to exposure
Figure 4.5. depicts the important steps involved in the exposure to nano-
materials. Two steps have to be considered for the determination of  risk from 
exposure to nanomaterial. In the first step, release has to be identified in order 
that the exposure assessment can be conducted. In the second step, the trans-
port and transformation of  the nanomaterial has to be described to identify the 
type of  potential exposure. After the type of  exposure is identified, information 
about their possible health effects can be provided.
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Figure 4.6. Nanomaterial life-cycle and release
 
Environmental behaviour and fate determine the transport / mobility of  
the nanomaterials as well as their transformation. These processes influence 
also the likelihood of  environmental exposure as well as possibly their hazard 
potential. An example is the environmental and biological degradability of  
nano materials. Unfortunately the number of  studies examining the potential of  
degradability as a remediation technology is currently rather small.
Life Cycle Assessment (LCA) is the best developed and standardized 
metho dology for assessing the environmental aspects and potential im-
pacts throughout a product’s life from raw materials and energy extraction, 
Figure 4.6. shows the life-cycle of  a given nanomaterial and illustrates that 
any release will end up in some compartments of  our environment. Conse-
quently, this may then lead to an exposure of  the environment, and humans 
through the environmental compartments.
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parts manufacture, assembly, distribution and sale, use and final disposition 
such as disposal, recycling, and energy recovery (i.e. cradle-to-grave). The 
environ mental and resource impacts include climate change, stratospheric 
ozone depletion, toxicological stress on human health and ecosystem, the 
depletion of  resources, water use and many others. The use of  LCA also 
avoids the problem being simply shifted from one stage of  the life cycle to 
another.
Life cycle assessment(LCA)
The ISO-framework for LCA (ISO 14040:2006) has been found to be ful-
ly applicable for nanomaterials and nanoproducts, even if  data regarding 
the elementary flows and impacts might be uncertain and scarce (Klöpffer 
et al., 2007). So far only a limited number of  research reports have ad-
dressed LCA of  nanotechnology-based materials and products. In addition 
to the qualitative environmental assessments of  the different manufacturing 
methods (Steinfeldt et al., 2007; Sengül et al., 2008), quantified material 
and energy flow data exist for only a very small number of  manufacturing 
processes and/or for individual nanomaterials. It shows that studies have 
mainly focused on cradle-to-gate  assessments. Cradle-to-gate is an assess-
ment of  a partial product life cycle; representing the stage from manufac-
ture to its exit from the factory gate. The use phase and the after use phase 
(recycling, disposal) of  the product are usually omitted (Meyer et al., 2009). 
For both of  these phases, there is almost no data investigating their envi-
ronmental impact.
Long-term environmental effects
The sensitivity of  terrestrial systems to possible long term effects of  ENMs 
to the environment has to be acknowledged in environmental studies, in con-
junction with LCA. Water and air are mobile environmental media which 
will dilute ENMs concentrations and hence exposure levels will depend very 
much on emission rates, while there may well be long term accumulation of  
engineered nanomaterials in sediments and soils. This may lead to long term 
exposure to elevated nanomaterial concentrations but little is known about 
this possibility. 
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The LCA includes four stages:
1. Definition of  the goal and scope of  the investigation –  
 description of  the product system in terms of  the system  
 boundaries and a functional unit
2. Inventory analysis – collection, compilation and calculation  
 of  data
3. Impact assessment – data of  life cycle inventory analysis is  
 organized and summarized according to its environmental  
 relevance
4. Interpretation – derivation of  conclusions and issuing  
 concrete recommendations
Life cycle assessment framework
Inventory
analysis
Impact
assessment
Interpretation
Goal and
scope
definition
Direct applications:
•	 Product development
•	 Strategic planning
•	 Public policy making
•	 Marketing
•	 Other
Figure 4.7. Steps in the preparation of life cycle assessment [adapted from ISO 14040]
The relationship between these steps and the iterative nature of  the LCA 
process is indicated in Figure 4.7. 
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Possible release during production may occur through leaks into water and 
air in closed systems or open production processes. These have been studied 
in several European and national studies such as NANOSH, CarboSafe, and 
nano GEM. “Handling and use” covers several process-related stages e.g. hand-
ling of  powders, diffuse emission from production plants, mechanical treatment 
of  nanomaterials, while “aging” encompasses all processes taking place in the 
environment such as selective degradation, wash-out, increased brittleness of  
the material.
End of  Life activities refer to activities related to i) re-use or recycling, such 
as disassembling, and mechanical or thermal processes like crushing, melting, 
torch cutting, ii) waste treatment, e.g. incineration, and iii) disposal, e.g. landfill. 
In particular, during high energy processes, the release of  nano objects may not 
be excluded.
Research and development activities aimed at understanding processes re-
lating to release of  ENM. This research and development activities are likely to 
increase in the near future since this will allow a) detailed studies of  processes, 
b) standardised testing for certain possibly relevant release mechanisms, c) inter-
national harmonisation, d) derivation of  quantitative information of  possible 
release rates, and e) good characterisation of  the physico-chemical character-
istics of  the released material. The importance of  the latter has been nicely 
illustrated by Nowak and Bucheli (2007) in Figure 4.8.
General processes and areas of  possible release of  nanomaterials 
include
1. Production
2. Handling and use 
3. Aging
4. End of  Life (EoL)
While ENM release is a prerequisite of  downstream exposure, little has been 
done so far to approach this area in a systematic manner.
Release
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Exposure in workplaces
The workplace is generally the best characterised exposure scenario due to the 
relatively high exposure probability and the fact that there may be significant 
concentrations of  nanomaterials being handled by workers and the relatively 
predictable nature of  processes and activities. In fact, most of  the studies con-
ducted have been mainly exposure related or even more release related. No spe-
cific personal exposure measurements at various workplaces leading to a robust 
exposure assessment via inhalation or oral uptake have been conducted so far. 
Dermal exposure has virtually not been examined with the exception of  Van 
Duuren-Stuurman et al. (2010) who utilized a shortened version of  the observ-
ational DeRmal Exposure AssessMent (DREAM) to estimate the likelihood for 
exposure. This report highlighted the relevance of  uptake via the intact skin 
(Grosera et al., 2009). With the exception of  the intended use of  nanomaterials 
in foodstuffs, possible oral uptake following inhalation exposure or from hand-
to-mouth contact has not yet been examined.
All studies that have been conducted to date have only focused on short 
term exposure to ENM. As far as we are aware, there are no details of  exposure 
monitoring or long term exposure assessments have been conducted. Another 
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Figure 4.8. Release of nanoparticles (NP) a) as free NP; b) as aggregated NP; c) of 
NP bound in a matrix; d) as functionalised NP. Environmental factors influence ag-
glomeration and deagglomerations (from Nowack & Bucheli, 2007). 
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topic to be addressed and in which major advances can be expected is related 
to the type of  workplaces and work processes. The current workplace investi-
gations have focussed on areas where nanomaterials are produced. Knowledge 
on use and processes with nanomaterials in the second or later stages can cur-
rently not be evaluated due to the lack of  knowledge on their use. Labelling, 
which is also needed to identify possible exposure via consumer goods, is one 
way to address this safety research topic. Most exposure-related studies have 
revealed that mainly larger agglomerates and aggregates of  Nano objects are re-
leased (e.g. Kuhlbusch et al., 2011) with only a few studies having clearly shown 
release and possible exposure to ENM that have at least one dimension below 
100 nm in size.
Exposure via consumer products 
The use of  a wide range of  consumer and food product types may result in 
different exposure scenarios, e.g. personal care products, cleaning, coating prod-
ucts etc. At present there are no relevant test scenarios of  release and exposure 
to Nano objects. Current knowledge is limited to selected tests conducted for a 
few spray and cream formulations. In addition, we lack information on the NP 
content in consumer’s products and foods despite their widespread use. Infor-
mation on their use and application is needed to permit a better evaluation of  
possible exposure sources and pathways. One of  the main obstacles in studying 
consumer exposure is how to undertake a reliable measurement of  particles in 
the different matrices of  consumer goods and food products. Strategies to over-
come this limitation will need to be developed. These may be based on testing 
of  different release processes and realistic exposure scenarios for consumers us-
ing ENM specific measurement techniques and strategies.
Exposure via the environment 
Environmental exposure to ENM represents potentially the most widespread 
mechanism for exposure, and therefore this is of  relevance for the whole popu-
lation as well as animals and plants. However, it is very difficult to study the inter-
actions and distributions of  nanomaterials in the wider environment, and when 
this problem is coupled with relatively low concentrations then scientists are 
faced with a major challenge. Environmental studies have so far been  limited to 
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release related studies such as the report of  Kaegi et al. (2008) which examined 
the TiO2 wash-off  from facades. Currently the main way of  assessing possible 
environmental concentrations is using emission based approaches and models 
such as the technique utilized by Gottschalk et al. (2010). These workers ex-
tracted information on production rates, release fractions, assumed or based on 
measurement (e.g. sewage plant studies), and environmental transport and used 
this data to model environmental concentrations. These concentrations may be 
compared with environmental no effect levels for plants, animals and humans to 
assess a possible risk. Nonetheless, the application of  the model is limited on a 
priori information and it would be advantageous to obtain better source data in 
the future. Currently no environmental monitoring technology is in place which 
could be used for monitoring of  the environmental concentrations of  persistent 
nanomaterials, concentrations of  which are expected to increase in the future. 
This is certainly one area of  future research, which although important, is cur-
rently not viewed as a straightforward task.
Transport and Transformation 
It is accepted that nanomaterials may undergo various changes during sub-
sequent processing activities and after their release, and changes may also  occur 
during environmental transport. Transformation processes may take place in 
air as well as in liquid environmental media, soils and sediments. One can give 
examples of  these kinds of  changes e.g. loss of  coatings, change in coating com-
position, development of  a corona which depends on the particle surface prop-
erties, and dissolution in liquid media. Also other pathways of  degradation exist 
which are not well identified or even used as a remediation technology.
Beyond state-of-the-art 
Release 
The major obstacle in studying ENM release, transformation and exposure is 
the identification of  the particles themselves. Discrimination of  particles by type 
(e.g. engineered vs. natural vs. particles produced during the manu facturing 
process itself) is of  importance when assessing exposures, and in subsequent 
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analyses that interface with health studies. This problem increases as the ENM 
become ever more removed from the actual source both in time and space. For 
example, in the workplace environment, specific nano-objects are expected and 
release / exposure can be targeted using specific search criteria and protocols, 
and hence it is possible to limit resources to those parameters exactly fitting 
the appropriate purpose. Some strategies and techniques have been developed 
and tested in workplaces (reviewed in Kuhlbusch et al., 2011). However, severe 
limitations exist even for those used for research purposes and the existing tech-
niques cannot be employed in routine workplace measurements. In the other 
extreme case, the environment, it becomes very difficult to develop an appropri-
ate and feasible analytical method as nanomaterials may undergo modifications 
e.g. aging processes.
Another limitation is that currently there are very few measurement tech-
niques that simulate aspiration efficiency and the deposition in the trachea-bron-
chial and alveolar regions resulting in mismatches between the concent rations 
measured, the concentrations inhaled, and the estimate of  the deposited dose. 
In order to obtain health related exposure information, modelling techniques 
have to be applied to the data. This lack of  health related exposure data, as well as 
some other factors, complicates the establishment of  occupational exposure limits.
Measurement techniques and strategies are crucial in studying nano-
material properties, behaviour, transport, exposure, uptake and fate. A few 
established techniques are currently available for these studies and have been 
summarised in the literature (Kuhlbusch et al. (2008), Tiede et al. (2008), Stone 
et al. (2010). In summary, the main techniques currently employed are either 
microscopic methods for information on particle morphology, state of  aggre-
gation and chemical composition, or methods discriminating particles accord-
ing to size in relevant media. The latter methods sometimes allow subsequent 
separate analysis for chemical composition. 
Exposure in workplaces
The next steps to pursue with regard to workplace exposure will be the deve-
lopment and testing of  personal monitoring devices delivering reliable results that 
can be used in health studies and/or for risk management. Focus should be placed 
on personal real time instruments that simulate uptake, e.g. deposition in the differ-
ent areas of  the respiratory tract. The development of  realistic exposure scenarios 
is needed to allow a comparative assessment of  different tasks and processes. They 
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should be based on an extensive data set on workplace exposure, generated in a 
harmonized way as much as possible (Brouwer et al., 2012). The data included 
should be accompanied by auxiliary contextual information that is required to 
interpret the measurement results for risk assessment and mediation purposes. 
The exposure scenarios are also needed since they can be useful in to derive 
information about uptake for combined assessments of  hazard and exposure 
potential.
Exposure via consumer products 
During consumer usage nanomaterials are subjected to mechanical, thermal 
and environmental stress situations. Studies based on the characterisation of  
airborne particles release due to individual processes can roughly be classified 
by the investigated nanomaterial used for coating and according to the nano-
materials used in composites. Coatings could be considered to be a thin layer of  
composite material, as the engineered nanoparticles are intentionally embed-
ded in a matrix material. However, in exposure studies, composites and coating 
cannot be compared and have to be analysed in different ways. The relatively 
long duration of  the current aerosol measurement has restricted the intensity 
of  abrasion. This means that with a higher abrasion intensity the coating could 
become worn off  before the measurement finishes. Therefore only a limited 
simulation of  exposure is possible. However, if  one wishes to assess the real 
potential impact of  nanomaterial on the environment and the human health, it 
will be necessary to characterise, with feasible techniques, the properties of  the 
particles once they have been released into the environment.
Transport and Transformation
There are very rapid developments occurring in the fields of  nanomaterial pro-
duction and current technologies are not sufficiently well-developed to provide 
rapid assessments in a coherent manner. At present, some research groups are un-
dertaking comprehensive research activities to develop some predictive models on 
how the material will interact with its surroundings, and how that may influence 
its subsequent transport, accumulation and reactivity; one must anti cipate that 
there will be a huge increase in the knowledge base relating to ENM transport and 
transformation - including predictive modelling - occurring within the next 10 years.
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Conclusions 
The main goal to be achieved will be the development and imple-
mentation of  integrated release to exposure models for nanomaterials 
in workplaces, consumer applications and the environment. One can 
anticipate that these will be based on the following ‘building blocks’:
Mechanistic understanding of  processes determining the release  
of  ENM
- studies on the behaviour of  ENM when processed, when  
 worked with, when being used taking into consideration  
 possible nanomaterial release, aerolised or the presence of   
 ENM in liquids
- comprehensive release and emission inventories covering  
 production and all subsequent processing, usage steps and  
 recycling
Understanding the transformation and transport of  ENM
- studies on environmental mobility and transformations during 
 transport and storage, including environmental persistence of   
 the corresponding nanomaterial
- effects of  ageing on nanoparticles, including changes in their  
 shape, surface morphology and chemistry induced by  
 environmental factors such as weathering, electromagnetic  
 fields, mechanical stress and chemical reactions
Understanding workplace, consumer and environmental  
exposure
- efficient exposure measurement approaches also which can be 
 applied in epidemiological studies
- harmonized inventories, which can be utilized in the  
 construction of  exposure models
- development of  personal devices to estimate deposition in the  
 respiratory tract
- evaluation of  information relevant to describe exposure and  
 inclusion of  these factors into risk assessment and mediation  
 strategies as well as into exposure modelling efforts
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Another achievement by 2020 will be the integration of  safe-
by-design, closed production-to-product and green nanotechnology 
approaches into the development stages of  new nanomaterials and 
their applications. The Social and economic benefits and/or problems 
should also be addressed in addition to the above mentioned aspects 
on exposure, transport, transformation and life cycle assessment if  we 
hope to achieve sustainable nanotechnologies. 
2015 2020 2025
Defining/priotizing release 
processes; lab simulations and 
process level understanding 
Identifying and process 
level understanding of key 
transformation processes in the 
environment and their testing
Integrating and advancing environmental transport models to 
include NM, their interaction with the environment as well as key 
transformation processes, combining all environmental 
compartments  link to effects e.g. by including NM uptake
Preparatory work for 
evaluated test methods for e.g. 
CEN, ISO, OECD etc..
Advance and validate release process related 
models for exposure of workers, consumer, 
population and the environment, including 
diffusive emissions
Set of well 
defined 
laboratory test 
procedures 
and evaluated 
models for 
use of product 
cycle and 
exposure 
assessment 
(for workplace, 
consumer 
and the 
environment).
Release-transport-transformation-fate exposure models
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4.3 Hazard mechanisms,  
biokinetics, and vulnerable  
populations
Generating a comprehensive understanding of  the biological behaviour 
of  ENMs based on their material characteristics allows creating a knowledge-
based ENM safety classification by the end of  this decade. This can lead to the 
development of  intelligent testing strategies for ENMs and would also provide 
solutions to other regulatory requirements related to ENMs, including afford-
able assessment of  safety and classification and labelling of  these materials. In 
addition, this research will also provide a firm foundation for resolving the safety 
classification challenges posed by the second, third, and fourth generation of  
ENMs.
The release of  ENMs as in real-life situations and the dispersion of  ENMs 
for toxicity assessment are of  paramount importance for adequate hazard as-
sessment. Since a multitude of  different ENMs in various exposure scenarios is 
expected, all-embracing testing will not be possible. Hence, hazard assessment 
must be targeted to ENMs that constitute actual concerns in realistic exposure 
scenarios. Moreover, hazard assessment should be addressed by possibilities for 
grouping of  ENMs and should also aid the grouping concept itself  (see page 
134).  
Given the growing use of  ENMs in a wide range of  applications, it is pre-
dicted that increasing amounts of  these materials will end up in the environ-
ment, leading to exposure of  environmental species. It is clear, therefore, that 
ENMs should be considered as potential emerging contaminants. Knowledge 
Hazard assessment of  ENMs has made good progress during recent 
years, but knowledge is still lacking in many areas including modes of  
action and mechanisms leading to toxicity, identification of  susceptible 
populations and vulnerable conditions, and aspects of  biokinetics and 
its impact on toxicity. 
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of  the behavior of  ENMs with respect to sorption, interaction with environ-
mental organisms, accumulation as well as degradation is a prerequisite for the 
performance of  scientifically sound hazard and risk assessments for ENMs.
State-of-the-art
Today, only a few EU funded nanosafety projects have, as their goal, the provi-
sion of  a conceptual foundation, based on an in-depth understanding of  the 
relationship between material characteristics and the mode of  action (toxicity) 
of  ENMs. This is done across species, and examining biological effects at the 
cellular, organ, and organism levels, to develop a general safety classification of  
ENMs. The emerging nanotechnologies are poised to deliver on the promise 
of  promoting industrial growth and the economic wellbeing of  EU citizens, 
but a solid framework for assessment of  nanosafety is still lacking, despite much 
recent effort conducted in the EU and elsewhere. The deliberation of  the new 
definition for a nanomaterial by the EU is one step forward, but the assessment 
of  the safety of  ENMs still proceeds as an ad hoc evaluation of  new materials 
(EU 2011), an approach that will not be viable in the future, due to the lack of  
resources and the huge number of  emerging ENMs. 
Understanding of  how nanomaterials interact with living system is incom-
plete and, thus, we are not yet in a position to assess the relevant end-points for 
nanomaterial toxicity. At the same time, we are faced with an onslaught of  new 
materials for which testing or screening of  toxicity is required. To resolve this 
situation, methods for prediction of  nanomaterial toxicity are needed.
There is uncertainty to what extend current methods to identify and assess 
the hazard of  ENMs can be applied to ENM testing. When the modes of  action 
of  hazardous ENMs are poorly known, it remains unclear, whether the assays 
reveal effects critical for the hazard. ENMs can be coated by all kinds of  sub-
stances, either deliberately (coating) or unintentionally (surface layer), and very 
little is known about the impact of  the resulting surface chemistry on both the 
toxicokinetics (absorption, biodistribution and clearance) and toxico dynamics 
(toxicity and recovery). The coating/surface layer has been show to influence 
both ENM biokinetics and toxicity at the level of  a cell, a tissue or an organism. 
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Mechanisms of  action leading to toxicity
Figure 4.9. shows a summary of  possible mechanisms of  toxic effects of  ENMs. 
The toxic mechanisms of  ENMs are still poorly known, and much of  the infor-
mation available on the adverse effects of  ENMs is based on experimental in 
vitro and in vivo studies using relatively high doses. Most of  the published toxicity 
data on ENMs derive from in vitro approaches, and it is presently still unclear, 
how well cell cultures could actually reflect the effects of  ENMs in vivo.
Figure 4.9. Possible interactions of ENM with the cell and subcellular structures. 
(adapted from Colognato et al. 2012 with permission). 
Inhalation exposure is considered the most relevant exposure route for po-
tential human exposure to ENMs, and most toxicological in vivo studies pub-
lished on ENMs have concerned the pulmonary inflammatory effects of  ENMs 
(Colognato et al, 2012). Most of  the oxidative burden related to particles is as-
sumed to originate from increased recruitment of  activated inflammatory cells, 
in particular granulocytes. Yet, the details of  the inflammatory mechanisms 
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of  ENMs are poorly known. In addition to inflammogenicity, relative bioper-
sistence has been proposed to be another driving factor of  the pulmonary tox-
icity of  inhaled particles. Exposure to highly biopersistent ENMs of  low toxicity 
may in fact result in a higher lung burden and associated inflammation than 
exposure to highly toxic ENM with low biopersistence (Pauluhn, 2013). 
Poorly soluble, inert nanoparticles, such as nanosized TiO2 and carbon 
black, are considered to represent granular biopersistent particles (GBPs) with 
no or little intrinsic toxicity. When inhaled, GBPs are thought to induce inflam-
mation, oxidative stress, and, due to these phenomena, secondary genotoxic 
effects in the lungs (Hartwig, 2013). Nanosized GBPs may exert these effects at 
lower doses that microsized GBPs, although this question has not systematically 
been studied. High doses of  GBPs appear to induce lung cancer in rats but not 
in other species; the carcinogenic effect has been associated with overloading 
due to particle deposition and retention on the respiratory epithelium, result-
ing in impairment of  the clearance mechanism of  the lung, inflammatory res-
ponse, production of  reactive oxygen and nitrogen species, epithelial cell injury 
and proliferation, and secondary genotoxic effects (ILSI Risk Science Institute 
Workshop Participants, 2000). Due to the suggested secondary mode of  action 
of  carcinogenic GBPs, cancer could be expected only in association with ad-
equate, prolonged inflammation or oxidative stress. This would indicate the pre-
sence of  a threshold exposure level below which carcinogenesis would not occur. 
However, very little is known about the carcinogenicity of  nanosized GBPs and 
the actual mechanisms involved. In vitro studies actually suggest that nanosized 
GBPs and other ENMs could also have some primary geno toxicity, as seen by 
the induction of  DNA damage and chromosomal alterations in cultured mam-
malian cells; in several studies, nanosized particles have shown higher geno-
toxic potency than larger particles (Schins et al., 2013). Although the observed 
increase in DNA damage in vitro is in many cases relatively low, it appears to be 
continuously produced (or persistent) in ENM-treated cells (Falck et al. 2009). 
The mechanisms behind these effects are not understood, but may involve, e.g., 
indirect effects of  oxidative stress generated by ENMs in the cell or, in some 
cases , direct interaction of  ENMs with DNA (Fig. 4.10.). As rather few com-
parative genotoxicity studies on EMNs are available in vivo, it is unclear, how 
well in vitro genotoxicity assays are able to reveal EMNs that are genotoxic in vivo. 
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Fibrous ENMs, such as carbon nanotubes (CNTs), may show, analogously 
to asbestos, fibre-like toxicity which depends on cumulative dose, the shape, 
dimensions, biopersistence, impurities, and other physicochemical character-
istics of  the material (Hartwig, 2013). Fibrous ENMs may have toxic effects 
on the lungs already shortly after single inhalation, possibly due to adsorptive 
depletion of  essential homeostatic factors involved in surfactant homeostasis 
and sub sequent dysfunction of  the air-blood barrier, whereas volumetric par-
ticle overload may trigger retention-related responses affecting biopersistence 
and long-term sequelae (Pauluhn, 2013). Several studies have suggested that 
bolus exposure to ENMs by intratracheal instillation or pharyngeal aspiration 
may result in differential ENM lung distribution and different types of  toxic ef-
fects than inhalation exposure. When injected intraperitoneally or intrascrotally, 
CNTs (especially long and rigid) have been shown to induce mesothelioma in 
mice and rats. The exact mechanisms behind these findings are not known. A 
number of  in vitro studies have shown genotoxic effects with various types of  
CNTs, again suggesting some primary genotoxicity in cells treated with these 
materials. Figure 4.11. shows aggregates of  carbon nanotubes in mouse lung. 
Figure 4.10. Fluorescence 
microphotograph of human 
lymphocytes treated with 
nanosized TiO2 for genotoxicity 
assessment. The arrow shows 
a micronucleus in a binucleate 
lymphocyte.  
(Image by Kati Hannukainen)
Figure 4.11.  
A light microscopic picture of a large  
granuloma in mouse lung tissue after  
inhalation exposure to carbon nanotubes  
(photo by Marit Ilves, FIOH).
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Partly soluble metal-based nanoparticles, such as copper and zinc oxides, 
may show, in addition to particle effects, specific toxicity due to the release of  
metal ions. The nature of  the toxic effects depends on the type of  the ions and 
may involve metal-specific cellular interactions (such as genotoxic effects) in ad-
dition to inflammation and oxidative stress, at relatively low doses. Partly soluble 
nanoparticles may be more toxic than similar particles of  larger size, possibly 
due to their higher intracellular bioavailability, even though this has not been 
confirmed experimentally (Hartwig, 2013). 
   
Biokinetics
At present, there is very little integration of  kinetic and toxicological effects 
testing for ENMs as for instance OECD Technical Guidelines for health effects 
testing substances do not require biokinetics. Biokinetics is not only important to 
increase our understanding on how (well) ENMs are distributed across the body, 
but the information is also used for interspecies extrapolations as well as for the 
design of  follow-up longer term exposure studies and in vitro studies. Lack of  in-
tegration leaves many questions open such as whether the data obtained during 
kinetics testing do apply to the results as obtained in the effects testing  studies 
that is pivotal for reliable risk assessment. Most information available is for 
the inhalation exposure which indicates a complex deposition of  ENMs based 
on their size distribution. For the oral route, the effect of  the various physico-
chemical conditions met during passage of  the gastro-intestinal tract is largely 
unknown. For the dermal route, the release rates of  cosmetic products and con-
sumer products is largely unknown, as is the influence of  sweat, tempera ture, 
sheer force, water as with showering and hand washing.
Absorption - Absorption is defined as the passive and/or active crossing of  
outer membranes. Currently, scarce information is available on rates of  absor-
ption of  ENMs upon exposure via the three most relevant routes (oral, dermal 
and inhalation). Differences in rates of  absorption are expected between routes 
and between ENMs and between an ENM and its non-nano counterpart. The 
information is still very limited due to the scarce availability of  routine analytical 
equipment for particle analysis in these systems.
Distribution – Intravenous studies have indicated that ENMs distribute 
rapidly from blood to tissues, mainly those that contain phagocytising cells. The 
apparent very rapid blood/plasma half-life is in sharp contrast to the apparent 
long whole-body half-life. Distribution profiles may differ between ENPs with 
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different characteristics and different distribution profiles of  ENPs may hamper 
combining hazard and exposure information.
Metabolism / Breakdown - Metabolism as known from classical soluble 
chemi cals is probably quite irrelevant for ENMs as such. ENMs are regarded 
as too large to fit into the active site of  biotransformation enzymes. Possibly, 
some oxidation may occur at the outer surface of  ENMs. This may be related 
to Fenton chemistry of  metals. These processes are generally not studied in 
biotransformation tests. What is more relevant for ENMs is twofold: first there 
is (time-dependent) dissolution into ions and secondly there is formation of  any 
kind of  surface layer such as corona formation.
Excretion - Excretion via the usual routes (biliary, urinary, via mammal 
glands, via saliva) is generally unknown. The rare studies available, however, 
suggest that excretion is very slow, which may be the reason for the sparse 
inform ation available. The longer the half-life, the longer study is needed for a 
reliable assessment of  the rate of  excretion. This makes these studies relatively 
expensive, nevertheless highly relevant to assess terminal half-life; the larger the 
higher the risk for bioaccumulation.
Accumulation - Persistence is a main driver for bioaccumulation. It is be-
lieved that the structure and dynamics of  protein corona is important to the 
rate of  ENM uptake and transport into cells, and final subcellular localization. 
In this context, certain proteomics methods to identify the nature, composition 
and dynamics of  the biomolecules associated to ENMs have been developed. 
Without suitable information on the potential for ENMs to bioaccumulate, it 
is infeasible to carry out higher-tier risk assessment or derive Environmental 
Quality Standards. 
Presently, the hazard/risk assessment of  ENMs can only be addressed on 
a case-by-case basis. However, given the large number of  existing and emerging 
nano formulations, this will be a very time-consuming and resource-intensive 
task. In this context, Integrated Testing Strategies (ITS) have become particu-
larly relevant since they are intended to speed up the risk assessment process and 
reduce testing costs and animal use. Good understanding of  ENM biokinetics 
and translocation is crucial in the development of  reliable ITS systems. 
Susceptible populations and vulnerable conditions 
The great majority of  the studies exploring potential pathogenic effects of  
ENMs have been conducted in settings mimicking effects in healthy individu-
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als, but only part of  the world’s population can be categorized into this group. 
Many individuals have impaired health conditions that are likely to make them 
more susceptible to develop health problems from particulate exposure. The 
most re levant groups of  potentially vulnerable conditions are: individuals with 
respi ratory or cardiovascular disorders; individuals with chronic inflammation 
of  the gut, or more permeable gut epithelium as a result of  chronic diseases like 
dia betes or obesitas. On the other hand pregnant women, children and elder ly 
people can be considered as, individuals in a susceptible physiologic state. There 
are at least two reasons for identifying susceptible high risk populations and in-
dividuals with vulnerable conditions in the safety evaluation process of  ENMs. 
The first one is that, even in the case of  absence of  adverse effects in normal 
healthy individuals, susceptible populations and individuals with vulner able 
conditions may nevertheless develop a disease state after exposure; the second 
one is that they may require special protective measures in the case of  the pres-
ence of  adverse effects in the general population. 
Vulnerable conditions - Currently, there is no direct evidence of  the presence 
of  groups highly vulnerable to ENM exposure. Their presence is suggested by 
epidemiological data concerning the ultrafine component of  air pollution, but 
some experimental data regarding ENMs are now becoming available. Ex posure 
to ultrafine particles present in air pollution exacerbate pre-existing asthma and 
COPD, increases inflammation and airway acidification. Experimental animal 
data show that intrapulmonary exposure to ENMs can aggravate pulmonary 
inflammation and airway hyper-reactivity. The rationale for the link between 
ENM exposure and asthma or COPD exacerbation can be made given that 
acute inflammatory events (e.g. infectious diseases) are known triggers of  both 
asthma and COPD exacerbation and ENMs are known to be able to induce 
acute pulmonary inflammation. Epidemiological data link acute exposure to 
pollution-related UFP to sudden cardiac death, which is in part due to acute 
ischemic events. An increased mortality due to ischemic heart disease (IHD) has 
been reported in a cohort of  workers exposed to metalworking fluids containing 
a substantial amount of  incidental ENMs. Rapid thrombus formation has been 
reported in experimental animals after exposure to carbon nanotubes, and it 
has been also shown that inhalation of  nano-TiO2 decreases the ability of  arte-
rioles to respond normally to vasodilators. An important point to be taken into 
con sideration is that both the surface chemistry of  ENMs and the physiological 
state of  the tissue are crucial for the behaviour of  ENMs in the case of  ischemic 
damage. Two events may lead to IHD in patients with CAD and both of  them 
may be triggered by ENMs. Also the permeability of  the gut epithelium is in-
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creased in typical welfare diseases like obesitas and diabetes affecting increas-
ingly larger segments of  the population.
Susceptible populations - Epidemiological studies also indicate that exposure 
to environmental air pollutants is associated with adverse pregnancy outcomes, 
such as premature birth, reduced birth weight, small size for gestational age, 
and stillbirth. A high rate of  severe malformations and abortions has been re-
ported in mice after in utero exposure to low dose carbon nanotubes; severe 
malformations have also been reported after exposure to fullerene, but at very 
high doses. Milder effects on development were seen after exposure to silica and 
TiO2 ENMs. TiO2 ENMs have been shown to affect adversely the fertility and 
cerebral functions of  offspring, whereas carbon black exposure was associated 
with genetic lesions in the liver of  offspring. The reported experimental studies 
show that ENMs administered through several routes may reach both the pla-
centa and the embryo, causing damage in both targets. In addition, they may be 
retained in the embryo, causing post-natal defects. 
Environmental fate
It is expected that many ENMs will ultimately reach the wastewater. In this con-
text silver nanoparticles are of  interest, because they are used in many products 
of  daily use, such as textiles, due to their antimicrobial activity. Furthermore, 
from silver nanowashing machines significant amounts of  silver are released 
into the environment and finally reach the effluent of  wastewater treatment 
plants (Farkas et al., 2011). Due to its physico-chemical properties, nanosilver is 
sorbed to sewage sludge. After degradation of  the sewage sludge organic matter 
the metal will become bioavailable with a negative impact on the soil micro-
flora. This result is not necessarily expected from the experiments on microbial 
degradation activity in wastewater treatment plants. These assumptions are sup-
ported by the findings of  Oleszczuk et al. (2011) showing that the aging period 
of  sewage sludge/CNT-mixtures affected root growth inhibition. 
ENMs with a low sorption capacity may leave the wastewater treatment 
plant with the effluent resulting in a contamination of  complex environmental 
compartments such as sediment and surface waters. Thus, sediment-dwelling 
organisms will be at particular risk to sediment-associated NMs which calls for a 
focus on research efforts to sediment/food exposure and subsequent accumula-
tion and toxicity. However, thus far most environmental studies have focused on 
water exposures and a limited number of  studies (e.g., from NanoReTox) have 
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included more complex matrices like soil, sediment and diet. Figure 4.12. shows 
daphnids born in clean water and in water containing fullerenes.
Biodegradation is one of  the possible environmental fate pathways for cer-
tain types of  ENMs. Specifically, any type of  ENM containing organic carbon, 
such as carbon nanotubes, may in principle be biodegraded. The possibility of  
biodegrading ENMs also suggests the potential of  induced biodegradation as a 
means of  remediating ENM-contaminated environments.
At present, there is some understanding of  the behaviour of  colloids in 
the environment, but the details of  how ENM behaviour relates to colloidal 
be haviour, and how they interact with organisms are unclear. Consequently, 
validated bioassays, hazard assessment tools, and especially predictive models, 
remain to be developed and tested for ENMs. It is critical that underpinning 
research be conducted that explores the fundamental principles that define the 
consequences of  the interactions of  ENMs with biota. These interactions go-
vern bioavailability, internal deposition, deleterious effects, and bioaccumula-
tion. In addition, long-term effects of  ENMs on these compartments are largely 
unknown. 
Beyond the State of  the Art
Mechanistic processes: nanomaterial biokinetics and translocation
At the end of  the time-horizon of  this document, kinetics testing has been 
integrated to a large extent in repeated dose toxicity assessment. Qualitative 
(charac teristics) and quantitative (concentration) measurements of  ENMs along 
Figure 4.12.
Two Daphnia magna aged 1-2 days. Upper 
daphnid was born in fullerene exposure. 
Fullerenes (black) fill the gut and have stuck 
onto antennas, carapace, and thoragic legs of 
the organism. Lower daphnid was born in the 
culture medium. The gut is filled with green 
algae, and antennas and carapace are clean. 
(Photo by Kukka Pakarinen, UEF)
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the exposure pathway are in common use during repeated dose toxicity assess-
ment. Standard integrated testing has been achieved by the widespread avail-
ability of  nanomaterial-specific analytical equipment as well as expertise by 
toxicity assessment facilities. Total element analytical equipment such as MS 
is replaced or at least complemented by specific nanomaterial analytical equip-
ment such as EM by 2020. Analytical capacity for qualitative and quantitative 
characterisation of  corona constitution, agglomeration and aggregation status 
has increased dramatically. 
Sampling and subsequent qualitative and quantitative analysis of  ENMs is 
common practice while performing in vitro and in vivo human and environmental 
toxicity experiments. This has enabled standard establishment of  kinetics in ex-
posure studies as well as toxicity testing. Toxicity testing provides highly relevant 
data for various necessary extrapolations in risk assessment, such as; in vitro-in 
vivo, interspecies, high-to-low dose, and route-to-route extrapolations. Adequate 
information on biokinetics will allow various hitherto hampered extrapolations 
in risk assessment and change default factor extrapolation to data-informed ex-
trapolations. By this development, important hypotheses have been generated 
as to the mechanisms of  and the physicochemical properties that drive the (pre)
biokinetics of  groups of  ENMs. This will facilitate ENM grouping and read-
across within these groups by 2020 and waive kinetics and effects test for every 
single ENM in every possible matrix over time.
In 2020, the understanding of  the mechanisms and significance of  absorp-
tion, including de-agglomeration, of  ENMs via different routes into and distri-
bution and translocation throughout the body as well as cell type-specific uptake, 
breakdown and excretion will have markedly improved, and the signifi cance 
of  biological barriers will be better understood, allowing for a more reliable 
assessment of  the possible health risks posed by ENMs to human health and 
environmental species. Kinetic data and kinetic modelling should become tools 
to evaluate whether an ENM behaves differently from another ENM or from 
the bulk material in order to assess if  ENMs can be grouped for risk assessment 
purposes. Based on the mechanistic understanding, it may be predicted in which 
cases overload of  various cell types will occur.
Mechanisms of  action leading to toxicity
By 2020, the main toxic mechanisms of  various types of  ENMs are understood 
and sound criteria to classify ENMs for toxicity exist. Adequate comparative 
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data, on identical ENMs, from relevant genotoxicity and immunotoxicity assays 
in vitro and in vivo will have been gathered together with omics information from 
the same experiments, to judge which in vitro approaches best reflect in vivo tox-
icity and to see if  other biomarkers or a systems biological approach could be 
applied to distinguish toxic ENMs. It will be clear which groups of  ENPs can 
be classified solely on the basis of  their physicochemical characteristics, which 
can exclusively be assessed by in vitro assays and which still require in vivo studies. 
Knowledge-based guidelines will exist on the correct way of  conducting high-
through-put in vitro toxicity assays with ENMs - not only for genotoxicity but 
also for. It will be possible to distinguish true genotoxic and immunotoxic effects 
that are predictive of  an in vivo response. Validated in vitro methods will exist to 
identify carcinogenic ENMs with a non-genotoxic mode of  action; for instance 
information on the ability of  in vitro cell transformation assays to reveal carcino-
genic ENMs will be available. Reliable and affordable techniques to determine 
intra-cellular ENM doses will have been validated and are routinely used in the 
in vitro tests.
The in vivo genotoxic and immunotoxic mechanisms of  ENMs will be 
understood, e.g., with respect to the possible role of  immunotoxicity in deter-
mining secondary genotoxicity. Guidelines will have been defined to conduct in 
vivo geno toxicity assays on target tissues of  carcinogenesis, using appropriate ex-
posure techniques and relevant endpoints. It will be known, if  acute or sub-acute 
exposures should be used in short-term identification of  carcinogenic ENMs 
with a genotoxic mode of  action. A representative set of  data will be avail-
able on the carcinogenicity of  different types of  ENMs, so that physicochemical 
characteristics, information on genotoxicity, and other relevant biomarkers can 
be used to classify ENMs for carcinogenicity. Alternative short-term in vivo test 
systems or biomarkers will have been developed to identify carcinogenic ENMs 
primarily acting via non-genotoxic mechanisms. 
Special considerations in regards to susceptible  
populations and vulnerable conditions
Cardiovascular diseases - In individuals with existing cardiovascular diseases (such 
as atherosclerosis patients) in vitro experiments generally show an activation of  
key cells, such as platelets and leukocytes, and it has been shown that CNTs 
can promote activation of  platelets collected from normal subjects. Currently, 
it is not known whether the same effect also concerns platelets and leukocytes 
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taken from patients with overt atherosclerosis. In 2020, this information will be 
available. Also, data on the possibility of  an accelerated transition to atheroscle-
rosis of  disorders such as hypertension and diabetes that are known to increase 
the risk of  this complication will be increased. Appropriate animal studies are 
advanced. The use of  the Badimon chamber or similar ex vivo models to screen 
different ENMs for their potential to induce thrombosis in the presence of  CAD 
is common.
Allergic diseases and asthma - Although considerable amount of  information 
exits in the effects of  ambient air particles on asthma symptoms and on allergic 
rhinitis only a little is known about the effects of  ENM on these respiratory dis-
eases. In 2020 knowledge about the induction of  asthma and allergies by ENM 
is substantially increased. Effects of  ENM exposure in asthmatic patients as well 
as in patients with skin allergies (e.g. contact allergies and atopic eczema) are 
investigated in sophisticated experimental in vitro and in vivo models. Some of  
the finding will be selectively validated also in human subjects. Moreover, ENM 
are classified based on their potential abilities to induce or exacerbate different 
types of  diseases (including allergies) using advanced computational models and 
user-friendly web-based interfaces.
Pregnancy- Knowledge of  ENMs’ ability to cross the placenta and reach 
the embryo and the possibility of  late post-natal effects will be increased. As the 
permeability of  human placenta changes during the course of  pregnancy, the 
appropriate experiments on ENMs at different stages during pregnancy will be 
performed. The fact that embryo toxicity may develop even in the absence of  
placental crossing by ENMs, if  they are able to damage the placenta itself, will 
be taken into consideration. The placenta represents the only way by which 
the embryo may obtain oxygen and nourishment and its substantial damage 
unavoid ably will cause embryo injury. Currently available in vitro and ex vivo 
models will be examined for an adequate number of  ENMs and validated in 
parallel in in vivo studies.
Elderly and Babies- In 2020, there are specific studies on possible augmented 
effects of  ENMs in elderly and babies. In elderly subjects the probability of  ath-
erosclerosis, even in the clinically silent stage, is much higher than at  younger ages; 
therefore the probability of  an accelerated course of  the disease may be higher 
in this group. Both in elderly and young the skin is thinner than in healthy adult 
individuals, and the studies showing minimal or no penetration of  ENMs through 
the skin will be re-evaluated in these groups. In general, the immune response and 
defensive capacity is hampered in these two age groups, with immature immune 
system in young and with age-induced de-regulation of  reactivity in the elderly.
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Environmental effects testing
Standardized ecotoxicological tests are suitable for the comparison of  chemicals 
with respect to their ecotoxicity and for a first risk assessment. For refined risk 
assessments tests with more realistic environmental conditions are required. 
Implementation of  standardized ecotoxicological tests for the effects of  
ENMs in the aquatic environment may be problematic as aggregation/agglo-
meration is concentrations dependent such that agglomeration increases with 
increasing concentration in the water/media. Consequently, a 3 dimensional 
exposure scenario will occur resulting in a non monotonic concentration-
response relationship (i.e., decreased toxicity with increasing overall concen-
tration). There exists some information in the literature suggesting that nano-
particle size affects accumulation of  metal NPs even after being mixed into a 
complex compartment such as the sediment. This calls for further studies on the 
fate of  ENMs in sediment, and subsequent consequences for accumulation and 
toxicity. In addition, accumulation appears size-dependent only in invertebrates 
with more complex digestive systems. Since there is evidence for delayed effects 
of  ENMs, future work should consider long-term effects in the aquatic environ-
ment. The research on the terrestrial environment needs to focus on long-term 
effects in realistic environmental concentrations of  ENMs. The present investig-
ations on mainly single species have shown effects in a concentration range 
much above the environmentally realistic level (mg/kg level). 
In general, there is still a need for investigation of  individual species dif-
fering e.g., in feeding mode (filter-feeding vs sediment-ingestion) and digestive 
complexity, but effects on populations, communities and ecosystems should also 
have high priority. Long-term tests at realistic concentrations and microcosm- 
and mesocosm-based test systems may offer environmentally more realistic sce-
narios. This will enable the assessment of  the interaction between different spe-
cies and the relative sensitivities of  organisms and also enhancing the basic for 
selection of  species for further standardized testing.
ENMs will most often reach the terrestrial compartment through appli-
cation of  sewage sludge on agricultural soil or landfills or via deposition from 
the air. ENMs will also reach the aquatic environment via sewage treatment 
plants and end up in the sediment compartment. Passage through a sewage 
system as well as the fate up to soil deposition and after introduction to the 
aquatic environ ment and subsequently in the sediment, will most likely change 
the ENMs significantly. These changes have to be considered and accounted for 
in future research. The influence of  the dosing or mixing of  the ENMs in a test 
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system has to be assessed. This requires an investigation of  medium preparation 
and of  methods for spiking of  test materials and effects of  possible carriers.
Beyond the more traditional endpoint included in e.g. OECD standard 
tests, multiple endpoints have to be investigated. This includes assessment of  
different biomarkers, such as oxidative stress, but also uptake of  ENMs in tissues 
and behaviour of  organisms. Knowledge about the fate of  ENMs in the soil is 
one of  the key topics in the design of  terrestrial effect studies and for the en-
vironmental risk assessment. There is a well-documented need for research on 
the transformation of  ENMs in water, sediment and soil systems. This includes 
agglomeration/aggregation kinetics, sorption and abiotic/biotic changes of  
ENMs in the food, sediment, soils, water and pore water. Reliable methods for 
characterization and quantification of  the ENM before and during the testing 
period are necessary prerequisites for future research.
Conclusions
Mechanistic knowledge should be included in technology development, 
to help the safe design of  new ENMs in a bottom-up approach, and will 
feed directly into the development of  a rational testing approach.
The key factors in developing knowledge and understanding the toxic-
ity of  ENMs are: 
•	 identification	of 	the	main	modes	of 	actions	of 	 
 toxicity for ENMs
•	 understanding	the	transformation	of 	ENMs	during	 
 their life cycle and how this may influence their  
 hazard potential
•	 identification	of 	the	key	physicochemical	 
 determinants that modulate ENM interactions and  
 toxicity in biological systems
By 2020, the following should have been achieved:
Hazard assessment enabling grouping of  ENMs
1) Scientifically sound grouping criteria 
2) Understanding the association between material  
 characteristics and perturbations in cellular events
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3) Guidelines for high-through-put toxicity screening 
4) Utilizing systems biology approaches in the  
 prediction of  ENM safety
Biokinetics including translocation and clearance  
(dissolution and excretion) 
1) biokinetics are much more integrated into toxicity  
 testing 
2) mechanistic knowledge resulting in groups of  ENMs  
 with similar kinetic modes of  action is obtained 
3) the mechanisms of  the bioaccumulative properties  
 of  ENMs are investigated with highest priority by  
 studying terminal whole body half-lives of  various  
 groups of  ENMs 
Susceptible populations and vulnerable conditions
1) Systematic research of  ENM effects on susceptible  
 populations (validated in vivo and ex vivo models  
 for pregnancy, children and elderly people)
2) Systematic research of  the effects of  ENM on  
 individuals with vulnerable conditions (validated  
 in vivo and ex vivo models for diseases e.g.  
 cardiovascular diseases, allergies, diabetes etc)
Environment
1) Fate of  ENMs in complex media such as food,  
 sediment, soil, water and porewater
2) Improved prediction of  the (bio)degradation rate of   
 organic nanomaterials help to describe the long  
 term fate of  ENMs in the environment.
3) Development of  standardized test methods for  
 water (hard, soft, brackish, marine), sediment and soil 
4) Establish relation between physiological factors  
 (feeding mode, digestive complexity) and ENM  
 accumulation and effects.
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2015 2020 2025
Key aspects of hazard assessment
Development of concern-driven testing to include NM type, their interaction 
with the enivornment as well as key transformation processes, combining all 
environmental compartments  link to exposure (fate and behaviour)
Understanding of characteristics -fate - 
effects relationships    link to grouping 
(sameness)
Development of High Thoughput 
Screening (HTS) approaches and 
Toxicogenomics and High Content 
Analysis (HCA) systems
Understanding uptake processes; 
experimental work with well characterised 
NMs and systems (Development of PBK 
models)
Develop-
ment and 
valida-
tion of  of 
QNAR ap-
proaches
Approaches 
to evaluate 
possible 
effects in 
vulnerable 
systems
Set of well 
defined 
laboratoty test 
procedures 
and evaluated 
models for use 
of product cycle 
and hazard 
assessment (for 
human and the 
environment).
Link to regulatory testing
(e.g. OECD work)
5) Effects under more ecologically relevant conditions:  
 effects on populations, communities, and  
 ecosystems e.g., by using long-term effects,  
 mesocosm-based test systems.
6) Further development of  biodegradation research to  
 assess the potential of  plant enzymes as a means of   
 remediating carbon nanotube contamination in the  
 environment.
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4.4 Risk prediction and  
management tools 
As the scientific basis of  risk assessment (RA) for ENMs suf-
fers from substantial limitations, both communication and 
dialogue are urgently needed with respect to risk manage-
ment (RM) driven desired or approved actions. Databases 
and epidemiological or health studies can be considered as 
enabling ‘tools’, supporting the processes of  RA and RM. 
Traditional risk assessment frameworks follows the  
four-step paradigm: 
1) hazard identification
2) hazard assessment 
3) exposure assessment
4) and risk assessment
Risk Assessment (RA), Risk Management (RM) and Risk Governance 
(RG) are closely related. RA can be considered as the scientific backbone of  
the process of  risk governance, whereas RM represents its subjective political 
part. Clearly, the RG includes the communication and dialogue between stake-
holders and the areas of  knowledge generation (RA) and decisions on actions 
and implementation (RM) (Renn et al., 2005). As the scientific basis of  RA for 
ENMs has substantial limitations, the communication and dialogue are urgently 
needed on RM driven desired or accepted actions. Informatics (data bases) and 
epidemiological or health studies can be considered as enabling ‘tools’, support-
ing the processes of  RA and RM. For example database studies which enable 
predictive hazard modeling, e.g (Q)SAR,PBPK or exposure modeling. 
Epidemiological studies can provide data supporting both hazard and risk 
assessment. Clusters of  a given hazard in an epidemiological study can serve 
hazard identification or hypothesis formulation, and odds ratios or risk ratios 
found in epidemiological studies may serve the evaluation of  the relevance of  
toxicological findings to human health. Furthermore, epidemiological studies 
may serve hazard and risk assessment by identifying unexpected potential bio-
logical adverse effects, or finding vulnerable (sub) populations. 
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With respect to RM, the outcome of  epidemiological studies could be im-
portant to assign or evaluate various threshold limit values such as occupational 
exposure limits (OEL) values in occupational settings for workers, or acceptable 
daily intake (ADI) values for consumers. The association between RA, RM, 
RG and databases and epidemiological studies is illustrated in the modified 
International Risk Governance Council (IRGC) Risk Governance Framework 
(Figure 4.13). 
Figure 4.13. Association between RA, RM, RG and databases and epidemiological 
studies (Modified IRGC Risk Governance Framework, adapted from Renn et al., 2005).
State-of-the-art
Risk assessment (RA) for ENM with respect to the life cycle of  these materials 
is challenging for several reasons. After their production, nanomaterials may be 
transformed, e.g. by agglomeration or de-agglomeration, or by loss, change or 
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development of  coatings, which may have impact on the uptake and bio logical 
effect after uptake. The information about the level of  exposure to ENM is 
fragmented, most of  the studies are rather explorative and the results cannot 
realistically be used for an estimation of  the exposed dose. Predictive exposure 
models are mass-based and this parameter might be less appropriate in cases 
where one wishes to evaluate the risks associated with a nanomaterial. To esti-
mate the impact of  a health risk, one needs to be aware of  the number of  people 
that could be exposed. This number relates very much to the penetration of  
nanomaterial-based products in the value chain and for the time being, accu-
rate information is lacking (Pronk et al., 2011). Clearly, most of  the parameters 
of  the risk assessment process involve uncertainties and this results in high un-
certainties when one tries to estimate the overall outcome of  this process. The 
same issues also apply to environmental risks, where during and after release, 
transformation reactions are even more important in changing the properties of  
the pristine nanomaterials (Gottschalk and Nowack, 2011). The conventional 
RA framework may fail to estimate the risks from ENMs due to over whelming 
methodological limitations and epistemic uncertainties. The present paucity 
of  quantitative nano-EHS data will lead to ambiguous, qualitative risk estima-
tions, based on expert judgments that may fail to be reflected in appropriate 
and timely regulatory decisions. Currently, quantitative risk assessment has been 
translated into operational requirements by using risk ratios, i.e. observed dose 
of  exposure divided by a reference dose or exposure limit. 
To date, for nanomaterials, only a few reference doses or health-based limit 
values have been proposed (Schulte et al., 2010), (NIOSH, 2010; 2013). Alter-
native risk analysis tools and frameworks as well as modifications to existing risk 
assessment approaches have been proposed for nanomaterials. 
To provide the risk assessment process with adequate information 
with respect to the hazard of  ENM, there are several issues that are of  
prime importance:
•	 Development	of 	‘grouping’	strategies	and	nano-QSARs	to	 
 identify high concern ENMs and predict relevant endpoints  
 of  toxicity and ecotoxicity
•	 Development	of 	standard	test	methods	and	validation	of 	 
 relevant in vitro models 
•	 Characterization	of 	the	hazard	in	terms	of 	quantitative	dose- 
 response relationships, relevant for establishing threshold limit values
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•	 Characterization	of 	the	hazard	in	terms	of 	quantitative	 
 time-response relationships, relevant for the development of   
 a reaction
•	 Globally	harmonized	epidemiological	studies	to	validate	 
 biomarkers and to prevent/assess health effects in a longer  
 perspective, and relevant field study approaches to assess  
 potential effects of  ENM at the population level of  different  
 environmental organisms
•	 Extrapolation	from	in vitro to in vivo (animals and man) and  
 vice versa
Currently, there is a paucity of  human exposure data; most workplace 
studies have focused on the emission of  nanoparticles and consequently the po-
tential for exposure rather than on quantitative assessment of  concentration at 
the breathing zone (Figure 4.14.). There have been very few estimates for expo-
sure further down in the life cycle, and since in most cases the ENM are matrix 
embedded, the likelihood of  an exposure is considered to be low. Some tiered 
approach exposure assessment strategies have been developed. However, scien-
tifically sound decision criteria to evaluate the release with respect to potential 
for exposure are lacking. For risk assessment or epidemiological studies, it is not 
clear which expression of  exposure is relevant, in fact it is not even clear what 
metric would be most appropriate for evaluating the amount of  ENM present. 
Figure 4.14.
Exposure assessment during  
liquid flame spray process  
(Photo by Joonas Koivisto, FIOH)
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Figure 4.15.
Black worms in the exposure 
container. As their typical  
behavior the worms have  
burrowed in the sediment and 
protruded their tails from the 
sediment for gas exhange and 
pellet production.  
(Photo by Kukka Pakarinen, UEF)
With regard to the fate and behavior in environmental compartments, it 
has been anticipated that nanomaterials in aquatic systems will tend to agglo-
merate/aggregate and potentially sink, resulting in general low availability, even 
though clearly conflicting results have been recently reported e.g. suggesting 
that sediments are not likely to be the ultimate sink of  ENM in aquatic environ-
ments (Pakarinen et al., 2011;2013) (Figure 4.15.). Some nanomaterials may 
exert detrimental effects on the activated sludge from waste water treatment sys-
tems (WWTS). It is still unclear what are the environmental levels of  exposure; 
some estimates have focused mostly on modeling with little regard for actual 
real-life exposures. 
If  one wishes to conduct a realistic risk assessment of  nanoparticles, it is 
extremely important to identify the physico-chemical properties that predict 
different toxicological outcomes. ENM are complex groups of  materials with 
diverse physicochemical properties, which not only can affect their biological 
activities but also their underlying mechanisms of  action. For the same reason, 
it is as important to identify the behavior of  ENM interacting with biological 
systems. They behave totally different than larger (micron) particles.
A suite of  risk prioritization tools have been developed to indicate the need 
for exposure control and risk management. However, only a few of  the ex posure 
assessment components of  these tools have been calibrated, and none of  them 
have been extensively tested or validated. The hazard component of  these tools 
is mainly based on the interpretation of  toxicological data of  the parent mate-
rial. Uncertainty by virtue of  sufficient data can then be the driver for very 
conservative risk assessment approaches.
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Beyond state-of-the-art
For progress beyond the state of  the art, the conventional Risk Assessment 
framework should be supplemented with non-conventional tools like Weight of  
Evidence (WoE) and Multi Criteria Decision Analysis (MCDA). In addition, a 
holistic (and if  possible a probabilistic) approach should be explored for human 
health risk assessment (HHRA) and freshwater/terrestrial ecotoxicological risk 
assessment (FTERA) by bridging the gaps between the current state of  the art 
and the conventional quantitative risk assessment approaches. This approach 
should involve a material life cycle perspective to enable comparison and aggre-
gation of  the health impact over the material’s life cycle stages. The applicability 
of  a general approach to estimate the human effect factors for both linear and 
non-linear dose response relations for different health endpoints, or alternative 
developed indictors for hazard values, resulting in compatible output values of  
HHRA (e.g. different human health metrics) will need to be explored.
Risk Assessment
Since nanomaterials are extensively modified regarding surface-coating, size, 
shape, agglomeration state etc, it is extremely important to identify the physico-
chemical properties that predict different toxicological outcomes, so that risk 
assessment of  nanoparticles can be made on the basis of  this information and 
using read-across to particles with similar physico-chemical characteristics. 
However, for NM, there is considerable debate surrounding the accuracy of  
reading across from other materials (e.g. the bulk form) and it is considered that 
this is not yet appropriate for NM without further study and validation. ENM 
are complex groups of  materials with diverse physicochemical properties, which 
not only can affect their biological activities but also the underlying mechanisms 
of  action. Using the ‘one size fit all’ approach in testing nanoparticles is there-
fore ignoring the complexity of  the toxicity and mechanism of  these nano-scale 
materials.   
Needs by 2020:
•	 Validated	predictive	hazard/toxicity	assessment	methods	for	 
 nanomaterials based on an understanding of  the biological  
 mechanism-of-action with a clarification of  the association between  
 material characteristics and toxic effects.
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•	 Predictive	assessment	of 	toxic	effects	including	inflammation,	 
 genotoxicity, immunotoxicity, carcinogenicity, cardiovascular toxicity  
 and pulmonary toxicity etc. 
•	 Development	and	validation	of 	high	throughput	screening	approaches	 
 to enable ‘high concern grouping approach’ with risk banding tools to  
 identify potential hot spots for risk and to enable straightforward  
 interpretation.  
•	 Testing	and	calibration	and	further	development	of 	risk	prioritization	 
 (or banding) tools.
•	 Development	of 	a	dermal	risk	prioritization/	banding	tool.
Risk management
Currently, a suite of  risk prioritization/ control banding tools has been deve-
loped to provide non-specialists with tools to decide on the need to manage a 
(potential) risk related to the use of  nanomaterial/products. The (virtual) risk 
bands relate to levels of  exposure control, according the hierarchy of  control. 
However, for most of  the control measures the effectiveness for nano particles 
has not been proven or quantified in practice. 
Needs by 2020:
•	 Quantification	of 	exposure	reduction	effectiveness	of 	general	and	 
 nano-specific control measures and strategies. Studies are warranted to 
 examine the impact of  ‘safety culture’ and human factors on the  
 efficiency of  control strategies.
•	 Calibration	of 	risk/control	banding	tools,	e.g.	by	expert	evaluation.
Risk governance: dialogue, communication, responsibility  
and trust 
To date, risk governance models have been conducted mainly on a ‘macro’ level, 
i.e. at the level of  governments or even multinational bodies (Renn & Roco, 
2006; IRGC, 2005; Roco et al., 2010). At the level of  individual companies 
and organizations, it seems that the current activities that could be considered 
as being related to implementing a governance approach can be characterized 
as both scattered and ‘ad hoc’ (Dijkman & Terwoert, 2011). A comprehensive, 
structured approach appears to be missing in practically all cases, and it seems 
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that individual companies will need guidance in order to improve this situation, 
if  they wish to counteract the potential threats to their business.
As far as communication and dialogue is concerned, many national and 
international initiatives for public dialogues have been started. Nonetheless, the 
involvement of  specific target groups, such as workers, has remained modest. In 
general, it has been assumed that the perception of  risks is influenced by wheth-
er the exposure to the risk is voluntary or involuntary (Sjöberg, 2000;  Senjen & 
Foss Hansen, 2011). Experts and governments often believe that simply provid-
ing sufficient information will convince people that the benefits of  a new tech-
nology outweigh its risks. This opinion assumes that the experts know the true 
risk, whereas often they do not. Few attempts have been made to involve workers 
in surveys of  risk perceptions on nanotechnology. The attempts that have been 
undertaken have shown very low responses, perhaps due to a lack of  awareness 
and a lack of  perceived urgency (Van Broekhuizen et al., 2011).
Figure 4.16. Risk governance for nano technology: key activities. Adopted from 
International Risk Governance Council, White Paper on Nanotechnology No 2 
(IRGC).
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Current risk assessment and governance frameworks lack the ability to 
incorporate flexibility and learning, and arrangements to facilitate listening 
for early warnings. The same holds true for listening and responding to stake-
holders’ concerns. They seem to overemphasize the role of  technical experts 
and hence to disenfranchise the general public or workers, people who ought 
to be involved and have a voice in risk assessment and an input into risk man-
agement (Senjen & Foss Hansen, 2011). It is necessary to look at risk and risk 
assessment for nanotechnology in a much wider sense. Non-technical issues, 
such as monitoring stakeholders’ concerns, risk communication, involvement 
of  and dialogue with stakeholders, making arrangements for the distribution of  
responsibilities and recording early warnings all have a role to play. Only if  these 
aspects are regarded, the threats and barriers described may become mitigated. 
However, there is a major lack of  practical guidance available for companies 
and other organisations on how to arrange proper governance of  the uncertain 
risks associated with nanotechnologies, dealing with the non-technical aspects 
of  risk management in addition to the technical aspects.
What appears to be needed is evidence-based, practicable, yet compre-
hensive guidance for companies and organisations, on the following aspects:
1) ‘Concern assessment’ - guidance on identifying stakeholders, their  
 concerns, risk perceptions, norms, values and interests and arranging a 
 dialogue on these issues.
2) ‘Concern management’ - guidance on channeling concerns raised  
 during stakeholder dialogue on how to strive for acceptance of   
 responsibilities, how to mitigate conflicts of  interest and on risk  
 communication strategies.
Human field studies and epidemiology 
Epidemiological studies are a key tool for assessing whether exposed popu lations 
are safe at given levels, to evaluate the relevance of  toxicological findings to 
human health and to identify potential biological effects that had not been pre-
dicted on the basis of  toxicological tests. 
Workers are likely to have earlier and higher exposures to ENMs than the 
general population, thus workers are a good target in which to conduct the first 
epidemiological studies. 
It is recognized that conducting epidemiologic studies for ENMs is chal-
lenging for several reasons, such as the heterogeneity of  particles and their 
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poten tial health effects, factors related to the assessment of  exposure, the need 
to identify a population of  workers with long-term exposure to ENMs espe-
cially those of  appropriate size (Trout & Schulte, 2010). When dealing with new 
and emerging technologies such as nanotechnologies, it is not unreasonable to 
assume that epidemiological studies will also be needed in the future.
A major challenge for setting up human field studies is the identification of  
a sufficiently large number of  workers with exposure to similar ENMs. More-
over, nanoparticles a likely to become more and more sophisticated because 
of  intentional manipulation of  the material at the nanoscale level (Maynard et 
al., 2011). Failure to account for particle heterogeneity can lead to a misclassi-
fication of  the exposure. A key requirement for all epidemiological studies is 
good quality exposure assessment. Ideally, quantitative exposure assessment 
should provide sufficient information to estimate the intake or deposited dose of  
the substance under study in the individual workers. 
Identifying health effects from ENM and potential biomarkers 
Since specific health end points of  ENMs are not known yet, studies on the 
chronic effects with adequate latency are probably not feasible in the near fu-
ture. In contrast, initial epidemiological studies should focus on short-term ef-
fects and biomarkers of  early effects in cross sectional and panel studies. Bio-
markers of  effect can be used in health surveillance programs aimed at the early 
diagnosis of  exposure-related or associated diseases, but the application of  effect 
monitoring is most often used to evaluate whether a well-characterized expo-
sure can be associated with a shift in the distribution of  relevant bio chemical or 
functional endpoints indicative of  early changes in the target or critical organs /
tissue. For preventive purpose, biomarkers should not be considered as dia-
gnostic tests but rather as indicators reflecting early modifications preceding 
progressive structural or functional damage at the molecular, cellular, and tissue 
level, i.e. changes possibly leading to adverse effects but completely reversible 
with the removal from the exposure. Therefore, there is a need for the selection 
of  candidate biomarkers of  early effects which can be used in human studies.
The relatively small current workforces in individual countries will proba-
bly necessitate the pooling of  international cohorts. A targeted European multi-
center study recruiting occupationally exposed workers and involving companies 
manufacturing and using ENM seems – at the moment – to be the most suitable 
way to attain a population with adequate size, homogeneous exposure type and 
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sufficient contrasts in exposure levels to permit exposure-effect relationships. 
To provide a coherent approach and make future epidemiological research a 
reality, a well-defined framework is needed for the careful choice of  materi-
als, exposure characterization, identification of  study populations, definition of  
health end-points, and evaluation of  the appropriateness of  study designs, data 
collection and analysis, and interpretation of  the results (Riediker et al., 2012). 
While future studies should address the specificity of  biomarkers, the pri-
ority is to evaluate whether quantitative changes in the already validated bio-
markers occur in groups of  exposed workers, and not to assess disease end-
points. While sensitivity is fundamental for preventive purposes, specificity is 
usually more important for diagnostic purposes. Since nano-specific biomarkers 
are difficult to demonstrate, practical considerations suggest that it would be 
 advisable to focus on the sensitivity to assess the causality of  exposure condi-
tions/scenarios and association with hazards.
Databases
Databases are crucial tools for storing and linking generated data. In nanosafety 
research, databases are used to link measurements of  nanoparticle’s character-
istics and their metrology protocols with the toxicology data. 
To perform quality assessments on the available data, it is preferable to 
collect and store the data in a structured way specifically designed for risk assess-
ment purposes. This approach can also provide guidance for future experi-
mental setup to facilitate comparability of  studies. The ultimate validation of  
data storage lies in the use of  the data to predict behavior of  ENMs, to assist in 
designing intelligent testing strategies, to provide advice to policy makers and 
regulators and to convince manufacturers to design low toxicity applications.
Currently, most FP7 projects in the NMP program have their own data-
bases. For risk assessment (RA) purposes an overview of  the current scientific 
status on all individual steps in the RA is essential. To facilitate such an overview 
there is a need for harmonization of  data storage in projects. The prospect of  
harmonization of  all databases generated by the FP7 NMP program (and other 
national projects in Europe and USA/Japan) is expected to facilitate a future 
inclusion of  all information and the possibility of  performing a meta-analysis on 
this comprehensible dataset to identify the Structure-Activity relationship and 
therefore move nearer to the vision of  ‘Safety-by-Design’ for nanotechnology.
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Due to the exponential growth of  the nanotechnology literature, including 
the reports concerned about nanosafety, there is an on-going need to obtain an 
integrated quantitative perspective on the knowledge state of  this literature. The 
most natural way to achieve this goal is to be able to automatically extract infor-
mation from the published, peer-refereed scientific literature. Thus the creation 
a database in the field of  nanosafety will involve collecting data from public do-
main sources and from internal ones (EU consortia) for automatic data mining 
and for allowing advanced search. This is the next step toward automating the 
relations between the nano data and toxicity. If  one wishes to achieve this goal, 
it will be necessary to develop an ontology, which should explicitly represent the 
knowledge in the scientific domain of  nanosafety.
Conclusions
To support the guidance in areas like risk management and de-
cision-making, additional research will be needed in the fields of  risk 
perception among many different targeted stakeholder groups and the 
main factors causing concerns. 
The main achievement will be the development of  integrated risk 
assessment and decision frameworks to enable forecasting the potential 
impacts of  nanomaterials on human health and the environment and 
adequate risk management; this undertaking may require the develop-
ment of  novel risk assessment strategies that will replace the current 
one, being equally reliable, affordable but faster.  
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2015 2020 2025
Studies on 
effectiveness of 
stakeholder dialogue & 
risk communication
Guidance on risk evaluation
Guidance on CONCERN Assessment
Release /fate exposure models
Prediction of hazard evaluation
Quantification of 
exposure reduction 
effectiveness 
Development and validation high throughput 
screenings approaches to enable “high concern 
grouping” approach in risk banding tools to 
identify potential hot spots for  risk
Improved risk communication and 
tools for risk assessment
These achievements will be based on the following ‘build-
ing blocks’: Prediction of  toxicity on the basis of  physi-
cal/chemical properties of  nanomaterials
•	 Models	for	release,	fate	and	exposure	to	 
 nanomaterials
•	 Integration	of 	life	cycle	considerations	into	risk	 
 assessment
•	 Integration	of 	risk	assessment	into	decision	 
 framework of  risk management
•	 Integration	of 	safe-by-design,	closed	production- 
 to-product and green nanotechnotology approaches  
 into the development stages of  new nanomaterials  
 and their applications
Key aspects of risk assessment and management
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5 Research  
Priorities and  
Roadmap 
Required research priorities to reach  
the goals of the roadmap 
The roadmap for nanosafety research 2015-2025 aims to provide an under-
standing of  where the European nanosafety research should be during the time 
frame 2015-2025. The roadmap also identifies the main achievements of  this 
research which should have been reached during this time frame. This time 
horizon has been chosen based on the timing of  the “Horizon 2020” Frame-
work Programme for Innovation and Research; its first calls will open in 2014. 
The execution of  the research of  the first projects of  the programme will start 
in 2015, and the implementation of  their results around 2019-2020. The last 
calls of  this programme will close in 2020 and the final projects will end around 
2025, and the implementation of  the results in full will start after that time 
point. The chosen window not only covers the time frame of  the “Horizon 
2020” funding Programme, but also takes into account the challenges associ-
ated with the prediction of  expected results and research that will be required 
to reach the set goals.  
The milestones in the roadmap indicate the expected achievements of  
nano safety research at different time points, with 5-year intervals, during 2013-
2025. These milestones are presented for the four thematic priority areas sepa-
rately in four tables below, and have been described in detail in the previous 
chapters. In each table, the research priorities have been grouped under larger 
heading, topics, that cover several defined research priorities. 
Within the topics the subheadings then provide the separate research pri-
orities in the four thematic areas separately. All the topic areas and research pri-
orities have been drawn from the topic areas and research priorities presented 
in the four chapters presented above 1) material characterization; 2) Exposure 
assessment and release during the life cycle; 3) Hazards, biokinetics, and vulner-
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able populations; and 4) Risk prediction tools.
This roadmap on nanosafety research provides the vision of  the Nano-
Safety Cluster on strategic and emerging issues in the nanosafety research area. 
These are the topics in which progress will be crucial in the discovery of  novel 
engineered nanomaterials and their nanotechnology applications. The roadmap 
is intended to guide the European Commission and also the national funding 
organizations when making strategic funding decisions on nanosafety research 
in the future.
The challenges in the prediction of  the ability to achieve set research goals 
have been considered in compiling this document. It will be imperative to con-
tinuously follow the progress of  the research and its impact on the emerging 
innovations as they are translated from laboratory to industry. This continu-
ous assessment of  the results of  the priority research areas will be compared 
with their impact on industrial innovations and breakthroughs in nanosafety 
research. This document also emphasizes the potential of  nanosafety research 
to nurture and support useful innovations that could lead progress in the under-
standing of  key-features of  safety and hazard mechanism of  ENM. However, an 
equally important aspect is their ability to provide opportunities for creation of  
new types of  consultative and service activities; many of  these could expand and 
soon become a significant commercial activity similarly as ENM and nanotech-
nologies become incorporated into more and more business sectors.
In the following section, the milestones for 2014, 2020, and 2025, related, 
topics, and related research priorities under different topic separately are pre-
sented in a set of  four tables.
Table 5.1. presents the roadmap, i.e. milestones 2015-2025, topics and re-
search priorities in different topics at different time points under the thematic 
chapter on material characterization and grouping.
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Milestone Topic By 2015 By 2020 By 2025
Material
classification
Definition Classification 
systems in 
place
Naming  
structure
Ontologies in 
place
Characteriza­
tion of ENM 
in complex 
matrices
Robust me-
thods for ENM 
size determina-
tion
Methods for 
ENM surface 
characteriza-
tion
Methods for 
multicomposite 
ENM characte-
riazation
Test& refe­
rence ENMs
Systematic sets 
of test ENMs
ENMs certified 
in reference 
biofluids
Full datasets 
on test ENMs
Validation Validated  
labelled versions 
of test ENMs
Validation of 
key metrics for 
impact
Correlation of 
uptake, form 
and impacts
Measurement 
principles
Versatile  
methods
Versatile refe-
rence methods 
available.
Bio-nano-
interactions
Biomolecules 
for uptake, 
transport etc.
Reference bio-
interactions
NM impacts 
on protein 
function
Reference bio-
interactions
NM proper-
ties leading 
to signalling 
disfunction
ENM  
engineering
Safety by  
design  
concepts
Safe design of 
new ENM in 
a bottom-up 
approach
ENM metrics 
for hazard 
assessment
Key descriptors Non-sperical 
descriptors 
defined
Dose metrics Effect of poly-
dispersity in 
physico-chemi-
cal properties
Table 5.1. Nanomaterial identification and classification
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Table 5.2. introduces the roadmap of  the Thematic chapter on Hazard 
mechanisms, biokinetics and toxicity testing, i.e. the roadmap for 2015-2025, 
the topics revealing several associated research priorities under them, and then 
the actual research priorities for different time-frame separately.
Milestone Topic By 2015 By 2020 By 2025
Biokinetics  
and  
trans location
Prerequisites 
for research on 
ENM kinetics
Nanomaterial-
specific analyti-
cal equipment 
available
Biokinetics 
integrated into 
toxicological 
testing
Hazard  
assessment
New app­
roaches for 
ENM hazard 
assessment
Developing 
systems biology 
approaches 
using omics 
technologies
Development 
of appropriate 
QSAR models
A computatio-
nal tool that 
can assess in 
the predicting 
of ENM safety
Vulnerable 
conditions 
ENM and 
susceptible 
populations 
Systematic re-
search of ENM 
with known 
disorders
Validated in 
vitro models 
of appropriate 
ENM
Validated in 
vivo and ex 
vivo models 
for different 
diseases
Science-based 
regulatory 
approaches
Choice of test 
methods
Improved 
strategies for 
testing
Intelligent te-
sting strategies 
available
Regulation
Table 5.2. Hazard
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Table 5.3. Exposure and transformation
Table 5.3. depicts the roadmap related to the Thematic Chapter on ex-
posure and transformation of  engineered nanomaterials, and presents the dif-
ferent topics areas covering a range of  specific priorities which make the more 
detailed list of  the priorities in this thematic area during 2015-2025.
Milestone Topic By 2015 By 2020 By 2025
Release and 
exposure 
Mechanistic 
understanding
Process know-
ledge to allow 
the set-up of 
realistic labo-
ratory simula-
tion
Database on 
emission  
(per time) and 
release  
(per material 
unit) factors
Process  
dependent 
transformation
Transform­
ation, mobility/
transport
Gain know-
ledge on 
environmental 
mobility and 
transformation 
for computer 
simulation
Under standing 
effects of 
 ageing on 
nano-objects
Exposure  
scenarios
Workplace, 
consumer and 
environmental 
exposure
Compre-
hensive, 
harmonized 
exposure  
inventories
Exposure regi-
stries developed
Exposure mo-
dels available
Evaluation of 
exposure sce-
nario models
Exposure data 
and models 
evaluated
Models avai-
lable for use of 
product cycle 
and exposure 
assessment
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Table 5.4. introduces the Thematic Chapter on Risk prediction and 
manage ment tools, and the relevant milestones to be achieved during 2015-
2025, the wider topic areas under this thematic area, and the specific research 
priorities at different time points during 2015-2025.
Milestone Topic By 2015 By 2020 By 2025
Risk assess-
ment
Pro­active risk 
management
Risk banding 
tools/ effec-
tive control 
measures deve-
lopment
High through-
put screening 
approaches 
validated
Tools Quantification 
of exposure 
reduction 
effectiveness
Testing and 
development 
of risk prioriti-
zation tools
RA-enabled 
LCA/ inte-
gration in 
decision tools
Health
Health effect Markers for 
short term  
effect identified
Markers for 
long term  
effect identified
Implemen-
tation of the 
markers
Register Health survei-
llance registries 
developed
Exposure 
registries deve-
loped
Using registries 
for research
Implementa-
tion of results 
for regulations
Study design Pilot panel stu-
dies completed
Case-control 
studies comple-
ted
Longitudinal 
studies started
Databases
Infrastructure Federated 
databases 
available
Format & data 
quality stan-
dards set
IT procedures 
for automatic 
uploading
Ontologies Ontologies in 
place
Automatisati-
on of ontolo-
gies
Table 5.4. The risk prediction and management tools
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Milestone Topic By 2015 By 2020 By 2025
Risk manage-
ment
Risk perception 
and guidance
Development 
of risk com-
munication 
strategies
Guidance on 
stakeholder 
concern assess-
ment
Guidance on 
risk evaluation
Prevention 
through design 
approach
Integration of 
safe-by-design 
approaches 
into the 
development 
stages of new 
nanomaterials 
and their appli-
cations
Table 5.4. The risk prediction and management tools (continued)
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Time Material Exposure Hazard Risk
2015
Reference 
methods and 
nano-bio - 
i nteractions
Laboratory 
and computer 
simulations
Systems bio-
logy app-
roaches 
available for 
hazard  
research
Improved risk 
communication 
and tools for 
risk assessment
2020
Data sets on 
reference ENM
Database on 
release
Understanding 
the association 
between ma-
terial charac-
teristics and 
hazard
Models and 
standars  
available
2025
Key metrics for 
harmful impact
Laboratory 
tests and  
models  
available for 
exposure  
assessment
A tool for  
safety  
assessment
A tool for the 
integration of 
safety by de-
sign strategies
Quidance, 
tools, and 
auto matisation
Table 5.5. Summary of thematic roadmap and research priorities
Table 5.5. summarizes at a more general level the main milestones for 
dif ferent thematic areas are presented in parallel to allow a general level com-
parison of  the main milestones in these thematic areas, and identification of  
their interrelationships so that they become apparent for the reader, and allow 
him/her to obtain a more general understanding of  the strategic goals of  the 
research priorities proposed in this document.
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We have listed some practical steps to achieve the goals of  this roadmap 
and research priorities on which the roadmap is built:
1 Understanding the properties of  both nanomaterials and cells or  
 organisms, driving the nano-bio interactions.
2 Generate the consciousness and the tools to develop the concept of   
 “safe by design” to be applied in the generation of  new materials and  
 devices targeting both industry and scientific world.
3 Technical development to allow more accurate measurements of   
 nanoparticles under realistic exposure condition, in situ in media like  
 soil, consumer products and food.
4 Develop guidelines on how to determine a nanomaterial including  
 easy to use instruments and agreed measurement protocols. Develop  
 agreed descriptors for complex non-spherical structures. 
5 Develop instruments to separate engineered from background  
 nanomaterials.
6 Develop dose-response relationships for the identified relevant  
 descriptors / parameters.
7 Master the nanosafety issues of  the 1st generation materials.
8 Tackle the issues associated with the second and third generation of   
 nanomaterials and complex mixtures entailing nanomaterials. Stability 
 and degradability as well as monitoring tools must be established.
9 Develop the tools for proper risk assessment on the above mentioned  
 issues, specially the Life Cycle analysis, where the nanosafety issues of   
 nanomaterials are considered from synthesis and fabrication to their 
 end of  life.
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of the roadmap 
Within the last 10-15 years a number of  novel basic methods to explore ENM-
induced environmental health and safety (EHS) effects have been developed and 
validated. The implementation strategy proposed here is based on this existing 
knowledge. To facilitate and to enhance the advancement of  nanotechnology, 
a successful implementation of  a comprehensive and implementable scientific 
research agenda is of  utmost importance.
The most important key for a successful implementation is 
the excellence of  the research proposed aimed at meeting well 
identified and justified priorities of  the Strategic Research Agenda 
(SRA). The SRA shall be realistic in terms of  goals and contents. 
Additional key elements of  a successful implementation of  such 
SRA for nanosafety research have been summarised in the key 
topics identified in the  report of  the National Research Council 
(NRC 2012; http://www.nap.edu/catalog/). 
 - Key audiences for implementing the strategy
 - Infrastructure for implementation and accountability
 - Evaluation of  research progress and revision of  the strategy
Resources to conduct research and suitability of  the 
SRA to be implementable within the framework of  
horizon
A successful implementation of  the SRA on nanosafety is based on the full inte-
gration of  all stakeholders in deciding the priorities to be pursued in the research 
agenda, in the transfer of  research results into applications and safety standards 
and in the evaluation of  the progress achieved based on the goals of  the SRA. 
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This integration requires one or more overarching bodies to facilitate the 
exchange of  information, discussion and decision making. Stakeholders to be 
involved in these decision making bodies are small-to-medium-sized enter prises, 
industry in general, political decision makers, regulators, occupational and  other 
hygienists, safety personnel and the scientific community. 
Some of  these stakeholders are organised in larger organisations working 
either on a European or a global scale such as European Chemicals Agency 
(ECHA), European Food Safety Authority (EFSA), OECD, ISO, CEN, WHO, 
NGO’s. These organizations need to become directly committed and included 
in the implementation of  the SRA to avoid duplication of  research, as well as 
providing valuable input in setting priorities and ensuring optimal and appro-
priate application of  the fruits of  the research efforts.
Infrastructure for implementation and  
accountability 
It is quite clear that the implementation of  the SRA it is crucial demands an 
effective infrastructure in order to ensure that the proposed milestones are 
achieved on time and on budget. Some initiatives to support the establishment 
such infrastructures already exist. These include the NanoSafety Cluster and 
NANOfuture. However, overarching platforms for exchange information be-
tween industry, decision makers, regulators, academic community and politi-
cians are still lacking. Not all stakeholders and groups of  stakeholders are aware 
of  the nanosafety research needs and progress being made in this area. To en-
able the accountability of  such platforms, it must be a part of  the bodies/organ-
izations executing the SRA. The different dimensions of  accountability which 
need to be managed are summarised in the report of  NRC (2012):
•	 Ensuring	and	assigning	ownership	of 	the	overall	strategy.
•	 Establishing	appropriate	means	of 	governance	among	parties	 
 implementing the strategy (−› an overarching body, exchange platform  
 integrating all stakeholder interests has to be formed). 
•	 The	above	point	can	be	related	to	the	proposal	made	in	the	chapter	on	 
 infrastructures required to support nanosafety research, notably the  
 establishment of  a virtual European Nanosafety Research Centre with  
 competence entry criteria with one of  the parties of  this network  
 coordinating this activity; the centre’s activities should be governed  
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 by the representatives from all of  the participating organizations.
•	 Establishing	and	applying	mechanisms	for	accomplishing	 
 exploratory, translational, and targeted research in the context of   
 the strategy, including an appropriate balance between government  
 and private-sector funding and facilitating needed or desired  
 interdisciplinary research. Such activities could be  
 coordi nated by the above mentioned European Virtual Nanosafety  
 Research Centre proposed in the chapter on infrastructure.
•	 Assigning	responsibility	for	executing	elements	of 	the	strategy	 
 (e.g. SRA executed by members of  the NSC). Implementation of   
 the SRA could be supported by the Virtual European Nanosafety  
 Research Centre described above together with the NSC with  
 shared responsibilities.
•	 Ensuring	that	stakeholders	are	involved	in	the	activities	of 	SRA	 
 and that they have substantial input into formulating and reviewing  
 these activities. 
•	 Monitoring	of 	progress	of 	the	identified	research	priorities	and	 
 timelines to ensure that the strategy is conducted effectively and  
 efficiently and to ensure that the responsible parties are held  
 accountable for the research progress.
•	 Coordinating	periodic	review	and	revisions	to	the	strategy.
•	 Ensuring	that	sufficient	resources	are	devoted	to	undertaking	the	 
 defined research and to implementing the overall strategy and  
 allocating and managing the resources.
Some of  the above bullet points have been annotated in accordance to a 
system already in operation and which is envisaged to be implemented by the 
NSC in the SRA. Nevertheless, open issues still remain to be solved for a full 
implementation of  the SRA.
Evaluation of  research progress and revision of  the 
strategy 
It is important that an independent research panel e.g. formed by the NanoSafety-
Cluster will review the advances after 2-3 years and will compare the results 
with the research roadmap presented here. This review will then facilitate the 
update and possibly demand some modifications to the research plans and calls. 
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The review has to be discussed in an open platform including all stakeholders. 
Facilitation and funding of  this activity, thus far limited to European research, 
has to be made e.g. in form of  CSAs funded by the EU Commission.
Resources needed to conduct  research and suit-
ability of  the SRA to be implementable within the 
framework of  horizon 2020
The task of  promoting and facilitating the implementation of  the SRA lies with 
the NSC, their working groups and the European research projects. A clear 
commitment to this role of  the NSC, their task and some basic funding will 
be needed to enable the implementation and review of  the progress. Ensuring 
a stable structure such as the earlier mentioned Virtual European Nanosafety 
 Research Centre, a network of  dedicated nanosafety research organizations, 
would add stability to these undertakings.
Different types of  research within the frame of  the 
Strategic Research Agenda for Nanosafety Research 
20145-2025
The development of  research within the framework of  Horizon 2020 can be 
generally divided into Breakthrough Innovation Research, Research in Support 
of  Regulation, and Research in Support of  the Market. This also applies to the 
environmental, health and safety (EHS) issues for nanotechnologies, nanomate-
rials and products based on nanomaterials. It is also important to differentiate 
those EHS tools which are developed and applicable independent of  a specific 
product or production/processing process and those which are specifically de-
veloped or adapted to specific needs.
Under the heading breakthrough innovation it is important to extend 
the detailed knowledge we have gained in the recent years to achieve a more 
generalised understanding and better models allowing the prediction of  beha-
viour, exposure, hazard and risk. Tools for driving this innovation are mainly 
the Research Framework Programme and nanosafety funding prorammes in the 
EU Member States for the next years to come. The research is complemented, 
as emphasized above, by specific projects such as the SIINN ERANET II, and 
by national activities of  all EU Member States. Topics to be dealt with in break-
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through innovation include the developments of  equipment and skills necessary 
to be in place, or a stabile network of  organizations, when the new technologies 
reach the market for the specific applications in the different industrial sectors. 
This includes all exposure pathways, such as a workers, consumers or exposure 
via the general environment as well as distinct environmental compartments. 
The main priority themes identified by the NSC SRA include the following 
topics:
a) Material identification and classification
b) Release, exposure and transformation
c) Hazard mechanisms and biokinetics
d) Risk assessment and managements
The above priority themes include several sub-headers which have been 
more specifically explained and prioritized in the corresponding sections.
To be prepared to cope with imminent challenges, the following topics are 
considered by the NSC to be of  importance and need to be dealt with in the 
next few years:
- Building a testing and modelling framework for nanomaterial release  
 potential into the environment
- Modelling environmental transformation, transport and fate of   
 nanomaterials
- Keeping pace with innovations by ensuring their nanosafety;  
 development of  next generation tools for risk governance of  existing  
 and next generation nanomaterials
- High Throughput and Toxicity Pathway approaches as a basis for  
 nanosafety assessment, nanomaterial grouping and read-across strategies
- Establishing advanced and realistic in vitro models for nanomaterial  
 toxicity testing
- Establishing extrapolation from in vitro to in vivo (animals, man) and  
 vice versa
- Utilizing material characterization techniques, and identifying  
 association of  material characteristics or bio-identity with hazardous  
 effects of  ENM with living organisms
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- Utilization of  these research outputs to develop a more affordable,  
 reliable and quicker paradigm for the assessment and management of   
 risks of  ENM
The above topics are major building blocks in creating a more complete 
EHS tool for the sustainable implementation of  nanotechnologies and products. 
The projects are mainly seen as large R&D projects coordinated on European 
scale. The tools developed in the first years will end in model understanding 
and applicable models. The research envisaged for 5-10 years will combine the 
information of  the first years into a set of  modelling and prediction tools needed 
for better risk assessments, risk management and risk governance. NanoEHS 
issues should further be integral parts in R&D activities directed towards new 
nanotechnology related production and products. By cross-linking the general 
development activities closely with technology developments the highest degree of  
information transfer can be achieved. NSC clearly recommends that such cross link-
ing should be an obligatory part in any nationally or internationally funded activity.
Another important building block to facilitate the safe implementation of  
nanotechnologies is research in support of  regulation, and its implemen-
tation is crucial for strongly promoting nanosafety within EU in the near future. 
This research is intended to provide science based regulatory approaches to en-
sure societal acceptance of  nanotechnologies and good understanding between 
authorities, industry and society about risks and their management. 
It is also important to encourage the EU Member State Governments to 
support applied research with a short time horizon that emphasizes the safety of  
products already on the market. This research in support of  the market is 
important in short term. This market-oriented research should include: 
- Support of  “safe markets”: knowledge networks / transfer to industry  
 / epidemiological cohorts / certification / training and skills /  
 benchmarking / best practice 
- Defining and quantifying acceptable risk / Risk communication /  
 Risk management
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Conclusions
This research roadmap aims at providing directions towards a sustain-
able development of  nanotechnology based tools and products. It is 
based on the premises that a level of  generalised knowledge in the diff-
erent areas mentioned and dealt with above shall be achieved within 
the next 10-15 years and this will mean that new materials will be safer 
by design and this philosophy will be beneficial not only for Europe but 
for the whole world.
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